Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

(Amendment No. 1)

 

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2023

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________________ to __________________

 

Commission File Number 001-40615

 

QUANTUM COMPUTING INC.

(Exact name of registrant as specified in its charter)

 

Delaware		82-4533053
(State or other jurisdiction of incorporation or organization)		(I.R.S Employer Identification No.)
5 Marine View Plaza, Suite 214, Hoboken, NJ		07030
(Address of principal executive offices)		(Zip Code)

 

Registrant’s telephone number, including area code [phone]

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $.0001		QUBT		The Nasdaq Stock Market LLC

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐  No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐  No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐  No ☒

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that registrant was required to submit and post such files). Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☒

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐  No ☒.

 

The aggregate market value of the voting and non-voting common stock held by non-affiliates of the registrant as of June 30, 2023 was $46,073,808 based on the closing price of $1.18 per share of Quantum Computing Inc. common stock on the Nasdaq Stock Market LLC on that date.

 

As of September 9, 2024, there were 94,210,626 shares of the registrant’s common stock issued and outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

None

 

 

 

 

 

 

EXPLANATORY NOTE

 

Quantum Computing Inc. (the “Company,” “we,” “us,” “our” and other similar terms) is filing this Amendment No. 1 (this “Amendment”) to its Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on April 1, 2024 (the “Original Form 10-K”), to restate its consolidated financial statements, including the notes thereto, for the years ended December 31, 2023 and 2022, contained in the Original Form 10-K, and to replace the Report of Independent Registered Public Accounting Firm prepared by BF Borgers CPA PC (“BF Borgers”) included in the Original Form 10-K with the Report of Independent Registered Public Accounting Firm from BPM LLP (“BPM”) included in this Amendment, and to make certain other changes as described herein. This Amendment is being filed as a result of the SEC’s order of May 3, 2024 suspending BF Borgers from appearing and practicing as an accountant before the SEC and the Company’s subsequent retention of BPM to replace BF Borgers as its independent registered public accounting firm.

 

The following items have also been amended to reflect the above-referenced amendments:

 

●

Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations;

 

●

Part III, Item 14. Principal Accountant Fees and Services; and

 

●

Part IV, Item 15. Exhibits and Financial Statement Schedules.

 

The Company’s Principal Executive Officer and Principal Financial Officer have provided new certifications dated as of the date of this filing in connection with this Amendment (Exhibits 31.1, 31.2, 32.1 and 32.2).

 

The restated and re-audited consolidated financial statements update and revise items in our consolidated financial statements and footnotes to the consolidated financial statements, including (1) expanding and revising certain disclosures; (2) changing the presentation of certain classifications, including the Series A Preferred Stock dividends and categorization of operating expenses; and (3) adjusting certain errors, omissions or changes in accounting policies, including (i) correcting the purchase accounting relating to the Company’s June 2022 merger with QPhoton, Inc., (ii) adjusting stock-based compensation expenses and related prior period retained earnings to reflect a change in our accounting policy election to account for forfeitures as they occur, (iii) adjusting the valuation of the Series A convertible preferred stock warrants, (iv) correcting the historical and subsequent accounting for debt and equity issuance costs, (v) reserving a collection risk for loans receivable; and (vi) adjusting the recognition period for certain operating expenditures.

 

Except as described above, no other portion of the Original Form 10-K is being amended and this Amendment does not reflect any events occurring after the filing of the Form 10-K.

 

 

 

The net effect of the adjustments on the consolidated statements of operations was to decrease net loss by $2.7 million and $12.6 million and loss per share, basic and diluted, by $0.04 and $0.04 for the years ended December 31, 2023 and 2022, respectively, as set forth below (in thousands, except percentages and per share data).

 

		Year Ended December 31, 2023												Year Ended December 31, 2022
		Amount				Change				% Change				Amount				Change				% Change
Revenue		$	358			$	-			-				$	136			$	-				-
Gross profit			162				-				-				75				-				-
Operating expenses			26,405				(979	)			(4	)%			28,720				(7,934	)			(22	)%
Other income and expense, net			(779	)			(1,730	)			(69	)%			2,667				4,682				232	%
Net loss			(27,022	)			2,709				(9	)%			(25,978	)			12,616				(33	)%
Less: Series A convertible preferred stock dividends			861				861				100	%			889				889				100	%
Net loss available to common stockholders		$	(27,883	)		$	1,848				(6	)%		$	(26,867	)		$	11,727				(30	)%
Loss per share – basic and diluted		$	(0.42	)		$	0.04				11	%		$	(0.73	)		$	0.04				6	%
Weighted average shares used in computing net loss per common share – basic and diluted			66,611				(10,840	)			(14	)%			36,680				(19,283	)			(34	)%

 

The decrease to stockholder’s equity from the adjustments as of December 31, 2023 and 2022 is $4.6 million and $9.8 million, respectively, as set forth below (in thousands, except percentages).

 

		Year Ended December 31, 2023												Year Ended December 31, 2022
		Amount				Change				% Change				Amount				Change				% Change
Current assets
Cash		$	2,059			$	-				-			$	5,308			$	-				-
Other current assets			597				(525	)			(88	)%			142				(279	)			(68	)%
Non-current assets			71,699				(3,848	)			(5	)%			73,061				(10,511	)			(13	)%
Total assets		$	74,355			$	(4,373	)			(6	)%		$	78,511			$	(10,790	)			(12	)%
Current liabilities		$	4,812			$	193				4	%		$	4,593			$	(727	)			(14	)%
Long-term liabilities			840				-				-				8,794				(290	)			(3	)%
Total liabilities			5,652				193				4	%			13,387				(1,017	)			(7	)%
Stockholders’ equity:
Common stock			8				-				-				6				-				-
Additional paid-in capital			200,635				(22,345	)			(10	)%			169,175				(25,704	)			(13	)%
Accumulated deficit			(131,940	)			17,779				(12	)%			(104,057	)			15,931				(13	)%
Total stockholders’ equity			68,703				(4,566	)			(6	)%			65,124				(9,773	)			(13	)%
Total liabilities and stockholders’ equity		$	74,355			$	(4,373	)			(6	)%		$	78,511			$	(10,790	)			(12	)%

 

 

 

 

TABLE OF CONTENTS

 

PART I
ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	1
ITEM 8.	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.	6
ITEM 14.	PRINCIPAL ACCOUNTANT FEES AND SERVICES	7
ITEM 15.	EXHIBITS AND FINANCIAL STATEMENT SCHEDULES	8

 

Introductory Comments

 

Throughout this Annual Report on Form 10-K, the terms “we,” “us,” “our,” “the Company,” “our Company,” “QCi” and “QUBT,” refer to Quantum Computing Inc., a Delaware corporation, and unless the context indicates otherwise, also includes our wholly-owned subsidiaries.

 

i

 

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The discussion and analysis set forth below in this Item 7 has been amended and restated to reflect the restatement of our consolidated financial statements as described in the Explanatory Note and in Note 3 of the Notes to Consolidated Financial Statements included elsewhere in this Amendment.

 

The following discussion and analysis of the results of operations and financial condition for the years ended December 31, 2023 and 2022 should be read in conjunction with our consolidated financial statements and the notes to those consolidated financial statements that are included elsewhere in this Amendment. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. See “Forward-Looking Statements.”

 

Overview

 

QCi is a development stage company with limited operations and revenue. The Company is developing quantum and ancillary non-quantum products for high-performance computing applications based on proprietary photonics technology. QCi’s products are designed to operate at room temperature and low power at an affordable cost in the areas of high-performance computing, sensing and imaging, and quantum cybersecurity. The Company has generated some revenue based on sales of products and related services to date and is expanding its sales and marketing efforts. The Company’s development team includes optical engineers, mathematicians, physicists, and software developers. 

 

Results of Operations

 

The following table summarizes the Company’s consolidated net loss (in thousands, except percentages).

 

		Year Ended December 31,								$				%
		2023				2022				Change				Change
		(Restated) (1)				(Restated) (1)
Revenue:
Total revenue		$	358			$	136			$	222				160	%
Gross profit			162				75				887				116	%
Gross profit margin			45	%			55	%
Operating expenses:
Research and development			8,891				5,216				3,675				70	%
Sales and marketing			1,806				2,092				(286	)			(14	)%
General and administrative			15,708				21,412				(5,704	)			(27	)%
Total operating expenses			26,405				28,720				(2,315	)			(8	)%
Loss from operations			(26,243	)			(28,645	)			(2,402	)			(8	)%
Non-operating income and (expense):
Interest and other income			295				47				248				528	%
Interest expense, net			(1,602	)			(772	)			(830	)			108	%
Change in value of warrant liability			528				3,392				(2,864	)			(84	)%
Total non-operating income (expense)			(779	)			2,667				(3,446	)			(129	)%
Net loss		$	(27,022	)		$	(25,978	)		$	(1,044	)			4	%

 

(1)	As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

 

1

 

 

Revenues

 

The Company’s revenues consist of (in thousands):

 

		Year Ended December 31, 2023								Year Ended December 31, 2022
		Amount				Mix				Amount				Mix				Change
Products		$	5				1	%		$	0				0	%			0	%
Services			353				99	%			136				100	%			160	%
Total		$	358				100	%		$	136				100	%			163	%

 

Revenues for the year ended December 31, 2023, were $358 thousand compared to $136 thousand for the year ended December 31, 2022, an increase of $222 thousand, or 163%. Revenue was derived from sales of hardware products and professional services in 2023, and solely from professional services in 2022. In each year, services were provided to multiple commercial and government customers under multi-month contracts; the year-over-year change was driven by increases in short-term contractual service revenue. In 2023, QCi continued to execute its business strategy to provide quantum-ready solutions for solving real-world problems. While we have made significant progress toward this overarching objective, the generation of revenue from customers has been slow to develop, in part due to the fact that quantum computing is a cutting-edge technology for most potential customers, who are therefore proceeding cautiously with small, exploratory contracts to better understand its applicability to their requirements. Accordingly, the Company has focused on both providing professional services to introduce customers to quantum-based solutions for their operating needs and on customer education to build customer awareness as a means to generate sales. The Company continues to transition towards commercialization, having developed and released multiple products that we are now in the process of marketing. We expect revenues to increase meaningfully in the coming years as we continue to emphasize our hardware capability. 

 

Cost of Revenues

 

Cost of revenues, which consists of labor consumed to fulfill our obligations under contractual service agreements as well as the component parts of finished goods sold, was $196 thousand for the year ended December 31, 2023 compared to $61 thousand for the prior year, an increase of $135 thousand, or 221%. Cost of revenues for each of the years ended December 31, 2023 and 2022 consists primarily of salary expense. The increase for 2023 was predominantly driven by the execution of new government service contracts. Cost of revenue for these services was contractually structured and limited to the direct salaries and actual hours worked to fulfill the work orders. Rates for these services remained materially unchanged year over year, with contract volume being the driver of growth.

 

Gross Margin

 

Gross margin for the year ended December 31, 2023 was $162 thousand compared to $75 thousand for the prior year, an increase of $87 thousand, or 116%. On a percentage basis, gross margin was 45%, a decrease of 10% year-over-year. The change was nearly entirely the result of the shift to contractual service revenue where the cost of goods sold was defined under the terms of our general professional services obligation. Our lack of a scaled and distributed base of revenue generation by product and sales channel can result in large swings in gross margin between reporting periods.

 

2

 

 

Operating Expenses

 

Information about our operating expenses for the years ended December 31, 2023 and 2022 is set forth in the below tables (in thousands, except percentages). Operating expenses for the year ended December 31, 2023 decreased primarily as a result of a decrease in general and administrative expenses, partially offset by an increase in research and development expenses.

 

		Year Ended December 31,								$				%
		2023				2022				Change				Change
Research and development		$	8,891			$	5,216			$	3,675				70	%

 

Research and development expenses consist primarily of employee compensation for employees that primarily engage in research and development efforts and fees for the development of hardware products and supporting software. We focus the bulk of our research and development activities on the continued development of existing products and the development of new offerings for emerging market opportunities.

 

Research and development expenses in 2023 increased compared with 2022 primarily due to higher headcount and related payroll costs and higher stock-based compensation to incentivize and retain key technologists, as well as higher recurring lab equipment and consumables costs.

 

		Year Ended December 31,								$				%
		2023				2022				Change				Change
Sales and marketing		$	1,806			$	2,092			$	(286	)			(14	)%

 

Selling and marketing expenses, which consist primarily of employee compensation as well as customer lead generation activities, tradeshow participation, advertising and other marketing and selling costs, also contributed to the decrease in selling and administrative expenses.

 

Selling and marketing expenses in 2023 decreased compared with 2022 primarily due to lower outsourced professional services costs and gains for forfeited stock-based compensation, offset partially for higher trade show and travel-related costs in 2023.

 

		Year Ended December 31,								$				%
		2023				2022				Change				Change
General and administrative		$	15,708			$	21,412			$	(5,704	)			(27	)%

 

General and administrative expenses consist primarily of compensation expenses for employees performing administrative functions, and professional fees incurred for legal, auditing and other consulting services.

 

General and administrative expenses in 2023 decreased compared with 2022 primarily due to expenses related to the merger with QPhoton in 2022 (the “QPhoton Merger”), including an $8.4 million decrease in stock-based compensation and a $700 thousand decrease in legal fees, offset primarily by increases of $1.3 million for additional months of intangibles amortization, and $1.5 million in salaries and benefits driven by higher headcount, related payroll costs, and severance.

 

Non-operating Income (Expense)

 

The following table summarizes our non-operating income (expense) for the years ended December 31, 2023 and 2022 (in thousands, except percentages).

 

		Year Ended December 31,								$				%
		2023				2022				Change				Change
Interest and other income		$	295			$	47			$	248				528
Interest expense			1,602				772				830				108
Change in value of warrant liability			528				3,392				(2,864	)			(84	)
Other income (expense)		$	(779	)		$	2,667			$	(3,446	)			(129	)

 

The increase in other expense for 2023 compared to 2022 is primarily the result of an increase in interest expense, net, and a decrease in the change in value of the warrant liability during 2023 compared to 2022.

 

Interest expense, net consists of interest on financial liabilities and amortization of debt issuance costs. The increase in interest expense in 2023 compared to 2022 was attributable to borrowings outstanding under our $8.25 million unsecured promissory note that we issued to Streeterville Capital, LLC in September 2022 (the “Streeterville Unsecured Note”). See Note 8, Financial Liabilities, in the accompanying notes to our consolidated financial statements for additional information.

 

Gain on change in value of warrant liability is primarily comprised of mark-to-market adjustments for the QPhoton Warrants, as defined below, which have no carrying value as of December 31, 2023. Future mark-to-market adjustments may result in losses if the Company’s stock price increases above the exercise price of the Underlying Options, as defined below. See Note 12, Stock-based Compensation, for additional information on the QPhoton Warrants.

 

3

 

 

Liquidity and Capital Resources

 

We have incurred net losses and experienced negative cash flows from operations since inception. Through December 31, 2023, the Company has raised $57.4 million through private placements of equity and $12.6 million through private placements of convertible promissory notes and other debt for a total of $70.0 million. The Company has no lines of credit, and $2.1 million in short-term debt obligations outstanding when excluding the remaining debt issuance costs. We expect to incur additional losses and higher operating expenses for the foreseeable future as we continue to invest in research and development and go-to-market programs. We have determined that additional financing will be required to fund our operations for the next 12 months and our ability to continue as a going concern is dependent upon obtaining additional capital and financing. As of December 31, 2023, the Company had cash and cash equivalents of $2.1 million.

 

Our primary uses of cash are to fund our operations as we continue to grow our business. We will require a significant amount of cash for expenditures to fund business operations and continue to invest in ongoing research and development for our non-linear quantum optical products and photonics chips. Until such time as we can generate significant revenue from sales or subscriptions of our hardware offerings, we expect to finance our cash needs through public and/or private equity and/or debt financings or other capital sources, including but not limited to U.S. government grant and loan programs. However, we may be unable to raise sufficient funds or enter into such other arrangements, when needed, on favorable terms, or at all. In particular, uncertain and unfavorable conditions in the United States and global macroeconomic environment, including inflationary pressures, rising interest rates, banking collapses, and financial and credit market fluctuations, could reduce our ability to access capital on favorable terms, or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be, or could be, diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, or substantially reduce our product development and go-to-market efforts. It is management’s opinion that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the date of the issuance of the accompanying consolidated financial statements. There can be no assurances that the Company will be able to secure additional equity investments or achieve an adequate sales level.

 

The following table summarizes total consolidated current assets, liabilities and working capital at December 31, 2023, compared to December 31, 2022 (in thousands).

 

		December 31, 2023				December 31, 2022				Increase/ (Decrease)
Current assets		$	2,656			$	5,450			$	(2,794	)
Current liabilities		$	4,812			$	4,593			$	219
Working capital (deficit)		$	(2,156	)		$	857			$	(3,013	)

 

At December 31, 2023, we had a working capital deficit of $2.2 million as compared to working capital of $0.9 million at December 31, 2022, a decrease of $3.0 million. The decrease in working capital is primarily attributable to the use of cash to pay for operating expenses and capital investments in property and equipment, satisfaction of accrued expense liabilities and the Streeterville Unsecured Note becoming a current portion of long-term debt payable.

 

Our independent registered public accounting firm included an explanatory paragraph in its report on our consolidated financial statements as of and for the year ended December 31, 2023, noting the existence of substantial doubt about our ability to continue as a going concern. This uncertainty arose from management’s review of our results of operations and financial condition and its conclusion that, based on our operating plans, we did not have sufficient existing working capital to sustain operations for a period of 12 months from the date of the issuance of the accompanying consolidated financial statements.

 

Cash Flows

 

The following table summarizes our cash flow for the years ended December 31, 2023 and 2022 (in thousands).

 

		Year Ended December 31,
		2023				2022
Net cash used in operating activities		$	(18,315	)		$	(15,378	)
Net cash used in investing activities			(2,612	)			(2,226	)
Net cash provided by financing activities			17,678				6,173
Net decrease in cash, cash equivalents, and restricted cash			(3,249	)			(11,431	)
Cash, cash equivalents, and restricted cash, beginning of year			5,308				16,739
Cash, cash equivalents, and restricted cash, end of year			2,059				5,308

 

Net cash used in operating activities for the years ended December 31, 2023 and 2022 was $18.3 million and $15.4 million, respectively, in each case primarily as a result of our net loss in each year offset by noncash adjustments for stock-based compensation, depreciation of property and equipment, amortization of intangibles, provision for credit losses, and change in fair value of our QPhoton Warrant liability, as defined below.

 

4

 

 

Net cash used in investing activities for the years ended December 31, 2023 and 2022 was $2.6 million and $2.2 million, respectively. Cash used in investing activities during the year ended December 31, 2023 was attributable to acquisition of laboratory equipment for $2.1 million and our $500 thousand loan to millionways, Inc. (“millionways”) in June 2023. On June 6, 2023, the Company entered into a Note Purchase Agreement with millionways pursuant to which the Company agreed to purchase from millionways up to three unsecured promissory notes in an aggregate principal amount of up to $2.0 million, subject to the terms and conditions thereof. On June 6, 2023, the Company purchased the notes from millionways and loaned it an aggregate principal amount of $500 thousand. This followed the Company’s entry into a Summary of Proposed Terms with millionways on May 16, 2023, to provide bridge loans to millionways and enter into due diligence to acquire up to 100% of the AI firm. The Company opted not to purchase further promissory notes from millionways. Cash used in investing activities during the year ended December 31, 2022 was attributable to acquisition of laboratory equipment for $870 thousand and our $2.5 million loan to QPhoton, consisting of two unsecured promissory notes, each in the principal amount of $1.25 million, per a Note Purchase Agreement with QPhoton on February 18, 2022 (the “QPhoton Loan”). Upon closing of the QPhoton Merger on June 16, 2022, the Company recouped approximately $1.1 million of the QPhoton Loan in cash, resulting in approximately $1.4 million net total cash used for the QPhoton Merger in our consolidated financial statements.

 

Net cash provided by financing activities for the year ended December 31, 2023, was $17.7 million compared to $6.2 million during the year ended December 31, 2022. Cash provided by financing activities during the year ended December 31, 2023 was attributable to net $24.7 million received from the sale of shares of our common stock through our At-The-Market (“ATM”) facility, partially offset by repayments of $6.2 million on the Streeterville Unsecured Note. During the year ended December 31, 2022, cash provided by financing activities was primarily attributable to the funds we received from the issuance of the Streeterville Unsecured Note.

 

On a long-term basis, our liquidity is dependent on continuation and expansion of operations and receipt of revenues. Demand for our products and services will be dependent on, among other things, market acceptance of our products and services, the technology market in general, and general economic conditions, which are cyclical in nature. As most of our revenues will be from the sales of our products and services, our business operations may be adversely affected by the actions of our competitors and prolonged recession periods.

 

Critical Accounting Estimates

 

Certain of our accounting policies require the application of significant judgment by our management, and such judgments are reflected in the amounts reported in our condensed consolidated financial statements. In applying these policies, our management uses judgment to determine the appropriate assumptions to be used in the determination of estimates. Those estimates are based on our historical experience, terms of existing contracts, our observance of market trends, information provided by our strategic partners and information available from other outside sources, as appropriate. Actual results may differ significantly from the estimates contained in our condensed consolidated financial statements.

 

Fair Value of Stock-based Compensation and Derivatives

 

We recognize stock-based compensation expense for all share-based payment awards in accordance with Accounting Standards Codification (“ASC”) 718, Compensation – Stock Compensation. Stock-based compensation expense for expected-to-vest awards is valued under the single-option approach and amortized on a straight-line basis, accounting for actual forfeitures as they occur. We utilize the Black Scholes pricing model in order to determine the fair value of stock-based option awards. The Black Scholes pricing model requires various highly subjective assumptions including volatility, expected option life, and risk-free interest rate. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management judgment. If factors change and different assumptions are used, our stock-based compensation expense could be materially different in the future.

 

Another area of critical accounting estimates involves determining the fair market value of the QPhoton Warrants, as defined below. The Company determines which underlying options and warrants are in-the-money or out-of-the-money at period end by comparing to the bid price of the Company’s common stock, then accounts for changes period-over-period by realizing a mark-to-market gain or loss for the period.

 

Fair Market Value and Useful Life of Intangible Assets

 

Determining the fair market value and useful life of the intangible assets acquired by the Company through the merger with QPhoton is another critical accounting estimate. In the absence of market pricing for the intangible assets, the Company relied on independent third-party appraisal experts and comparison with similar transactions to arrive at estimates of value as well as useful life. The Company will perform periodic assessments of the intangible assets for impairment, but if any of the initial estimates are incorrect, that could result in a calculation of amortization expense that is too high or too low.

 

Valuation Allowances for Deferred Taxes

 

Our income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect management’s assessment of estimated current and future income taxes to be paid. We are subject to income taxes in the United States. Significant judgments and estimates are required in determining the consolidated income tax expense, deferred tax assets and liabilities and reserves for unrecognized tax benefits.

 

5

 

 

Deferred tax assets and liabilities arise from temporary differences between the tax basis of assets and liabilities and their reported amounts in the consolidated financial statements, which are expected to result in taxable or deductible amounts in the future. In evaluating our ability to recover our deferred tax assets within the jurisdiction from which they arise, for all material jurisdictions, we consider all available positive and negative evidence, including scheduled reversals of deferred tax balances, projected future taxable income, tax-planning strategies and results of recent operations. In projecting future taxable income, we begin with historical results and incorporate assumptions about the amount of future state, federal and foreign pretax operating income adjusted for items that do not have tax consequences. The assumptions about future taxable income require significant judgment and are consistent with the plans and estimates we use to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating results.

 

As of December 31, 2023, we had federal and state net operating loss (“NOL”) carryforwards of $49 million, or $13 million on a tax-effected basis at an assumed tax rate of 25%. We believe that it is more likely than not that the benefit from these NOL carryforwards will not be realized. Accordingly, we have provided a full valuation allowance on any potential deferred tax assets relating to these NOL carryforwards. If our assumptions change and we determine we will be able to realize these NOLs, the tax benefits relating to any reversal of the valuation allowance on deferred tax assets as of December 31, 2023, will be accounted for as a reduction of income tax expense.

 

The calculation of our tax liabilities involves evaluating uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. ASC 740, Income Taxes, states that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including the resolution of any related appeals or litigation processes, on the basis of the technical merits.

 

We record unrecognized tax benefits as liabilities in accordance with ASC 740 and adjust these liabilities when our judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a tax payment that is materially different from our current estimate of the unrecognized tax benefit liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is made available.

 

We believe that none of the unrecognized tax benefits may be recognized by the end of 2023.

 

Legal and Other Contingencies

 

The outcomes of legal proceedings and claims brought against us are subject to significant uncertainty. An estimated loss from a loss contingency such as a legal proceeding or claim is accrued by a charge to income if it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. In determining whether a loss should be accrued we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss. Changes in these factors could materially impact our consolidated financial statements.

  

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 

Our consolidated financial statements are contained in pages F-1 through F-29 which appear at the end of this Amendment.

 

6

 

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

 

BPM LLP served as our independent registered public accountants for the years ended December 31, 2023 and 2022.

 

Audit Fees

 

For the Company’s fiscal years ended December 31, 2023 and 2022, we were billed approximately $132 thousand and $112 thousand, respectively, for professional services rendered by BF Borgers for its original audit of our consolidated financial statements, including those appearing in the Original Form 10-K, and approximately $300 thousand by BPM for the re-audit of our consolidated financial statements contained in this Amendment.

 

Tax Fees

 

For the Company’s fiscal years ended December 31, 2023 and 2022, we were billed approximately $9 thousand each year for professional services rendered by BF Borgers for tax compliance, tax advice, and tax planning.

 

All Other Fees

 

For the Company’s fiscal years ended December 31, 2023 and 2022, we were billed approximately $27,500 and $49,500, respectively, for professional services rendered by BF Borgers related to the Company’s Registration Statements on Form S-3 and amendments thereto filed with the SEC in those years.

 

Pre-Approval Policies

 

All of the above services and fees were reviewed and approved by the entire Board. No services were performed before or without approval. 

 

7

 

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

 

Exhibit				Reference				Filed or Furnished
Number		Exhibit Description		Form		Exhibit		Filing Date		Herewith
3.1(i)		Amended and Restated Certificate of Incorporation		10-K/A		3.1(i)		07/10/2023
3.1(ii)		Certificate of Designations of the Series A Convertible Preferred Stock		8-K		3.1		11/17/2021
3.1(iii)		Certificate of Amendment of Certificate of Designations of Series A Convertible Preferred Stock of Quantum Computing Inc., filed with the Delaware Secretary of State on December 16, 2021		8-K		3.1		12/17/2021
3.2		Amended and Restated By-laws		10-K/A		3.2		07/10/2023
3.3		Certificate of Designation with respect to the Series B Preferred Stock, par value $0.0001 per share, dated June 14, 2022		8-K		3.1		06/21/2022
4.1		Common Stock Specimen		10-12(g)		4.1		01/09/2019
4.4		Description of Securities		10-K		4.4		04/01/2024
4.5		Promissory Note in the amount of $8,250,000 issued by Quantum Computing Inc. to Streeterville Capital, LLC, dated September 23, 2022		8-K		4.1		09/28/2022
10.1		ATM Agreement, dated as of December 5, 2022, between Quantum Computing Inc. and Ascendiant Capital Markets, LLC		8-K		1.1		12/06/2022
10.2		First Amendment to ATM Agreement, dated as of August 17, 2023, between Quantum Computing Inc. and Ascendiant Capital Markets, LLC		8-K		1.1		08/21/2023
10.3		Employment Agreement between Quantum Computing Inc. and Christopher Boehmler, dated as of June 26, 2023		8-K		10.1		06/26/2023
10.4*		2019 Quantum Computing Inc. Equity and Incentive Plan		S-1		10.8		11/22/2019
10.10*		Form Director Agreement		8-K		10.1		02/23/2021
10.11		Form of Warrant dated November 9, 2021		8-K		10.2		11/17/2021
10.12		Form Amendment to Common Stock Purchase Warrant		8-K		10.2		12/17/2021
10.13*		Employment Agreement between William J. McGann and Quantum Computing Inc., dated as of January 3, 2022		8-K		10.2		01/03/2022
10.14*		Amended and Restated Employment Agreement, dated as of April 26, 2021, by and between Quantum Computing Inc. and Robert Liscouski		8-K		10.1		04/30/2021
10.15*		Employment Agreement between Christopher Roberts and Quantum Computing Inc., dated as of April 26, 2021		8-K		10.2		04/30/2021
10.16		Note Purchase Agreement, dated as of February 18, 2022, between Quantum Computing Inc. and QPhoton, Inc.		8-K		10.1		02/23/2022
10.17		Unsecured Promissory Note issued by QPhoton, Inc. to Quantum Computing Inc., in the amount of $1,250,000, dated February 18, 2022		8-K		10.2		02/23/2022
10.18		Agreement and Plan of Merger by and among Quantum Computing Inc., Project Alpha Merger Sub I, Inc., Project Alpha Merger Sub II, LLC, QPhoton, Inc., and Yuping Huang, dated as of May 18, 2022		8-K		10.1		05/23/2022
10.19		Escrow Agreement, dated as of June 16, 2022, by and among Quantum Computing Inc., Yuping Huang and Worldwide Stock Transfer, LLC		8-K		10.2		06/21/2022
10.20		Stockholders Agreement by and among Quantum Computing Inc. and each of the Stockholders set forth on Exhibit A thereto, dated as of June 16, 2022		8-K		10.3		06/21/2022

 

8

 

 

10.21		Form Registration Rights Agreement		8-K		10.4		06/21/2022
10.22*		Employment Agreement, dated as of June 15, 2022, by and between Quantum Computing Inc. and Yuping Huang		8-K		10.5		06/21/2022
10.23		Note Purchase Agreement, dated as of September 23, 2022, by and between Quantum Computing Inc. and Streeterville Capital, LLC		8-K		10.1		09/28/2022
10.24*		Director Agreement between Quantum Computing Inc. and Dr. Carl Weimer, dated January 6, 2023		8-K		10.1		01/09/2023
10.25*		Quantum Computing Inc. 2022 Equity and Incentive Plan		10-K/A		10.42		07/10/2023
10.26*		Separation Agreement, dated as of March 15, 2024, by and between Quantum Computing Inc. and Robert Liscouski		10-K		10.26		04/01/2024
10.27*		Director Agreement, dated as of March 8, 2024, by and between Quantum Computing Inc. and Robert Liscouski		10-K		10.27		04/01/2024
10.28*		Separation Agreement, dated as of June 30, 2023, by and between Quantum Computing Inc. and Christopher Roberts		10-K		10.28		04/01/2024
10.31		Consulting Services Agreement, dated as of July 1, 2023, by and between Quantum Computing Inc. and Christopher Roberts		10-K		10.31		04/01/2024
10.32		Modification 1 to Consulting Services Agreement, dated as of January 2, 2024, by and between Quantum Computing Inc. and Christopher Roberts		10-K		10.32		04/01/2024
21.1		List of Subsidiaries		10-K		21.1		04/01/2024
23.1		Consent of BPM, LLP								X
31.1		Principal Executive Officer Certification Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.								X
31.2		Principal Financial Officer Certification Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.								X
32.1		Principal Executive Officer Certification Pursuant to Item 601(b)(32) of Regulation S-K, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.								X
32.2		Principal Financial Officer Certification Pursuant to Item 601(b)(32) of Regulation S-K, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.								X
97		Policy relating to recovery of erroneously awarded compensation.		10-K		97		04/01/2024
101.INS		Inline XBRL Instance Document.								X
101.SCH		Inline XBRL Taxonomy Extension Schema Linkbase Document.								X
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.								X
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.								X
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.								X
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.								X
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).								X

 

*	Indicates a management contract or compensatory plan or arrangement.

 

9

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: September 11, 2024	Quantum Computing Inc.
	By:	/s/ Dr. William McGann
		Dr. Willan McGann
		Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the dates indicated.

 

Name		Capacity		Date
/s/ Robert Liscouski		Chairman of the Board of Directors		September 11, 2024
Robert Liscouski
/s/ Dr. William McGann		Chief Executive Officer		September 11, 2024
Dr. Willan McGann		(Principal Executive Officer)
/s/ Christopher Boehmler		Chief Financial Officer, Treasurer		September 11, 2024
Christopher Boehmler		(Principal Financial Officer and Principal Accounting Officer)
/s/ Dr. Yuping Huang		Chief Quantum Officer and Director		September 11, 2024
Dr. Yuping Huang
/s/ Michael Turmelle		Director		September 11, 2024
Michael Turmelle
/s/ Robert Fagenson		Director		September 11, 2024
Robert Fagenson
/s/ Dr. Carl Weimer		Director		September 11, 2024
Dr. Carl Weimer
/s/ Dr. Javad Shabani		Director		September 11, 2024
Dr. Javad Shabani

 

10

 

 

QUANTUM COMPUTING INC.

 

Index to the Consolidated Financial Statements

 

Description		Page
Report of Independent Registered Public Accounting Firm (PCAOB ID: 207)		F-2
Consolidated Balance Sheets		F-3
Consolidated Statements of Operations		F-4
Consolidated Statements of Stockholders’ Equity		F-5
Consolidated Statements of Cash Flows		F-6
Notes to the Consolidated Financial Statements		F-7

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of

Quantum Computing Inc.

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Quantum Computing Inc. (a Delaware Corporation) and its subsidiaries (collectively, the “Company”) as of December 31, 2023 and 2022, and the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the two years in the period ended December 31, 2023, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2023 and 2022, and the consolidated results of its operations and its consolidated cash flows for each of the two years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern Uncertainty

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company’s recurring losses from operations, available cash, and cash used in operations raises substantial doubt about the Company’s ability to continue as a going concern. Management’s plans regarding these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financing reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

Valuation of intangible assets acquired in a business combination

 

As described in Note 4, on June 16, 2022, the Company merged with QPhoton, Inc., which was accounted for as a business combination using the acquisition method of accounting. The acquired intangible assets principally consisted of non-compete agreement with founder, trademarks, and patents, along with goodwill. The net carrying values of the identified intangible assets and goodwill as of December 31, 2023 were $12.1 million and $55.6 million, respectively.

 

The principal considerations for our determination that performing procedures relating to the valuation of intangible assets acquired in a business combination is a critical audit matter at due to the significant amount of judgment by management required in estimating their acquisition date fair values, including the use of valuation methodologies that were sensitive to significant assumptions, which were affected by expected future market or economic conditions, which in turn led to significant auditor judgment, subjectivity and effort in performing audit procedures and evaluating audit evidence relating to the analysis.

 

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others, assessing the appropriateness of the valuation methodologies and testing the significant assumptions discussed above and the completeness and accuracy of the underlying data used by the Company, including evaluating the reasonableness of assumptions used to determine the projected revenue growth rates by comparing the forecasted assumptions to historical performance, projected industry growth rates, and other factors considered by management in developing the model.

 

/s/ BPM LLP

 

We have served as the Company’s auditor since 2024.

 

San Jose, California

September 11, 2024

 

F-2

 

 

QUANTUM COMPUTING INC.

Consolidated Balance Sheets

(In thousands, except par value)

 

		December 31,				December 31,
		2023				2022
		(Restated) (1)				(Restated) (1)
Assets
Current assets
Cash and cash equivalents		$	2,059			$	5,308
Accounts receivable			65				13
Inventory			73				-
Loans receivable, net of provision for credit losses of $279 and zero			279				-
Prepaid expenses and other current assets			180				129
Total current assets			2,656				5,450
Property and equipment, net			2,870				975
Operating lease right-of-use assets			1,051				1,273
Intangible assets, net			12,076				15,180
Goodwill			55,573				55,573
Other non-current assets			129				60
Total assets		$	74,355			$	78,511
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable		$	1,462			$	872
Accrued expenses			639				2,961
Financial liabilities, current, net of issuance costs			1,925				-
Other current liabilities			786				760
Total current liabilities			4,812				4,593
Financial liabilities, net of issuance costs			-				7,188
Warrant liability			-				528
Operating lease liabilities			840				1,078
Total liabilities			5,652				13,387
Contingencies (see Note 9)
Stockholders’ equity
Preferred stock, $0.0001 par value, 1,550 shares Series A Preferred authorized; 1,490 and 1,500 shares issued and outstanding as of December 31, 2023 and 2022, respectively; 3,080 shares of Series B Preferred Stock authorized, no shares issued and outstanding as of December 31, 2023 and 2022			-				-
Common stock, $0.0001 par value, 250,000 shares authorized; 77,451 and 55,963 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively			8				6
Additional paid-in capital			200,635				169,175
Accumulated deficit			(131,940	)			(104,057	)
Total stockholders’ equity			68,703				65,124
Total liabilities and stockholders’ equity		$	74,355			$	78,511

  

(1)

As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 

QUANTUM COMPUTING INC.

Consolidated Statements of Operations

(In thousands, except per share data)

 

		Year Ended December 31,
		2023				2022
		(Restated) (1)				(Restated) (1)
Total revenue		$	358			$	136
Cost of revenue			196				61
Gross profit			162				75
Research and development			8,891				5,216
Sales and marketing			1,806				2,092
General and administrative			15,708				21,412
Operating expenses			26,405				28,720
Loss from operations			(26,243	)			(28,645	)
Non-operating income (expense)
Interest and other income			295				47
Interest expense, net			(1,602	)			(772	)
Change in value of warrant liability			528				3,392
Loss before income tax provision			(27,022	)			(25,978	)
Income tax provision			-				-
Net loss			(27,022	)			(25,978	)
Less: Series A convertible preferred stock dividends			861				889
Net loss available to common stockholders		$	(27,883	)		$	(26,867	)
Loss per share – basic and diluted		$	(0.42	)		$	(0.73	)
Weighted average shares used in computing net loss per common share – basic and dilutive			66,611				36,680

 

(1)

As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

QUANTUM COMPUTING INC.

Consolidated Statements of Stockholders’ Equity

(In thousands, except par value)

 

		Series A Preferred Stock								Common Stock								Additional Paid-in				Accumulated				Total Stockholders’
		Shares				Amount				Shares				Amount				Capital				Deficit				Equity
Balances, January 1, 2022
As previously reported			1,545			$	-				29,157			$	3			$	97,593			$	(81,394	)			16,202
Adjustments (1)			-				-				-				-				(5,384	)			4,204				(1,180	)
As restated			1,545				-				29,157				3				92,209				(77,190	)			15,022
Cancellation of shares			-				-				(11	)			-				-				-				-
Conversion of preferred stock			(45	)			-				48				-				-				-				-
Issuance of shares in conjunction with QPhoton Merger											26,615				3				67,127				-				67,130
Preferred stock dividends			-				-																(889	)			(889	)
Preferred OID Amortization																			318								318
Stock-based compensation											20				-				9,493				-				9,493
Stock-based compensation for services											135				-				28				-				28
Net loss			-				-												-				(25,978	)			(25,978	)
Balances, December 31, 2022 (Restated) (1)			1,500			$	-				55,963			$	6			$	169,175			$	(104,057	)		$	65,124
Issuance of shares for cash											17,572				2				24,728								24,730
Conversion of preferred stock			(10	)							11								1				-				1
Preferred stock dividends																							(861	)			(861	)
Stock-based compensation											2,330								4,238				-				4,238
Stock-based compensation for services											1,575								2,493				-				2,493
Net loss			-				-												-				(27,022	)			(27,022	)
Balances, December 31, 2023 (Restated) (1)			1,490				-				77,451			$	8			$	200,635			$	(131,940	)		$	68,703

  

(1)

As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

QUANTUM COMPUTING INC.

Consolidated Statements of Cash Flows

For the Years Ended December 31, 2023 and 2022

(In thousands)

 

		Year Ended
		December 31,
		2023				2022
		(Restated) (1)				(Restated) (1)
Cash flows from operating activities:
Net loss		$	(27,022	)		$	(25,978	)
Adjustments to reconcile net loss to net cash used in operations
Depreciation and intangibles amortization			3,307				1,863
Amortization of issuance costs			925				547
Change in fair value of warrant liabilities			(528	)			(3,392	)
Provision for credit losses			279				-
Other recognized losses (gains)			5				78
Stock-based compensation expense			4,271				9,323
Stock-based compensation expense for services			284				2,350
Changes in operating assets and liabilities
Accounts receivable			(52	)			(13	)
Inventory			(70	)			-
Prepaid expenses and other current assets			(110	)			(145	)
Other non-current assets			153				(1,214	)
Accounts payable			596				219
Accrued expenses and other current liabilities			110				(319	)
Other long-term liabilities			(463	)			1,303
Net cash used in operating activities			(18,315	)			(15,378	)
Cash flows from investing activities:
Purchase of property and equipment			(2,112	)			(870	)
Issuance of loan receivable			(500	)			-
Net cash used for QPhoton, Inc. merger			-				(1,356	)
Net cash used in investing activities			(2,612	)			(2,226	)
Cash flows from financing activities:
Proceeds raised from financial liabilities, net of issuance costs			-				6,960
Payments of financial liabilities, net of interest			(6,187	)			-
Series A Preferred dividend payments			(865	)			(787	)
Proceeds from stock issuance related to ATM facility			24,730				-
Net cash provided by financing activities			17,678				6,173
Net decrease in cash			(3,249	)			(11,431	)
Cash and cash equivalents, beginning of period			5,308				16,739
Cash and cash equivalents, end of period		$	2,059			$	5,308
Supplemental disclosures of Cash flow information:
Cash paid for interest		$	813			$	-
Non-cash operating activities
Non-cash issuance of shares for services		$	2,651			$	502
Non-cash financing activities
Common stock, preferred stock and warrants issued in connection with QPhoton Merger		$	-			$	71,050

  

(1)

As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

 

QUANTUM COMPUTING INC.

Notes to Consolidated Financial Statements

December 31, 2023

 

Note 1 – Nature of the Organization and Business

 

Corporate History

 

Quantum Computing Inc. (“QCi” or the “Company”) was formed in the State of Nevada on July 25, 2001, under its prior name, Ticketcart, Inc. The Company redomiciled to Delaware on February 22, 2018 and changed its name to Quantum Computing Inc. Effective July 20, 2018, the trading symbol for the Company’s common stock, par value $0.0001, on the OTC Market changed from “IBGH” to “QUBT”. On July 15, 2021 the Company uplisted to the Nasdaq Stock Market LLC (“Nasdaq”). On June 16, 2022, the Company merged with QPhoton, Inc. (“QPhoton”), a developer of quantum photonic systems and related technologies and applications.

 

Nature of Business

 

QCi is an American company utilizing integrated photonics and non-linear quantum optics to deliver quantum and ancillary non-quantum products for high-performance computing applications based on proprietary photonics technology. Quantum’s products are designed to operate at room temperature and low power. Our core photonics technology enables the execution of a go-to-market strategy which emphasizes accessibility and affordability. Our quantum systems enable subject matter experts (SMEs) and end users to deliver critical business solutions today.

 

The Company initially focused on providing software tools and applications for several commercially available quantum computers. However, following the June 2022 merger with QPhoton and its associated intellectual property and engineering team, the Company now offers integrated high-performance quantum systems, ancillary non-quantum products and services.

 

The core of our quantum offerings today is our Entropy Quantum Computing (“EQC”) technology. We have built room-temperature, photonic quantum information processing systems underpinned by a series of patented and patent pending technologies. Our technology, supported by professional services through our “Quantum Solutions” offering, enables our clients to solve complex optimization problems. In addition, our engineering teams are using our leading-edge photonics technology to continue to enhance and further develop quantum LIDAR sensing and imaging systems, quantum-secured network solutions, and photonic chips.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the continuity of operations, the realization of assets, and the satisfaction of liabilities in the normal course of business. Cash and cash equivalents on hand were $2.1 million as of December 31, 2023. The Company has historically incurred losses and negative cash flows from operations. As of December 31, 2023, the Company also had an accumulated deficit of $131.9 million and a working capital deficit of $2.2 million. Furthermore, we have not achieved a level of sales adequate to support the Company’s cost structure and may need to raise additional funds in the next twelve months by selling additional equity or incurring debt. It is management’s opinion that these conditions raise substantial doubt about our ability to continue as a going concern.

 

Note 2 – Significant Accounting Policies:

 

Basis of Presentation and Principles of Consolidation:

 

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as determined by the Financial Accounting Standards Board (the “FASB”), including ASC 810, Consolidation. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year end is December 31.

 

F-7

 

 

Risk and Uncertainties

 

The Company is subject to certain risks and uncertainties and believes changes in any of the following areas could have a material adverse effect on the Company’s future financial position or results of operations or cash flows: new product development, including market receptivity; litigation or claims against the Company based on intellectual property, patent, product regulation or other factors; competition from other products; general economic conditions; the ability to attract and retain qualified employees; and, ultimately, to sustain profitable operations.

 

Use of Estimates

 

These consolidated financial statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the valuation of goodwill and intangible assets, deferred tax assets, equity-based transactions and liquidity assessment. Actual results may differ from these estimates.

 

Cash and Cash Equivalents

 

Highly liquid investments with a maturity of three months or less when purchased are considered to be cash equivalents. As of December 31, 2023 and 2022, there were no cash equivalents. The Company maintains its cash in deposit and money market accounts with high quality financial institutions which, at times, may exceed federally insured limits. The Company has not experienced any losses on these deposits and believes it is not exposed to significant credit risk on cash.

 

Revenue

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, by analyzing contracts with its customers using a five-step approach:

 

	1.	Identify the contract
	2.	Identify the performance obligations
	3.	Determine the transaction price
	4.	Allocate the transaction price to the performance obligations
	5.	Recognize revenue when performance obligations are satisfied

 

The Company recognized a small amount of revenue in 2023 and 2022, which was primarily derived from contracts to perform professional services. Revenue from time and materials-based contracts is recognized as the direct hours worked during the period times the contractual hourly rate, plus direct materials and other direct costs as appropriate, plus negotiated materials handling burdens, if any. Revenue from units-based contracts is recognized as the number of units delivered or performed during the period times the contractual unit price. Revenue from fixed price contracts is recognized as work is performed with estimated profits recorded on a percentage of completion basis. The Company has no cost-plus type contracts at this time.

 

The Company includes depreciation and amortization expenses in manufacturing overhead, which is a component of cost of revenue. However, at the present time manufacturing overhead, including depreciation and amortization expense related to production equipment, is not material and the primary components of cost of revenue are direct labor and direct materials, with a small amount of shipping expenses.

 

Accounts Receivable

 

Accounts receivable consists of amounts due from customers for work performed on contracts. The Company records accounts receivable at their net realizable value. Periodically the Company evaluates its accounts receivable to establish a provision for credit losses, when deemed necessary, based on the history of past write-offs, collections and current credit conditions. Within 2022, certain accounts receivable, attributable to a single customer, were determined not to be collectible and management recorded a provision and wrote off the uncollectible receivables against that account. The customer accounts receivable as of December 31, 2023 are considered fully collectible and thus management has not recorded a provision for credit losses.

 

F-8

 

 

Provision for Credit Losses

 

The Company estimates losses on loans and other financial instruments in accordance with Accounting Standards Update (“ASU”) 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 introduces the current expected credit losses (“CECL”) methodology for estimating allowances for credit losses. The CECL framework requires the Company to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supporting forecasts. Under CECL, the allowance for credit losses is measured as the difference between the financial asset’s cost basis and the net amount expected to be collected on the financial asset. CECL allows us to use information about past events including historical loan loss experience, current conditions, and reasonable and supportable forecasts to assess the collectability of the financial assets. The receivables for financial assets as of December 31, 2023 are not considered fully collectible and thus management has recorded a provision for credit losses. Note 10, Loan Receivable, for additional information.

 

Inventory

 

Inventory is stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis which approximates actual cost on a first in-first out (“FIFO”) method. Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory, deterioration and other factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are made for estimated excess, obsolescence or impaired inventory and are charged to cost of revenue. Once the cost of the inventory is reduced, a new lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. Factors influencing these adjustments include changes in demand, product life cycle and development plans, component cost trends, product pricing, physical deterioration and quality issues. Revisions to these adjustments would be required if these factors differ from our estimates.

 

Operating Leases

 

The Company determines if an arrangement is a lease at inception. Operating lease right-of-use (“ROU”) assets are included in right-of-use assets, net on the consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current operating lease liabilities and non-current operating lease liabilities, respectively, on the consolidated balance sheets.

 

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheet. All of our operating leases are comprised of office space leases, and as of December 31, 2023 and 2022, we had no finance leases.

 

Business Combinations and Valuation of Goodwill

 

We account for business combinations under the acquisition method of accounting. This method requires the recording of acquired assets and assumed liabilities at their acquisition date fair values. The excess of the purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Results of operations related to business combinations are included prospectively beginning with the date of acquisition and transaction costs related to business combinations are recorded withing general and administrative expenses.

 

F-9

 

 

The Company reviews goodwill for impairment on an annual basis or whenever events or changes in circumstances indicate the carrying value may not be recoverable. The Company performs an annual impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, income tax effects from any tax-deductible goodwill carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable. The Company has determined that it has a single reporting unit for purposes of performing its goodwill impairment test. As the Company uses the market approach to assess impairment, its common stock price is an important component of the fair value calculation. If the Company’s stock price continues to experience significant price and volume fluctuations, this will impact the fair value of the reporting unit and can lead to potential impairment in future periods. The Company performed its annual impairment test during the second quarter of fiscal 2023 and 2022 and determined that its goodwill was not impaired. As of December 31, 2023 and 2022, we had not identified any factors that indicated there was an impairment of our goodwill and determined that no additional impairment analysis was then required.

 

Property and Equipment

 

Property and equipment are stated at cost or contributed value. Depreciation of furniture, software and equipment is calculated using the straight-line method over their estimated useful lives, and leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the lease term. The cost and related accumulated depreciation of equipment retired or sold are removed from the accounts and any differences between the undepreciated amount and the proceeds from the sale are recorded as a gain or loss on sale of equipment. Maintenance and repairs are charged against expense as incurred.

 

Impairment of Long-Lived Assets

 

The Company has long-lived assets such as tangible property and equipment, identified intangible assets consisting of acquired patents and core technology. When events or changes in circumstances occur that could indicate the carrying value of long-lived assets may not be recoverable, the Company assesses recoverability by determining whether the undiscounted cash flows estimated to be generated by those assets are less than the carrying amounts of those assets. If the undiscounted cash flow is less, an impairment charge is recognized for the excess of the carrying amounts of these assets over the fair values. Fair values are determined by discounted future cash flows, appraisals or other methods.

 

During the years ended December 31, 2023 and 2022, the Company did not record any impairment from long-lived assets.

 

Fair Value of Financial Instruments

 

The carrying amount of certain financial instruments held by the Company, such as cash equivalents, accounts receivable, contract assets and liabilities, accounts payable, and accrued and other current liabilities, approximate fair value due to their short maturities. The carrying amount of the liabilities for the convertible preferred stock warrants represent their fair value. The carrying amounts of the Company’s borrowings and lease liabilities approximate fair value due to the market interest rates that these obligations bear and interest rates currently available to the Company.

 

Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:

 

Level 1

Unadjusted quoted prices in active markets for identical assets or liabilities;

 

Level 2

Inputs other than quoted prices included within Level 1 that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

 

Level 3

Unobservable inputs that are supported by little or no market activity for the related assets or liabilities.

 

The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. As of December 31, 2023, the Company had $793 thousand in Level 1 assets, comprised of U.S. Government mutual funds, and no carrying value for Level 3 liabilities, comprised of the QPhoton Warrants, as defined below. As of December 31, 2022, the Company had $528 thousand in carrying value for Level 3 liabilities, comprised of the QPhoton Warrants.

 

Research and Development Costs

 

Research and development costs include costs directly attributable to the conduct of research and development programs to enhance existing products and services and to develop future technologies, including the cost of services provided by outside contractors, and mandatory compliance fees and contractual obligations. All costs associated with research and development are expensed as incurred.

 

F-10

 

 

Software Development Costs

 

Software development costs incurred subsequent to the establishment of technological feasibility for software intended to be sold, licensed or otherwise marketed to customers will be capitalized, but development costs not meeting the criteria for capitalization are expensed as incurred. With respect to internal use software, the Company will capitalize such development costs incurred during the application development stage, but development costs incurred prior to that stage will be expensed as incurred. No amortization expense will be recorded until the software is ready for its intended use. To date the Company has not incurred any capitalizable software development costs.

 

Stock-Based Compensation

 

The Company has adopted ASU 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 expands the scope of ASC 718, Share-Based Payment, to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of ASC 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost. ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, and that ASC 718 does not apply to share based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606, Revenue from Contracts with Customers.

 

Stock-based compensation expense for expected-to-vest awards is valued under the single-option approach and amortized on a straight-line basis, accounting for actual forfeitures as they occur. We utilize the Black Scholes pricing model in order to determine the fair value of stock-based option awards. The Black Scholes pricing model requires various highly subjective assumptions including volatility, expected option life, and risk-free interest rate. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management judgment. If factors change and different assumptions are used, our stock-based compensation expense could be materially different in the future.

 

Loss Per Share

 

Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if the common share equivalents had been issued (computed using the “If-Converted” method), unless the effect of such issuances would have been anti-dilutive.

 

The following table sets forth the computation of basic and diluted loss per share (in thousands, except per share data):

 

		Year Ended December 31,
		2023				2022
Numerator:
Net loss		$	(27,022	)		$	(25,978	)
Less: Series A convertible preferred stock dividends			861				889
Net loss available to common stockholders – basic and diluted		$	(27,883	)		$	(26,867	)
Denominator:
Weighted average shares used in computing net loss per common share – basic and diluted			66,611				36,680
Loss per share - basic and diluted		$	(0.42	)		$	(0.73	)

 

Net loss per share is based on the weighted average number of common shares and common share equivalents outstanding during the period.

 

In periods with a reported net loss, the effect of anti-dilutive stock options, unvested restricted common stock and warrants are excluded and diluted loss per share is equal to basic loss per share. Due to a net loss in the years ended December 31, 2022 and 2023, there were therefore no dilutive securities and hence basic and diluted loss per share were the same. The following is a summary of the weighted average common stock equivalents for the securities outstanding during the respective periods that have been excluded from the computation of diluted net loss per common share, as their effect would be anti-dilutive (in thousands):

 

		Year Ended December 31,
		2023				2022
Warrants			6,053				3,976
Options			12,280				6,830
Unvested restricted common stock			1,192				-
Total potentially dilutive shares			19,525				10,778

 

As all potentially dilutive securities are anti-dilutive as of December 31, 2023 and 2022, diluted net loss per share is the same as basic net loss per share for each period.

 

F-11

 

  

Recently Issued Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption. The Company has evaluated the recently implemented accounting standards and concluded that none currently apply to the Company.

 

Note 3 – Restatement of Previously Issued Financial Statements

 

Subsequent to the issuance of our Original Form 10-K and our subsequent retention of BPM to replace BF Borgers as our independent registered public accounting firm, management became aware of various adjustments to be recorded to our consolidated financial statements. Accordingly, our consolidated balance sheets as of December 31, 2023 and 2022, and our consolidated statements of operations, consolidated statements of stockholders’ equity, and our consolidated statements of cash flows for the years ended December 31, 2023 and 2022, have been restated for various errors, omissions, reclassifications or changes to accounting policy made primarily with regard to the purchase accounting of the QPhoton Merger, stock-based compensation accounting, financing costs, and other matters further described below. The restated consolidated financial statements also reflect the correction of certain previously-identified errors and out-of-period adjustments that were deemed immaterial to the annual or interim period in which they were recorded and have now been restated to properly reflect the corrections in the appropriate periods.

 

Disclosures

 

In Note 1, we expanded disclosures (i) for risks and uncertainties, valuation of goodwill, impairment of long-lived assets, income taxes, and net loss and (ii) to clearly indicate that depreciation and amortization expenses are included in cost of revenue, but that the amounts are not material.

 

In Note 2, we expanded and revised disclosures (i) to clarify (a) that software development costs incurred subsequent to the establishment of technological feasibility for software intended to be sold, licensed or otherwise marketed to customers will be capitalized, but development costs not meeting the criteria for capitalization are expensed as incurred, (b) that with respect to internal use software, the Company will capitalize such development costs incurred during the application development stage, and (c) that through December 31, 2023, the Company has not incurred any material capitalizable development costs, (ii) to appropriately detail the methodology and computation of basic and diluted loss per share and (iii) to reflect the Company’s change in accounting policy election for stock based compensation to no longer estimate forfeitures, but rather to account for forfeitures as they occur.

 

In Note 3, we explained the drivers of the restatements of the Previously Issued Financial Statements.

 

In Note 12, we clarified the basis for calculating the number of reported warrants to purchase shares of the Company’s common stock issued in connection with the QPhoton Merger.

 

In Note 14, we expanded the disclosure to clarify that the interest rates implicit in our leases are not readily determinable and therefore that is the basis for using our incremental borrowing rate as the discount rate for our leases.

 

Reclassifications

 

We have made certain reclassifications. In the Consolidated Statements of Operations and Consolidated Statements of Cash Flows, we reclassified certain ATM facility-related financing fees and Series A Preferred Stock dividends, which were each previously presented as Interest Expense in Other Income and Expense and have been reclassified as direct deductions to equity and shown as cash used for financing activities. We additionally revised the presentation of operating expenses to classify expenses as (1) Research and Development, (2) Sales and Marketing, and (3) General and Administrative, as compared to previously-reported categories that included (1) Salaries and Benefits, (2) Professional Services, (3) Research & Development, (4) Stock Based Compensation, and (5) Selling General & Administrative. For the Consolidated Balance Sheets, we made certain reclassifications related to (1) right-of-use assets and operating liabilities and (2) other current liabilities for litigation reserves.

 

Adjustments

 

The following is a description of the areas in which the errors were identified and for which we made correcting adjustments to our consolidated financial statements.

 

(1) QPhoton purchase accounting – We adjusted the final purchase price accounting for identifiable intangibles and the value attributable to the QPhoton Warrants, as defined below, including associated mark-to-market quarterly adjustments.

 

(2) Stock-based compensation – We adjusted expenses and prior period retained earnings to reflect the change in our accounting policy election to account for forfeitures as they occur, as well as to refine assumptions used in calculating the fair value. We also ensured all such expenditures were accrued and accounted for in the appropriate periods based on vesting schedules and underlying agreements.

 

F-12

 

 

(3) Debt issuance costs – We corrected errors to appropriately accrete issuance costs for the Streeterville Unsecured Note, as defined below, over the life of the loan.

 

(4) Uncollectable reserve – We identified a reserve for collection risk related to notes receivable.

 

(5) Accrued Expenses – We identified and corrected errors to record liabilities for performance-based bonus expenditures and state franchise fees to reflect the expenses in the appropriate period.

 

(6) Financing Expenditures – We corrected the presentation of Series A Preferred Stock dividends and ATM proceeds and adjusted the valuation of the Series A convertible preferred stock warrants.

 

(7) Other - We corrected certain classifications, previously identified errors and out of period adjustments that were deemed immaterial to the annual or interim period in which they were recorded and restated prior periods to reflect these corrections in the appropriate periods.

 

The following table presents the effect of the aforementioned adjustments on our Consolidated Balance Sheets as of December 31, 2023 and 2022 and indicates the category of the adjustments by reference to the above descriptions of the errors for which we made corrections:

 

		Year Ended December 31, 2023
		As Previously								Description of
		Reported				Adjustments				Adjustments				As restated
Assets
Current assets
Cash and cash equivalents		$	2,059			$	-							$	2,059
Accounts receivable			65				-								65
Inventory			73				-								73
Loans receivable, net of provision for credit losses			557				(278	)			(4	)			279
Prepaid expenses and other current assets			427				(247	)			(7	)			180
Total current assets			3,181				(525	)							2,656
Property and equipment, net			2,870				-								2,870
Operating lease right-of-use assets			800				251				(7	)			1,051
Intangible Assets, net			11,388				688				(1	)			12,076
Goodwill			60,360				(4,787	)			(1	)			55,573
Other non-current assets			129				-								129
Total assets		$	78,728			$	(4,373	)						$	74,355
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable		$	1,462			$	-							$	1,462
Accrued expenses			411				228				(2)(5	)			639
Financial liabilities, current, net of issuance costs			2,496				(571	)			(3	)			1,925
Other current liabilities			250				536				(7	)			786
Total current liabilities			4,619				193								4,812
Operating lease liabilities			840				-								840
Total liabilities			5,459				193								5,652
Stockholders’ equity
Preferred stock			-				-								-
Common stock			8				-								8
Additional paid-in capital			222,980				(22,345	)			(1)(2)(6)(7	)			200,635
Accumulated deficit			(149,719	)			17,779				(1)(2)(3)(4)(5)(6)(7	)			(131,940	)
Total stockholders’ equity			73,269				(4,566	)							68,703
Total liabilities and stockholders’ equity		$	78,728			$	(4,373	)						$	74,355

 

F-13

 

 

		Year Ended December 31, 2022
		As Previously								Description of
		Reported				Adjustments				Adjustments				As restated
Assets
Current assets
Cash and cash equivalents		$	5,308			$	-							$	5,308
Accounts receivable			13				-								13
Prepaid expenses and other current assets			408				(279	)			(7	)			129
Total current assets			5,729				(279	)							5,450
Property and equipment, net			975				-								975
Operating lease right-of-use assets			1,187				86				(7	)			1,273
Intangible assets, net			22,224				(7,044	)			(1	)			15,180
Goodwill			59,126				(3,553	)			(1	)			55,573
Other non-current assets			60				-								60
Total assets		$	89,301			$	(10,790	)						$	78,511
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable		$	872			$	-							$	872
Accrued expenses			3,780				(819	)			(2)(5	)			2,961
Financial liabilities, current			536				(536	)			(7	)			-
Other current liabilities			132				628				(6)(7	)			760
Total current liabilities			5,320				(727	)							4,593
Financial liabilities, net of issuance costs			7,858				(670	)			(3	)			7,188
Warrant liability			-				528				(1	)			528
Operating lease liabilities			1,226				(148	)			(7	)			1,078
Total liabilities			14,404				(1,017	)							13,387
Stockholders’ equity
Preferred stock			-				-								-
Common stock			6				-								6
Additional paid-in capital			194,879				(25,704	)			(1)(2)(6)(7	)			169,175
Accumulated deficit			(119,988	)			15,931				(1)(2)(3)(4)(5)(6)(7	)			(104,057	)
Total stockholders’ equity			74,897				(9,773	)							65,124
Total liabilities and stockholders’ equity		$	89,301			$	(10,790	)						$	78,511

 

F-14

 

 

The following tables present the effect of the aforementioned reclassifications and adjustments on our consolidated statements of operations for the years ended December 31, 2023 and 2022 and indicate the category of the adjustments by reference to the above descriptions of the errors for which we made corrections:

 

		Year Ended December 31, 2023
		As Previously								Description of
		Reported				Adjustments				Adjustments				As restated
Total revenue		$	358			$	-							$	358
Cost of revenue			196				-								196
Gross profit			162				-								162
Operating expenses			27,384				(979	)			(2)(5	)			26,405
Loss from operations			(27,222	)			979								(26,243	)
Non-operating income (expense)
Interest and other income			295				-								295
Interest expense, net			(2,804	)			1,202				(3)(6	)			(1,602	)
Change in value of warrant liability			-				528				(1	)			528
Loss before income tax provision			(29,731	)			2,709								(27,022	)
Income tax provision			-				-								-
Net loss			(29,731	)			2,709								(27,022	)
Less: Series A convertible preferred stock dividends			-				(861	)			(6	)			(861	)
Net loss available to common stockholders		$	(29,731	)		$	1,848							$	(27,883	)
Loss per share – basic and diluted		$	(0.38	)		$	(0.04	)						$	(0.42	)
Weighted average shares used in computing net loss per common share – basic and dilutive			77,451				(10,840	)							66,611

 

		Year Ended December 31, 2022
		As Previously								Description of
		Reported				Adjustments				Adjustments				As restated
Total revenue		$	136			$	-							$	136
Cost of revenue			61				-								61
Gross profit			75				-								75
Operating expenses			36,654				(7,934	)			(2	)(5)			28,720
Loss from operations			(36,579	)			7,934								(28,645	)
Non-operating income (expense)
Interest and other income			47				-								47
Interest expense, net			(2,062	)			1,290				(3	)(6)			(772	)
Change in value of warrant liability			-				3,392				(1	)			3,392
Loss before income tax provision			(38,594	)			12,616								(25,978	)
Income tax provision			-				-								-
Net loss			(38,594	)			12,616								(25,978	)
Less: Series A convertible preferred stock dividends			-				(889	)			(6	)			(889	)
Net loss available to common stockholders		$	(38,594	)		$	11,727							$	(26,867	)
Loss per share – basic and diluted		$	(0.69	)		$	(0.04	)						$	(0.73	)
Weighted average shares used in computing net loss per common share – basic and dilutive			55,963				(19,283	)							36,680

  

F-15

 

 

The following tables present the effect of the aforementioned adjustments on our consolidated statements of cash flows for the years ended December 31, 2023 and 2022 and indicate the category of the adjustments by reference to the above descriptions of the errors for which we made corrections:

 

		Year Ended December 31, 2023
		As Previously								Description of
		Reported				Adjustments				Adjustments				As restated
Cash flows from operating activities:
Net loss		$	(29,731	)			2,709								(27,022	)
Adjustments to reconcile net loss to net cash from operations
Depreciation and intangibles amortization			1,958				1,349				(1	)			3,307
Amortization of issuance costs			-				925				(3	)			925
Change in fair value of warrant liabilities			-				(528	)			(1	)			(528	)
Provision for credit losses			-				279				(4	)			279
Other recognized losses (gains)			4				1				(7	)			5
Stock-based compensation expense			8,723				(4,452	)			(2	)			4,271
Stock-based compensation expense for services			-				284				(2	)			284
Changes in operating assets and liabilities
Accounts receivable			(52	)			-								(52	)
Inventory			(70	)			-								(70	)
Prepaid expenses and other current assets			(78	)			(32	)			(7	)			(110	)
Other non-current assets			318				(165	)			(7	)			153
Accounts payable			583				13								596
Accrued expenses and other current liabilities			(985	)			1,095				(2)(7	)			110
Other long-term liabilities			(611	)			148				(7	)			(463	)
Net cash used in operating activities			(19,941	)			1,626								(18,315	)
Cash flows from investing activities:
Purchase of property and equipment			(2,118	)			(6	)			(7	)			(2,112	)
Issuance of loan receivable			(500	)			-								(500	)
Net cash used in investing activities			(2,618	)			(6	)							(2,612	)
Cash flows from financing activities:
Payments of financial liabilities, net of interest			(6,187	)			-								(6,187	)
Series A Preferred dividend payments			-				(865	)			(6	)			(865	)
Proceeds from stock issuance related to ATM facility			25,496				(766	)			(6	)			24,730
Net cash provided by financing activities			19,309				(1,631	)							17,678
Net decrease in cash			(3,249	)			-								(3,249	)
Cash and cash equivalents, beginning of period			5,308				-								5,308
Cash and cash equivalents, end of period		$	2,059			$	-							$	2,059

 

F-16

 

 

		Year Ended December 31, 2022
		As Previously								Description of
		Reported				Adjustments				Adjustments				As restated
Cash flows from operating activities:
Net loss		$	(38,594	)			12,616								(25,978	)
Adjustments to reconcile net loss to net cash from operations
Depreciation and amortization			3,433				(1,570	)			(1	)			1,863
Amortization of issuance costs			-				547				(3	)			547
Change in fair value of warrant liabilities			-				(3,392	)			(1	)			(3,392	)
Other recognized losses (gains)			-				78				(7	)			78
Stock-based compensation expense			17,761				(8,438	)			(2	)			9,323
Stock-based compensation expense for services			-				2,350				(2	)			2,350
Changes in operating assets and liabilities
Accounts receivable			(13	)			-								(13	)
Prepaid expenses and other current assets			92				(237	)			(7	)			(145	)
Other non-current assets			(1,128	)			(86	)			(7	)			(1,214	)
Accounts payable			219				-								219
Accrued expenses and other current liabilities			(462	)			143				(2)(7	)			(319	)
Other long-term liabilities			1,451				(148	)			(7	)			1,303
Net cash used in operating activities			(17,241	)			1,863								(15,378	)
Cash flows from investing activities:
Purchase of property and equipment			(870	)			-								(870	)
Net cash used for QPhoton, Inc. Merger			(1,356	)			-								(1,356	)
Net cash used in investing activities			(2,226	)			-								(2,226	)
Cash flows from financing activities:
Proceeds raised from financial liabilities, net of issuance costs			8,036				(1,076	)			(3	)			6,960
Series A Preferred dividend payments			-				(787	)			(6	)			(787	)
Net cash provided by financing activities			8,036				(1,863	)							6,173
Net decrease in cash			(11,431	)			-								(11,431	)
Cash and cash equivalents, beginning of period			16,739				-								16,739
Cash and cash equivalents, end of period		$	5,308			$	-							$	5,308

 

F-17

 

 

Note 4 – Business Combinations

 

Merger with QPhoton, Inc.

 

On May 19, 2022, the Company, QPhoton, and Yuping Huang, the principal stockholder of QPhoton, entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which the Company agreed to acquire QPhoton through a series of merger transactions (collectively with the other transactions contemplated by the Merger Agreement, the “Transaction”). On June 16, 2022, all conditions precedent having been met or waived by the Parties, the Company closed the Transactions. The merger with QPhoton adds to the Company’s portfolio of quantum computing products and enables the Company to offer a wider range of quantum information services. The Company accounted for the Transactions using the acquisition method in accordance with ASC 805, Business Combinations, with the purchase price being allocated to tangible and identifiable intangible assets acquired and liabilities assumed based on their respective estimated fair values on the acquisition date. Fair values were determined using management estimates. The results of QPhoton are included within the consolidated financial statements commencing on the acquisition date.

 

Pursuant to the Merger Agreement, immediately following the closing of the Transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub I (a wholly owned subsidiary of the Company) merged with and into QPhoton, with QPhoton surviving the merger as a wholly-owned subsidiary of the Company, immediately after which the surviving corporation merged with and into Merger Sub II (also a wholly owned subsidiary of the Company), with Merger Sub II surviving the merger as a wholly-owned subsidiary of the Company (the “Surviving Company”). The merger consideration payable to the stockholders of QPhoton (the “Merger Consideration”) consisted of (i) 5,802,206 shares of the Company’s common stock, par value $0.0001 per share, (ii) 2,377,028 shares of a new series of the Company’s preferred stock, par value $0.0001 per share, designated Series B convertible preferred stock (“Series B Preferred Stock”), and (iii) warrants to purchase up to 7,028,337 shares of Common Stock (the “QPhoton Warrants”). Each share of Series B Preferred Stock converts into 10 shares of the Company’s common stock. On an as-converted basis, the total Merger Consideration consisted of 36,600,823 shares of the company’s common stock. The Merger Consideration for shareholders Yuping Huang and Stevens Institute of Technology was issued in 2022. A third alleged shareholder, BV Advisory, rejected the Merger Consideration and commenced litigation in Delaware Chancery Court (see Note 9, Contingencies – Legal Proceedings, in this Amendment for additional information and Item 3, Legal Proceedings, in the Original Form 10-K for a full discussion), and to date that litigation has not been resolved. Accordingly, as of December 31, 2023 and 2022, we had only issued 32,940,738 shares of the Company’s common stock on an as-converted basis, which includes 26,615,235 shares of common stock and 6,325,503 of the QPhoton Warrants.

 

and the remaining Merger Consideration for the other stockholder of QPhoton will be issued upon presentation of certain required documents and surrender of their QPhoton shares.

 

The purchase price was approximately $71.0 million, or $69.9 million net of cash acquired, consisting of Company common stock, Series B Preferred Stock and QPhoton Warrants. The Merger Agreement did not include any contingent consideration, and under ASC 805, transaction costs are required to be expensed so legal and accounting fees incurred for the Transactions were not included in the purchase price. As the Transactions were structured as an exchange of equity securities, the purchase price was calculated based on the fair market value (in this case the Nasdaq closing price) of the total shares of the Company securities payable to the shareholders of the acquired company, QPhoton. The closing price of the Company’s common stock on June 16, 2022 was $2.27 (the “Merger Closing Stock Price”). While the total shares of the Company’s common stock offered for QPhoton on an as-converted basis was 36,600,823, the fair market valuation contemplated 31,299,417 of the shares, which assumed full conversion of the 2,377,028 shares of Series B Preferred Stock to common stock at the 10:1 ratio, and that only 1,726,931 of the 7,028,337 QPhoton Warrants would eventually be exercised to purchase common stock (specifically only the QPhoton Warrants for which the associated Company options and/or warrants had an exercise price at or below $2.27 at the time of the Transaction). The 1,726,931 QPhoton Warrants were valued at the Merger Closing Stock Price. Further, the QPhoton Warrants are treated as a derivative, whose value is tied to future value of the Company’s common stock, and will be marked-to-market on a quarterly basis.

 

The fair value of the prepaid expenses and security deposits was set at book value, and the fair value of the property and equipment was written up to the purchase cost to reflect the recent purchase dates of the equipment relative to the closing date of the Transactions. To estimate the fair value of the identifiable intangible assets, the Company engaged a third-party valuation expert (the “Third-Party Valuation Expert”), to conduct an independent analysis in line with purchase price accounting standards. The Third-Party Valuation Expert concluded:

 

●

that there was no fair value attributable to customer relationships due to the lack of current customer contracts;

 

F-18

 

 

●

a fair value of $3.25 million attributable to the non-compete agreement with the founder using the with-and-without method, based on a variation of the income approach. The with-and-without methodology employed uses two scenarios to value the non-compete asset: (1) the “with scenario” captures the estimated cash flows from the business if all of the existing assets were in place including the non-compete asset; and (2) the “without scenario” captures the estimated cash flows from the business if all of the existing assets were in place except the non-compete asset. The difference between the two scenarios is attributed to the presumed loss of cash flows without the non-compete asset in place and represents the value of the non-compete agreement;

 

●

a fair value of $1.0 million attributable to the QPhoton trade name and trademark using the relief from royalty methodology. In the application of the relief from royalty method, the Third-Party Valuation Expert estimated the value of the trade names/trademarks by capitalizing the royalties saved by virtue of the Company owning the trade names/trademarks. In other words, the Company realizes a benefit from owning the intangible asset rather than paying a rent or royalty for the use of the asset;

 

●

a fair value of $12.7 million attributable to the technology and licensed patents using the relief from royalty methodology. In calculating the fair value of the technology and licensed patents, the Third-Party Valuation Expert followed the same approach as the trade name/trademark analysis.

  

The Company accepted the Third-Party Valuation Expert’s valuation. Although the valuation analysis was performed in 2023, for the purposes of the consolidated financial statements in this Amendment, the Company has recorded and reported the results of the valuation as of the Closing date, June 16, 2022.

 

The following table summarizes the purchase price paid and adjusted acquisition date fair values of assets acquired and liabilities assumed by the Company, including the final results of the analysis performed by the Third-Party Valuation Expert for the intangibles (in thousands):

 

Purchase price
Common stock		$	13,171
Series B convertible preferred			53,959
Contingently issuable warrants			3,920
Purchase price			71,050
Less: cash acquired			(1,144	)
Purchase price, net of cash acquired			69,906
Less:
Prepaid expenses			16
Property and equipment at cost			116
Security deposits			98
Non-compete agreement with founder			3,251
Trade names and trademarks			1,009
Developed Technology and licensed patents			12,731
Accounts payable and other current liabilities			(2,888	)
Goodwill		$	55,573

  

F-19

 

 

The amount allocated to goodwill and intangible assets reflects the benefits the Company expected to realize from the growth of the acquisition’s operations.

 

Note Purchase Agreement – the Company and QPhoton

 

On February 18, 2022, the Company entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with QPhoton, pursuant to which the Company agreed to loan money to QPhoton using two unsecured promissory notes (each, a “Note”), each in the principal amount of $1.25 million, subject to the terms and conditions of the Note Purchase Agreement. Also, on February 18, 2022, pursuant to the terms of the Note Purchase Agreement, the Company loaned the principal amount of $1.25 million to QPhoton. On April 1, 2022, pursuant to the terms of the Note Purchase Agreement, the Company loaned the principal amount of $1.25 million to QPhoton, for a total loan under the two Notes of $2.5 million.

 

The Note Purchase Agreement contains customary representations and warranties by QPhoton and the Company, as well as a “most favored nations” provision for the benefit of the Company. The Notes issued under the Note Purchase Agreement, including the Notes issued on February 18, 2022 and April 1, 2022, provide that the indebtedness evidenced by the applicable Note bears simple interest at the rate of 6% per annum (or 15% per annum during the occurrence of an event of default, as defined in the Notes), and becomes due and payable in full on the earlier of (i) March 1, 2023, subject to extension by one year at the option of QPhoton, (ii) a change of control (as defined in the Notes) of QPhoton or (iii) an event of default. As a result of the merger, the Note and accrued interest is eliminated through consolidation. However, the two Notes were not forgiven or converted to equity and remain outstanding under the terms and conditions of the Note Purchase Agreement.

 

Note 5 – Intangible Assets and Goodwill

 

As a result of the merger with QPhoton, the Company has the following amounts related to intangible assets (in thousands):

 

 

		December 31, 2023												December 31, 2022
		Gross Carrying Amount				Accumulated Amortization				Net Carrying Amount				Gross Carrying Amount				Accumulated Amortization				Net Carrying Amount
Non-compete agreement with founder		$	3,251			$	(1,716	)		$	1,535			$	3,251			$	(632	)		$	2,619
Website domain name and trademark			1,009				(320	)			689				1,009				(118	)			891
Technology and licensed patents			12,731				(2,880	)			9,851				12,731				(1,061	)			11,670
Total		$	16,991			$	(4,915	)		$	12,076			$	16,991			$	(1,811	)		$	15,180

 

F-20

 

 

The amortization expense of the Company’s intangible assets for the years ended December 31, 2023 and 2022 was $3.1 million and $1.8 million, respectively. The Company expects future amortization expense to be the following (in thousands):

 

		Amortization
2024		$	3,104
2025			2,472
2026			2,021
2027			1,903
2028			1,819
Thereafter			757
Total		$	12,076

 

The Company recorded goodwill resulting from the Transactions, calculated as the difference between the total purchase price and the value of tangible and intangible assets acquired less the liabilities assumed. The Company recorded goodwill of $55.6 million resulting from the Transactions. The following table provides a summary of the changes in goodwill for the years ended December 31, 2023 and 2022 (in thousands):

 

		December 31,
		2023				2022
Goodwill, at beginning of year		$	55,573			$	-
Goodwill additions			-				55,573
Goodwill, at end of year		$	55,573			$	55,573

 

The Company tested the intangible assets and goodwill for impairment as of December 31, 2023 and concluded there was no impairment of intangible assets or goodwill at that time.

 

Note 6 – Income Taxes:

 

The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, management concludes that it is more-likely-than-not that the deferred tax assets will not be realized. Realization of deferred tax assets is also dependent upon future earnings, if any, the timing and amount of which are uncertain.

 

The Company records a liability for the uncertain tax positions taken or expected to be taken on the Company’s tax return when it is more-likely-than-not that the tax position might be challenged despite the Company’s belief that the tax return positions are fully supportable, and additional taxes will be due as a result. To the extent that the assessment of such tax positions changes, for example, based on the outcome of a tax audit, the change in estimate is recorded in the period in which the determination is made. The provision for income taxes includes the impact of provisions for uncertain tax positions.

 

F-21

 

 

Income tax expense attributable to pretax loss from continuing operations differed from the amounts computed by applying the U.S. federal income tax rate of 21% to pretax loss from continuing operations as a result of both temporary and permanent differences in the U.S. GAAP vs tax treatment of certain types of expenses, including stock-based compensation, depreciation and amortization, research and development and meals and entertainment. Additionally, the Company's policy is to account for interest and penalties as income tax expense. As of December 31, 2023, the Company had no interest related to unrecognized tax benefits, and no amounts for penalties related to unrecognized tax benefits were recognized in the provision for income taxes. We do not anticipate any significant change within twelve months of this reporting date.

 

As of December 31, 2023, the Company had federal and state net operating loss carryforwards of approximately $49 million. All of the federal NOL carryforwards were generated during 2018 or later and will carryforward indefinitely but will be subject to 80% taxable income limitation beginning tax years after December 31, 2021, as provided by the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act (PL 116-136). Furthermore, the utilization of NOLs and tax credit carryforwards to offset future taxable income may be subject to an annual limitation as a result of ownership changes that have occurred previously or may occur in the future. Under Sections 382 and 383 of the Internal Revenue Code, a corporation that undergoes an ownership change may be subject to limitations on its ability to utilize its pre-change NOLs and other tax attributes otherwise available to offset future taxable income and/or tax liability. An ownership change is defined as a cumulative change of 50% or more in the ownership positions of certain stockholders during a rolling three-year period. The Company has determined that ownership changes have occurred, primarily driven by the Transactions, and hence the Company’s ability to use its NOLs or tax credit carryforwards may be restricted.

 

As of December 31, 2023, in addition to the $13 million in tax-effected NOL carryforwards, at an assumed tax rate of 26%, the significant components of the Company’s net deferred tax assets included stock-based compensation of $11 million, capitalized research and development expenditures of approximately $2 million and an intangible asset basis difference of $1 million. As of December 31, 2022, in addition to the $9 million in tax-effected NOL carryforwards, also at an assumed tax rate of 26%, the significant components of the Company’s net deferred tax assets included stock-based compensation of $10 million and capitalized research and development expenditures of approximately $1 million. The Company believes that it is more likely than not that the benefit from the net deferred tax assets will not be realized. Accordingly, it has provided a full valuation allowance on any potential deferred tax assets The valuation allowance increased by approximately $6.0 million for the period ended December 31, 2023. The provision for income taxes is not material in the years presented due to there being no taxable income.

 

The Company has federal R&D credit carryforwards of approximately $250,000 which will be applied against payroll taxes, not against income taxes. The Company has no state R&D credit carryforwards.

 

The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions, with varying statutes of limitations. The tax years from inception through 2023 remain open to examination due to the carryover of unused net operating losses that are being carried forward for tax purposes.

  

F-22

 

 

Note 7 – Property and Equipment

 

The Company’s property and equipment are primarily located at the Company’s leased facilities in Hoboken, NJ and Tempe, AZ and consist of (in thousands):

 

		December 31,
Classification		2023				2022
Computer and lab equipment		$	2,999			$	985
Network equipment			29				12
Furniture and fixtures			32				28
Software			49				19
Leasehold improvements			33				3
Total cost of property and equipment			3,142				1,046
Accumulated depreciation			272				71
Property and equipment, net		$	2,870			$	975

 

The Company recorded depreciation expense of $203 thousand and $52 thousand during the years ended December 31, 2023 and 2022, respectively, using useful lives of the Company’s long-lived assets are as follows:

 

		Estimated Useful Life (Years)
Computer and laboratory equipment		5
Network equipment		4
Furniture and fixtures		7
Software		3
Leasehold improvements		Lessor of lease term or 5

 

Maintenance and repairs are charged to operations when incurred. When property and equipment are sold or otherwise disposed, the asset account and related accumulated depreciation and amortization accounts are relieved, and any gain or loss is included in other income or expense.

 

Note 8 – Financial Liabilities

 

The Company has the following amounts related to financial liabilities (in thousands):

 

		December 31,
		2023				2022
Remaining loan balances		$	2,063			$	8,250
Remaining unamortized debt issuance costs			(138	)			(1,062	)
Financial liabilities, net		$	1,925			$	7,188

 

Additionally, the Company has accrued interest of $14 thousand and $223 thousand as of December 31, 2023 and 2022, respectively, which is included in Other Current Liabilities.

 

Unsecured Promissory Note

 

On September 23, 2022, the Company entered into a note purchase agreement (the “Unsecured NPA”) with Streeterville Capital, LLC (“Streeterville”), pursuant to which Streeterville purchased an unsecured promissory note (the “Note” or the “Streeterville Unsecured Note”) in the initial principal amount of $8.25 million. The Note bears interest at 10% per annum. The maturity date of the Note is 18 months from the date of its issuance (the “Maturity Date”). The Note carries an original issue discount of $750 thousand, which is included in the principal balance of the Note. If the Company elects to prepay the Note prior to the Maturity Date, it must pay to Streeterville 120% of the portion of the Outstanding Balance the Company elects to prepay.

 

Beginning on the date that was six months after the issuance date of the Note, Streeterville has the right to redeem up to $750 thousand of the outstanding balance of the Note per month (“Redemption Amount”) by providing written notice to the Company (“Redemption Notice”). Upon receipt of any Redemption Notice, the Company shall pay the applicable Redemption Amount in cash to Streeterville within three trading days of the Company’s receipt of such Redemption Notice. No prepayment premium shall be payable in respect of any Redemption Amount. As of December 31, 2023, Streeterville has redeemed $7.0 million of the outstanding balance of the Note. The outstanding balances were $1.9 million and $7.2 million as of December 31, 2023 and 2022, respectively

 

F-23

 

 

Pursuant to the terms of the Unsecured NPA, the parties provided customary representations and warranties to each other. Also, until amounts due under the Note are paid in full, the Company agreed, among other things, to: (i) timely make all filings under the Securities Exchange Act of 1934, (ii) ensure the Company’s common stock continues to be listed on the Nasdaq, (iii) ensure trading in the Company’s common stock will not be suspended, halted, chilled, frozen, reach zero bid or otherwise cease trading on Company’s principal trading market, (iv) ensure the Company will not make any Restricted Issuance (as defined in the Note) without Streeterville’s prior written consent, which consent may be granted or withheld in Streeterville’s sole and absolute discretion, (v) ensure the Company will not enter into any agreement or otherwise agree to any covenant, condition, or obligation that locks up, restricts in any way or otherwise prohibits the Company from entering into certain additional transactions with Streeterville, and (vi) with the exception for Permitted Liens (as defined in the Note) ensure the Company will not pledge or grant a security interest in any of its assets without Streeterville’s prior written consent, which consent may be granted on withheld in Streeterville’s sole and absolute discretion.

 

The Note sets forth certain standard events of default (such event, an “Event of Default”) that generally, if uncured within seven trading days, may result in the discretion of Streeterville in certain penalties under the terms of the Note. In this regard, upon an Event of Default, Streeterville may accelerate the Note by written notice to the Company, with the outstanding balance becoming immediately due and payable in cash at the Mandatory Default Amount (as defined in the Note). Additionally, upon written notice given by Streeterville to the Company, interest shall accrue on the Outstanding Balance beginning on the date the applicable Event of Default occurred at an interest rate equal to the lesser of 15% per annum simple interest or the maximum rate permitted under applicable law upon an Event of Default.

 

Note 9 – Contingencies 

 

Indemnification Arrangements

 

We enter into standard indemnification arrangements in our ordinary course of business. Pursuant to these arrangements, we indemnify, hold harmless, and agree to reimburse the indemnified parties for losses suffered or incurred by the indemnified parties (generally our business partners or customers) in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to our products. The term of these indemnification agreements is generally perpetual any time after the execution of the agreement. The maximum potential amount of future payments we could be required to make under these agreements is not determinable. We have never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the estimated fair value of these agreements is minimal.

 

We have entered into indemnification agreements with our directors and officers that may require us to indemnify our directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of a culpable nature. These agreements also require us to advance their expenses incurred as a result of any proceeding against them as to which they could be indemnified and to make good faith determination whether or not it is practicable for us to obtain directors and officers insurance. We currently have directors and officers liability insurance.

 

Legal Proceedings

 

From time to time, we may be involved in legal proceedings arising in the ordinary course of business. In general, management believes that ordinary course of business matters will not have a material adverse effect on our financial position or results of operations and are adequately covered by our liability insurance. However, it is possible that consolidated cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one of more of these contingencies or because of the diversion of management’s attention and the incurrence of significant expenses.

 

As part of our business combination with QPhoton in June 2022, we acquired a payable to BV Advisory Partners, LLC (“BV Advisory”). On March 1, 2021, QPhoton entered into a Note Purchase Agreement with BV Advisory. Under the Note Purchase Agreement, on March 1, 2021, March 23, 2021 and July 9, 2021, BV Advisory purchased convertible promissory notes from QPhoton for $200 thousand, $150 thousand, and $150 thousand, respectively, for a total of $501 thousand (the “BV Notes”), which is included in Other Current Liabilities as of December 31 2023 and 2022. The BV Notes all bore interest at a rate of 6% per annum and matured two years from the grant date. However, QPhoton only received approximately $375 thousand in cash proceeds as $125 thousand was paid by BV Advisory directly to The Trustees of the Stevens Institute of Technology (“Stevens Institute”) on behalf of QPhoton to satisfy QPhoton’s obligations to reimburse costs incurred under the terms of their patent license agreement with the Stevens Institute.

 

On June 16, 2022, QPhoton tendered a cashier’s check to BV Advisory in the amount of $535,684, representing the full principal balance of the BV Notes and accrued interest through June 16, 2022. On July 14, 2022 BV Advisory returned the cashier’s check and disputed the calculation of the amount paid to settle the BV Notes. The BV Notes and accrued interest are recorded as short-term liabilities. On August 15, 2022, BV Advisory filed a complaint in the Court of Chancery of the State of Delaware naming the Company and certain of its directors and officers (among others) as defendants. BV Advisory Partners, LLC v. Quantum Computing Inc., et al., C.A. No. 2022-0719-VCG (Del. Ch.). BV Advisory seeks, among other relief, monetary damages for an alleged breach of the Note Purchase Agreement between BV Advisory and QPhoton, Inc., the predecessor in interest to QPhoton, LLC, as well as monetary damages for breach of an alleged binding letter of intent among Barksdale Global Holdings, LLC, Inference Ventures, LLC and QPhoton, Inc. The Company believes that BV Advisory’s claims have no merit and intends to defend itself vigorously. The Company filed a motion to dismiss the complaint in December 2022, and in March 2023 Plaintiff filed a second amended complaint. The Company filed a motion to dismiss the second amended complaint, oral argument was held on October 11, 2023 and at this time that motion is pending before the Court. BV Advisory’s claims are not covered by the Company’s liability insurance. The Company does not believe it is necessary to accrue an amount in addition to the principal and interest on the BV Notes at this time. 

 

Note 10 – Loan Receivable

 

On May 16, 2023, the Company entered into a Summary of Proposed Terms (the “Letter of Intent”) with millionways to provide bridge loans to millionways and enter into due diligence to acquire up to 100% of the AI firm. On June 6, 2023, the Company entered into a Note Purchase Agreement (the “MW Agreement”) with millionways, pursuant to which the Company agreed to purchase from millionways up to three unsecured promissory notes (each, a “MW Note”), in an aggregate principal amount of up to $2.0 million, subject to the terms and conditions of the MW Agreement. Also on June 6, 2023, pursuant to the terms of the MW Agreement, the Company purchased the MW Notes from millionways and loaned an aggregate principal amount of $500 thousand to millionways.

F-24

 

 

The MW Agreement contains customary representations and warranties by millionways and the Company, as well as a “most favored nations” provision for the benefit of the Company. The MW Notes issued under the MW Agreement, including the MW Notes issued on June 6, 2023, provide that the indebtedness evidenced by the applicable MW Note bears simple interest at the rate of 10% per annum (or 15% per annum during the occurrence of an event of default, as defined in the MW Notes), and becomes due and payable in full on the earlier of (i) May 16, 2024, (ii) a change of control (as defined in the MW Notes) of millionways, (iii) dollar-for-dollar prepayment for additional capital received through any vehicle from a third party or (iv) an event of default.

 

The Company reserved $279 thousand of the outstanding $558 thousand receivable as uncollectible based on credit risk in the consolidated financial statements as of December 31, 2023.

 

Note 11 – Capital Stock:

 

Series A Convertible Preferred Offering

 

From November 10, 2021 through November 17, 2021, the Company conducted a private placement offering (the “Private Placement”) pursuant to securities purchase agreements with 7 accredited investors (the “Series A Investors”), whereby the Series A Investors purchased from the Company an aggregate of 1,545,459 shares of the Company’s newly created Series A convertible preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”) and warrants to purchase 1,545,459 shares of the Company’s common stock (the “Preferred Warrants”) for an aggregate purchase price of $8.5 million. The Private Placement was completed and closed to further investment on November 17, 2021.

 

The Series A Preferred Stock ranks senior to common stock with respect to the payment of dividends and liquidation rights. Each holder of Series A Preferred Stock is entitled to receive, with respect to each share of Series A Preferred Stock then outstanding and held by such holder, dividends at the rate of 10% per annum (the “Preferred Dividends.”) The Company is obligated to pay the Preferred Dividends quarterly, in arrears, within fifteen days of the end of each quarter. The Company has the option to pay the Preferred Dividends in cash or in the Company’s common stock, at a price per share of common stock equal to the average of the closing sale price of the common stock for the five trading days preceding the applicable dividend payment date. The Preferred Dividends are accrued monthly, but not compounded, and are recorded as interest expense, because the Preferred Dividends are mandatory and not declared at the discretion of the Board of Directors.

 

The number of shares of the Company’s common stock issuable upon conversion of any share of Series A Preferred Stock shall be determined by dividing (x) the Conversion Amount of such share of Series A Preferred Stock by (y) the Conversion Price. “Conversion Amount” means, with respect to each share of Series A Preferred Stock, as of the applicable date of determination, the sum of (1) the stated value thereof plus (2) any accrued dividends. “Conversion Price” means, with respect to each share of Series A Preferred Stock, as of any optional conversion date, Mandatory Conversion Date or other date of determination, $5.50, subject to adjustment for stock splits, dividends, recapitalizations and similar corporate events.

 

The Preferred Warrants are two-year warrants to purchase shares of the Company’s common stock at an exercise price of $7.00 per share, subject to adjustment, and are exercisable at any time on or after the date that is six months following the issuance date. The Preferred Warrants provide for cashless exercise in the event the underlying shares of the Company’s common stock are not registered. As of December 31, 2023, all of the Preferred Warrants had expired unexercised.

 

In connection with the Purchase Agreement, the Company and the Series A Investors entered into a registration rights agreement (the “Registration Rights Agreement”) pursuant to which the Company agreed to file a registration statement to register the shares of common stock underlying the Series A Preferred Stock and warrants within 180 days. Pursuant to the Registration Rights Agreement, the Series A Investors received certain rights, including but not limited to piggyback registration rights, providing that the holder be given notice of any proposed registration of securities by the Company, and requiring that the Company register all or any portion of the registrable securities that the holders request to be registered, in each case, subject to the terms and conditions of the Registration Rights Agreement.

 

On April 27, 2022, the Company filed a Resale Form S-3 as required by the Registration Rights Agreement, pursuant to which the Company agreed to file a registration statement to register the shares of common stock underlying the Series A Preferred Stock and warrants within 180 days from the closing of the Private Placement. The Resale Form S-3 went effective on June 2, 2022.

 

On June 13, 2022, one of the Series A Investors, Falcon Capital Partners, converted 45,455 shares of Series A Preferred stock into 47,728 shares of the Company’s common stock.

 

On February 9, 2023, one of the Series A Investors, Greenfield Children, LLC, converted 10,000 shares of Series A Preferred stock plus accrued dividends into 11,096 shares of the Company’s common stock.

 

Authorized Classes of Stock

 

As of September 9, 2024, the Board has authorized two classes of preferred stock. The Board has authorized 1,550,000 shares of preferred stock as the Series A Preferred stock, par value $0.0001 per share, of which 1,490,004 shares are issued and outstanding. The Board has also authorized 3,079,864 shares of preferred stock as the Series B Preferred Stock, par value $0.0001 per share, none of which are issued and outstanding.

 

F-25

 

 

At-the-Market Facility

 

From January 19, 2023 through December 31, 2023, the Company sold 17,571,926 shares of common stock through its At-The-Market (ATM) facility, managed by Ascendiant Capital Markets, LLC, at an average price of $1.45. The Company received net proceeds of $24.7 million.

 

Warrants

  

The table below summarizes the warrants outstanding as of December 31, 2023 (in thousands, except exercise prices):

 

Issuance Date		Expiration Date		Exercise Price				Issued				Exercised				Forfeited / Canceled				Warrants Outstanding
August 18, 2020		August 18, 2025		$	2.00				171				(150	)			-				21
November 15, 2021		November 15, 2023		$	7.00				1,545								(1,545	)			-
June 16, 2022		May 9, 2027		$	0.0001				6,325				-				(3,309	)			3,016

 

In connection with a restricted stock units offering in June 2020, the Company issued warrants in August 2020 to purchase 171,000 shares of the Company’s common stock, at an exercise price of $2.00. Those warrants are exercisable for five years from the date of issuance.

 

In connection with the offering of Series A Preferred Stock in November 2021, the Company issued warrants to purchase 1,545,459 shares of the Company’s common stock at an exercise price of $7.00. Those warrants were exercisable for two years from the date of issuance and have now expired.

 

In connection with the QPhoton Merger on June 16, 2022, the Company issued warrants to purchase 6,325,503 shares of the Company’s common stock at an exercise price of $0.0001. Those warrants are exercisable when and if stock options and warrants issued and outstanding as of June 15, 2022 (the “Underlying Options”), are exercised. As of December 31, 2023, none of the QPhoton Warrants linked to the outstanding Underlying Options are expected to be exercised as the exercise prices of the Underlying Options are above the current stock price as of December 31, 2023. The total Merger Consideration consisted of 36,600,823 shares of the Company’s common stock on an as-converted basis, including the 7,028,337 QPhoton Warrants. As discussed in Note 4, Business Combinations, two QPhoton shareholders received their Merger Consideration and a third alleged shareholder rejected the Merger Consideration and commenced litigation in Delaware Chancery Court (see Note 9, Contingencies – Legal Proceedings, in this Amendment for additional information and Item 3, Legal Proceedings, in the Original Form 10-K for a full discussion), and to date that litigation has not been resolved. Accordingly, as of December 31, 2023 and 2022, we had only issued 6,325,503 of the QPhoton Warrants, of which approximately 52% have been forfeited as of December 31, 2023. Further, as discussed in Note 2, Significant Accounting Policies – Fair Value of Financial Instruments, the QPhoton Warrants issued on June 16, 2022, are considered Level 3 liabilities for fair value measurement on the valuation hierarchy. Accordingly, the Company recognized mark-to-market gains of $528 thousand and $3.4 million during the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, the QPhoton Warrants have no carrying value as a liability on the Company’s consolidated balance sheet.

 

Note 12 – Stock-based Compensation

 

Incentive Plans

 

The Company’s 2019 Equity and Incentive Plan, as amended in 2021 (the “2019 Plan”) enabled the Company to grant incentive stock options or nonqualified stock options and other equity awards to employees, directors and consultants of the Company up to a total of 3 million shares of common stock. All 3 million shares available for issue under the 2019 Plan have been issued.

 

On July 5, 2022, the Board of Directors adopted the Company’s 2022. Equity and Incentive Plan (the “2022 Plan”), which provides for the issuance of up to 16 million shares of the Company’s common stock. The 2022 Plan was approved by a majority of the stockholders in September 2022. Per the 2022 Plan, the 2022 Plan reserves increased automatically by 1 million shares on January 1, 2023, providing for a total issuance of up to 17 million shares of common stock. As of December 31, 2023, a total of 13.8 million shares and options were issued and outstanding under the 2022 Plan.

 

Options

 

The following table presents the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted:

 

		Year Ended
		December 31,
		2023				2022
Exercise price			$0.85 – 1.84				$1.67 – 2.61
Risk-free interest rate			4.7 – 5.0%				0.6 – 4.5%
Expected volatility			98 – 137%				127 – 164%
Expected dividend yield			0%				0%
Expected life of options (in years)			5.0				5.0

 

F-26

 

 

The following table summarizes the Company’s option activity:

 

Weighted Average Number of Shares (in thousands)		Weighted Average Exercise Price								Contractual Term (in years)
Outstanding as of December 31, 2021
As previously reported			5,197			$	7.68				2.5
Adjustments (1)			(1,100	)			(2.45	)			1.4
As restated			4,097				5.23				3.9
Granted			6,853				1.38				5.0
Forfeited			(1,785	)			3.17				-
Outstanding as of December 31, 2022			9,165				3.51				4.2
Granted			5,340				1.38				5.0
Forfeited			(662	)			4.41				-
Outstanding as of December 31, 2023			13,843			$	2.64				3.7
Vested as of December 31, 2022			6,413			$	3.58				4.2
Vested as of December 31, 2023			8,803			$	3.21				3.4

 

The following table summarizes the exercise price range as of December 31, 2023 (in thousands):

 

Exercise Price				Outstanding Options				Exercisable Options
$	0.00 – 1.00				180				10
$	1.00 – 2.00				5,695				1,935
$	2.00 – 3.00				6,359				5,318
$	3.00 – 5.00				65				65
$	5.00 – 7.00				726				713
$	7.00 – 12.00				818				762
					13,843				8,803

 

The weighted average grant-date fair value of stock options granted during the years ended December 31, 2023 and 2022 was $1.38 per share and $2.39 per share, respectively, and as of December 31, 2023, total unrecognized compensation cost related to common stock options was $5.8 million, which is expected to be recognized over a period of 4.0 years.

 

Stock-based compensation

 

The Company recognized stock-based compensation expense related to common stock options and restricted shares of common stock in the following expense categories of its consolidated statements of operations (in thousands):

 

		Year Ended December 31,
		2023				2022
Research and development			2,080				509
Selling and marketing			(279	)			494
General and administrative			2,470				8,320
Total stock-based compensation		$	4,271			$	9,323

 

For the years ended December 31, 2023 and 2022, the statement of stockholders’ equity was lower by $33 thousand and higher by $170 thousand, respectively, as compared to the statement of cash flows for timing differences between award dates and the realization of stock-based compensation expense.

 

In terms of new issuances, the Company issued 2,353,600 shares of common stock to employees in 2023 as performance and incentive awards (the “2023 Incentive Shares”), as compared to 20,000 in such awards in 2022. The 2023 Incentive Shares included 853,600 shares of common stock issued to 35 employees as payment in lieu of cash for 2022 performance bonuses (the “Bonus Incentive Shares”) and 1,500,000 shares of common stock as long-term incentive bonuses to five employees identified as key technical staff (the “Retention Incentive Shares”). The Bonus Incentive Shares are restricted with the following vesting schedule: one-half vested on December 31, 2023 and one-half vesting on December 31, 2024. As of December 31, 2023, the Company canceled 23,600 of the issued shares that were forfeited by employees no longer with the Company. The Retention Incentive Shares are restricted and will vest annually in equal amounts over a five-year period as follows: twenty percent (20%) will vest on each of December 31, 2023, December 31, 2024¸ December 31, 2025, December 31, 2026, and December 31, 2027, subject to the grantee continuing to perform services for the Company in the capacity in which the grant was received on each applicable vesting date. In conjunction with these offerings, the Company recognized $1.1 million of stock-based compensation expense during the year ended December 31, 2023, and expects future expense related to these offerings to total $2.1 million over the remaining vesting periods. 

  

F-27

 

 

Stock-based compensation for services

 

The Company recognized $284 thousand and $2.4 million during the years ended December 31, 2023 and 2022, respectively, in stock-based compensation for services in lieu of cash payments to certain consultants, including expenses for both shares issued and stock option awards granted. The difference in stock-based compensation for services on the statement of stockholders’ equity as compared to the statement of cash flows for the years ended December 31, 2023 and 2022, was driven by approximately $2.3 million in shares awarded to a consultant who served as an advisor on the QPhoton Merger, comprised of 750,000 shares of common stock to Draper, Inc. and 750,000 shares of common stock to Carriage House Capital, Inc. The expense was recognized in 2022 at the time of the merger, though the shares were not awarded and issued until 2023. Also in 2023, the Company issued 75,000 shares of common stock to FMW Media Works as compensation for services rendered in support of marketing and communications.

 

In 2022, the Company issued 157,000 shares of common stock as compensation for services rendered in support of business development activities.

 

Note 13 – Related Party Transactions

 

There were no related party transactions during the years ended December 31, 2023 and 2022. 

 

Note 14 – Operating Leases:

 

The Company has use of space in five different locations, Hoboken, NJ, Tempe, AZ, Leesburg, VA, Arlington, VA, and Minneapolis, MN, under lease or membership agreements, which expire at various dates through October 31, 2028. The Company’s leases do not provide an implicit rate, and the rates implicit in our leases are not readily determinable. Therefore, the Company uses its incremental borrowing rate as the discount rate when measuring operating lease assets and liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. The Company’s leases all contain options to extend or renew the lease or membership term.

 

The table below reconciles the undiscounted future minimum lease payments under these operating leases to the total operating lease liabilities recognized on the consolidate balance sheet as of December 31, 2023 (in thousands):

 

Year		Lease Payments Due
2024		$	383
2025			576
2026			592
2027			516
2028			191
Total minimum payments			2,258
Less: imputed Interest			(1,298	)
Present value of operating lease liabilities			960
Less: current portion included in other current liabilities			(120	)
Long-term operating lease liabilities			840

 

Other information related to operating lease liabilities consists of the following:

 

		Year Ended December 31,
		2023				2022
Cash paid for operating lease liabilities (in thousands)		$	411			$	125
Weighted average remaining lease term in years			3.7				4.7
Weighted average discount rate			10	%			10	%

 

F-28

 

 

Note 15 – License Agreement – Stevens Institute of Technology

 

Effective December 17^th, 2020, QPhoton signed a License Agreement with the Stevens Institute. The License Agreement enables the Company to commercially use technology such as licensed patents, licensed patent applications and licensed “Know-How”. QPhoton is also able to issue sublicenses for the technology under the agreement. The agreement is effective until the later of: (i) the 30-year anniversary of the effective date, or (ii) the expiration of the licensed patent or licensed patent application that is last to expire. As part of the merger of the Company and QPhoton, the Stevens License Agreement was assigned to the Company.

 

During the term of the agreement and prior to any commercialization or sublicensing of the technology by the Company, the Company shall be required to submit annual reports to the Stevens Institute reporting on all research, development, and efforts toward commercialization and/or sublicensing made during the year. Once any commercialization and/or sublicensing has been initiated, the Company shall deliver quarterly reports to the Stevens Institute reporting on the revenue received by the Company, all sublicenses derived from the sale of licensed products, and the net sales price associated with each transaction. The Company will be responsible for reimbursing Stevens for any costs associated with the prosecution and maintenance of the licensed patents and licensed patent applications moving forward.

 

Consideration for the agreement

 

As consideration for the license and other rights granted under the agreement, QPhoton agreed to pay the following: (i) $35 thousand within 30 days of execution of the agreement, (ii) $28 thousand within 30 days of each annual anniversary of the effective date, (iii) equity in the Company equivalent to nine percent of the membership units of the Company within 30 days of the execution of the agreement, and (iv) royalties of 3.5% of the Net Sales Price of each licensed product sold or licensed by the Company during the quarter then-ended, for which it also received payment, concurrent with the delivery of the relevant quarterly report.

 

As of December 31, 2023, the Company has begun to commercialize some of the licensed technology, though the Company has not recorded any related revenue and hence has not incurred any royalty expenses payable to the Stevens Institute.

 

Note 16 – Subsequent Events 

 

On January 31, 2024, BV Advisory and its chief executive officer, Keith Barksdale (the “BV Defendants”), alleged stockholders of and claimants against the Company, filed a motion for reconsideration of his original 2023 motion to dismiss. The motion and our opposition were argued before the Superior Court of New Jersey (the “NJ Court”) on February 15, 2024. On March 7, 2024, the NJ Court issued an order, granting the BV Defendant’s motion dismissing the Company’s case on procedural grounds because, according to the NJ Court, the Company can assert its claims. On April 1, 2024, the Company filed a motion in New Jersey Superior Court for reconsideration of the Court’s March 7, 2024 order dismissing the Company’s defamation and fraud complaint (the “QCi v BV Complaint in NJ Court”) against the BV Defendants on procedural grounds. On May 1, 2024, the NJ Court affirmed its initial order dismissing the case with prejudice and directed the Company to file its claims in Delaware. The Company, as plantiff on the QCi v BV Complaint in NJ Court, is currently evaluating whether it should file the claims in Delaware. On May 28, 2024, the Delaware Court of Chancery issued rulings dismissing the BV Advisory petition to appoint a receiver for the Company without prejudice and granting in part the Company’s motion to dismiss the BV Advisory lawsuit for breach of contract and related claims, dismissing eight of the ten counts in the complaint. The Parties are working with the Court to schedule briefing and resolution of the two remaining counts.

 

From January 1, 2024, through March 1, 2024, the Company repaid $2,094,378 of principal and accrued interest on the Streeterville Unsecured Note, for a cumulative redemption amount of $9,094,378. As of March 1, 2024, the Company had fully repaid the Streeterville Unsecured Note.

 

On March 19, 2024, the Company entered into a Redemption and Waiver Agreement (the “Redemption Agreement”) with the current holders (the “Series A Holders”) of its Series A Preferred Stock. Pursuant to the Redemption Agreement, the Company agreed to redeem all outstanding shares of the Series A Preferred Stock for an aggregate cash purchase price of $8,195,000, or $5.50 per share, at its sole discretion, in 18 monthly payments (each a “Monthly Redemption Threshold” payment), which may be accelerated at the Company’s sole discretion. In addition, the Series A Holders agreed to waive (the “Waivers”), on a month-by-month basis following each monthly payment, certain rights granted to them in (i) the Preferred Stock Certificate of Designation (the “Preferred Stock COD”), including for the accrual and payment of accrued and future dividends; and (ii) the Preferred Stock Securities Purchase Agreement (the “Preferred Stock SPA”). In the event the Company opts to not make a Monthly Redemption Threshold payment, the Waivers are forfeited and the terms revert to those detailed in the Preferred Stock COD and Preferred Stock SPA. As of September 9, 2024, the Company has redeemed 496,698 shares of Series A Preferred Stock for a cumulative redemption amount of $2.7 million in cash paid to the Series A Holders. As of September 9, 2024 there are 993,306 shares of Series A Preferred Stock issued and outstanding.

 

On August 6, 2024, the Company entered into a Securities Purchase Agreement with Streeterville, pursuant to which the Company issued and sold to Streeterville a Secured Convertible Promissory Note (the “Streeterville Secured Convertible Note”) in the original principal amount of $8.25 million (the “Principal Amount”). The Principal Amount includes an original issue discount of $750 thousand. In exchange for the Streeterville Secured Convertible Note, Streeterville paid $7.5 million in cash. The Streeterville Secured Convertible Note accrues interest at a rate of 10% per annum and has a maturity date of 18 months from the Effective Date, unless earlier prepaid, redeemed or accelerated in accordance with its terms prior to such date. The Company intends to use the net proceeds from the sale of the Streeterville Secured Convertible Note primarily for general working capital purposes, including for (i) operations as the Company increases its sales and marketing efforts; (ii) capital expenditures in outfitting its chip fabrication facility in Tempe, AZ; and (iii) for any other planned or unplanned expenditures that might arise in support of the Company’s business plan. Ascendiant Capital Markets, LLC served as the placement agent on the transaction and received a fee of $450 thousand.

 

There are no other events of a subsequent nature that in management’s opinion are reportable.

 

F-29

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-269063, 333-268064 and 333-264518) of Quantum Computing Inc. of our report (which contains an explanatory paragraph relating to the Company’s ability to continue as a going concern as described in Note 1 to the consolidated financial statements) dated September 11, 2024 relating to the consolidated financial statements, which appears in this Amendment No. 1 to the Annual Report on Form 10-K.

 

/s/ BPM LLP

 

San Jose, California

September 11, 2024

 

 

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Dr. William McGann, certify that:

 

1.	I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of Quantum Computing, Inc.;

 

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.	[Omitted]; and

 

5.	[Omitted].

 

Date: September 10, 2024	By:	/s/ Dr. William McGann
		Dr. William McGann
		Principal Executive Officer Quantum Computing, Inc.

 

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Christopher Boehmler, certify that:

 

1.	I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of Quantum Computing, Inc.;

 

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.	[Omitted]; and

 

5.	[Omitted].

 

Date: September 10, 2024	By:	/s/ Christopher Boehmler
		Christopher Boehmler
		Principal Financial Officer Quantum Computing, Inc.

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Amendment No. 1 to the Annual Report of Quantum Computing, Inc. (the “Company”) on Form 10-K/A for the period ended December 31, 2023, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Dr. William McGann, Principal Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: September 10, 2024	By:	/s/ Dr. William McGann
		Dr. William McGann
		Principal Executive Officer Quantum Computing, Inc.

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Amendment No. 1 to the Annual Report of Quantum Computing, Inc. (the “Company”) on Form 10-K/A for the period ended December 31, 2023, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher Boehmler, Principal Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: September 10, 2024	By:	/s/ Christopher Boehmler
		Christopher Boehmler
		Principal Financial Officer Quantum Computing, Inc.

 

 

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2023	Sep. 09, 2024	Jun. 30, 2023
Document Information Line Items
Entity Registrant Name	QUANTUM COMPUTING INC.
Trading Symbol	QUBT
Document Type	10-K/A
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		94,210,626
Entity Public Float			$ 46,073,808
Amendment Flag	true
Amendment Description	Quantum Computing Inc. (the “Company,” “we,” “us,” “our” and other similar terms) is filing this Amendment No. 1 (this “Amendment”) to its Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on April 1, 2024 (the “Original Form 10-K”), to restate its consolidated financial statements, including the notes thereto, for the years ended December 31, 2023 and 2022, contained in the Original Form 10-K, and to replace the Report of Independent Registered Public Accounting Firm prepared by BF Borgers CPA PC (“BF Borgers”) included in the Original Form 10-K with the Report of Independent Registered Public Accounting Firm from BPM LLP (“BPM”) included in this Amendment, and to make certain other changes as described herein. This Amendment is being filed as a result of the SEC’s order of May 3, 2024 suspending BF Borgers from appearing and practicing as an accountant before the SEC and the Company’s subsequent retention of BPM to replace BF Borgers as its independent registered public accounting firm.The following items have also been amended to reflect the above-referenced amendments: ●Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; ●Part III, Item 14. Principal Accountant Fees and Services; and ●Part IV, Item 15. Exhibits and Financial Statement Schedules. The Company’s Principal Executive Officer and Principal Financial Officer have provided new certifications dated as of the date of this filing in connection with this Amendment (Exhibits 31.1, 31.2, 32.1 and 32.2).The restated and re-audited consolidated financial statements update and revise items in our consolidated financial statements and footnotes to the consolidated financial statements, including (1) expanding and revising certain disclosures; (2) changing the presentation of certain classifications, including the Series A Preferred Stock dividends and categorization of operating expenses; and (3) adjusting certain errors, omissions or changes in accounting policies, including (i) correcting the purchase accounting relating to the Company’s June 2022 merger with QPhoton, Inc., (ii) adjusting stock-based compensation expenses and related prior period retained earnings to reflect a change in our accounting policy election to account for forfeitures as they occur, (iii) adjusting the valuation of the Series A convertible preferred stock warrants, (iv) correcting the historical and subsequent accounting for debt and equity issuance costs, (v) reserving a collection risk for loans receivable; and (vi) adjusting the recognition period for certain operating expenditures.Except as described above, no other portion of the Original Form 10-K is being amended and this Amendment does not reflect any events occurring after the filing of the Form 10-K.
Entity Central Index Key	0001758009
Entity Current Reporting Status	No
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
ICFR Auditor Attestation Flag	false
Document Annual Report	true
Document Transition Report	false
Entity File Number	001-40615
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-4533053
Entity Address, Address Line One	5 Marine View Plaza
Entity Address, Address Line Two	Suite 214
Entity Address, City or Town	Hoboken
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07030
City Area Code	(703)
Local Phone Number	436-2121
Title of 12(b) Security	Common Stock, par value $.0001
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Document Financial Statement Error Correction [Flag]	true
Document Financial Statement Restatement Recovery Analysis [Flag]	false
Documents Incorporated by Reference [Text Block]	None
Auditor Firm ID	207
Auditor Name	BPM LLP
Auditor Location	San Jose, California

Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	[1]	$ 2,059	$ 5,308
Accounts receivable	[1]	65	13
Inventory	[1]	73
Loans receivable, net of provision for credit losses of $279 and zero	[1]	279
Prepaid expenses and other current assets	[1]	180	129
Total current assets	[1]	2,656	5,450
Property and equipment, net	[1]	2,870	975
Operating lease right-of-use assets	[1]	1,051	1,273
Intangible assets, net	[1]	12,076	15,180
Goodwill	[1]	55,573	55,573
Other non-current assets	[1]	129	60
Total assets	[1]	74,355	78,511
Current liabilities
Accounts payable	[1]	1,462	872
Accrued expenses	[1]	639	2,961
Financial liabilities, current, net of issuance costs		1,925
Other current liabilities	[1]	786	760
Total current liabilities	[1]	4,812	4,593
Financial liabilities, net of issuance costs	[1]		7,188
Warrant liability	[1]		528
Operating lease liabilities	[1]	840	1,078
Total liabilities	[1]	5,652	13,387
Contingencies (see Note 9)	[1]
Stockholders’ equity
Preferred stock, $0.0001 par value, 1,550 shares Series A Preferred authorized; 1,490 and 1,500 shares issued and outstanding as of December 31, 2023 and 2022, respectively; 3,080 shares of Series B Preferred Stock authorized, no shares issued and outstanding as of December 31, 2023 and 2022	[1]
Common stock, $0.0001 par value, 250,000 shares authorized; 77,451 and 55,963 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	[1]	8	6
Additional paid-in capital	[1]	200,635	169,175
Accumulated deficit	[1]	(131,940)	(104,057)
Total stockholders’ equity	[1]	68,703	65,124
Total liabilities and stockholders’ equity	[1]	$ 74,355	$ 78,511
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Consolidated Balance Sheets (Parentheticals) - $ / shares shares in Thousands		Dec. 31, 2023	Dec. 31, 2022
Common stock, par value (in Dollars per share)	[1]	$ 0.0001	$ 0.0001
Common stock, shares authorized	[1]	250,000	250,000
Common stock, shares issued	[1]	77,451	55,963
Common stock, shares outstanding	[1]	77,451	55,963
Series A Convertible Preferred Stock
Preferred stock par value (in Dollars per share)	[1]	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	[1]	1,550	1,550
Preferred stock, shares issued	[1]	1,490	1,500
Preferred stock, shares outstanding	[1]	1,490	1,500
Series B Convertible Preferred Stock
Preferred stock, shares authorized	[1]	3,080	3,080
Preferred stock, shares issued	[1]
Preferred stock, shares outstanding	[1]
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Total revenue	[1]	$ 358	$ 136
Cost of revenue	[1]	196	61
Gross profit	[1]	162	75
Research and development	[1]	8,891	5,216
Sales and marketing	[1]	1,806	2,092
General and administrative	[1]	15,708	21,412
Operating expenses	[1]	26,405	28,720
Loss from operations	[1]	(26,243)	(28,645)
Non-operating income (expense)
Interest and other income	[1]	295	47
Interest expense, net	[1]	(1,602)	(772)
Change in value of warrant liability	[1]	528	3,392
Loss before income tax provision	[1]	(27,022)	(25,978)
Income tax provision	[1]
Net loss	[1]	(27,022)	(25,978)
Less: Series A convertible preferred stock dividends	[1]	861	889
Net loss available to common stockholders	[1]	$ (27,883)	$ (26,867)
Loss per share – basic (in Dollars per share)	[1]	$ (0.42)	$ (0.73)
Weighted average shares used in computing net loss per common share – basic (in Shares)	[1]	66,611	36,680
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Consolidated Statements of Operations (Parentheticals) - $ / shares shares in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Loss per share – diluted	[1]	$ (0.42)	$ (0.73)
Weighted average shares used in computing net loss per common share – dilutive	[1]	66,611	36,680
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands		Series A Preferred Stock As previously reported	Series A Preferred Stock Adjustments	[1]	Series A Preferred Stock		Common Stock As previously reported	Common Stock Adjustments	[1]	Common Stock		Additional Paid in Capital As previously reported	Additional Paid in Capital Adjustments	[1]	Additional Paid in Capital		Accumulated Deficit As previously reported	Accumulated Deficit Adjustments	[1]	Accumulated Deficit		As previously reported	Adjustments		Total
Balance at Dec. 31, 2021							$ 3			$ 3		$ 97,593	$ (5,384)		$ 92,209		$ (81,394)	$ 4,204		$ (77,190)		$ 16,202	$ (1,180)	[1]	$ 15,022
Balance (in Shares) at Dec. 31, 2021		1,545,000			1,545,000		29,157,000			29,157,000
Cancellation of shares
Cancellation of shares (in Shares)										(11,000)
Conversion of preferred stock
Conversion of preferred stock (in Shares)					(45,000)					48,000
Issuance of shares in conjunction with QPhoton Merger										$ 3					67,127										67,130
Issuance of shares in conjunction with QPhoton Merger (in Shares)										26,615,000
Preferred stock dividends																				(889)					(889)
Preferred OID Amortization															318										318
Stock-based compensation															9,493										9,493
Stock-based compensation (in Shares)										20,000
Stock-based compensation for services															28										28
Stock-based compensation for services (in Shares)										135,000
Net loss																				(25,978)		(38,594)	12,616		(25,978)	[2]
Balance at Dec. 31, 2022						[1]				$ 6	[1]				169,175	[1]				(104,057)	[1]	74,897	(9,773)		65,124	[3]
Balance (in Shares) at Dec. 31, 2022	[1]				1,500,000					55,963,000
Issuance of shares for cash										$ 2					24,728										$ 24,730
Issuance of shares for cash (in Shares)										17,572,000
Cancellation of shares (in Shares)																									23,600
Conversion of preferred stock															1										$ 1
Conversion of preferred stock (in Shares)					(10,000)					11,000
Issuance of shares in conjunction with QPhoton Merger (in Shares)																									36,600,823
Preferred stock dividends																				(861)					$ (861)
Stock-based compensation															4,238										4,238
Stock-based compensation (in Shares)										2,330,000
Stock-based compensation for services															2,493										2,493
Stock-based compensation for services (in Shares)										1,575,000
Net loss																				(27,022)		(29,731)	2,709		(27,022)	[2]
Balance at Dec. 31, 2023						[1]				$ 8	[1]				$ 200,635	[1]				$ (131,940)	[1]	$ 73,269	$ (4,566)		$ 68,703	[3]
Balance (in Shares) at Dec. 31, 2023	[1]				1,490,000					77,451,000
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements. [2] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements. [3] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	[1]	$ (27,022)	$ (25,978)
Adjustments to reconcile net loss to net cash used in operations
Depreciation and intangibles amortization	[2]	3,307	1,863
Amortization of issuance costs	[2]	925	547
Change in fair value of warrant liabilities	[1]	(528)	(3,392)
Provision for credit losses	[2]	279
Other recognized losses (gains)	[2]	5	78
Stock-based compensation expense	[2]	4,271	9,323
Stock-based compensation expense for services	[2]	284	2,350
Changes in operating assets and liabilities
Accounts receivable	[2]	(52)	(13)
Inventory	[2]	(70)
Prepaid expenses and other current assets	[2]	(110)	(145)
Other non-current assets	[2]	153	(1,214)
Accounts payable	[2]	596	219
Accrued expenses and other current liabilities	[2]	110	(319)
Other long-term liabilities	[2]	(463)	1,303
Net cash used in operating activities	[2]	(18,315)	(15,378)
Cash flows from investing activities:
Purchase of property and equipment	[2]	(2,112)	(870)
Issuance of loan receivable	[2]	(500)
Net cash used for QPhoton, Inc. merger	[2]		(1,356)
Net cash used in investing activities	[2]	(2,612)	(2,226)
Cash flows from financing activities:
Proceeds raised from financial liabilities, net of issuance costs			6,960
Payments of financial liabilities, net of interest		(6,187)
Series A Preferred dividend payments		(865)	(787)
Proceeds from stock issuance related to ATM facility	[2]	24,730
Net cash provided by financing activities	[2]	17,678	6,173
Net decrease in cash	[2]	(3,249)	(11,431)
Cash and cash equivalents, beginning of period	[2]	5,308	16,739
Cash and cash equivalents, end of period	[2]	2,059	5,308
Supplemental disclosures of Cash flow information:
Cash paid for interest	[2]	813
Non-cash operating activities
Non-cash issuance of shares for services	[2]	2,651	502
Non-cash financing activities
Common stock, preferred stock and warrants issued in connection with QPhoton Merger	[2]		$ 71,050
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements. [2] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Nature of the Organization and Business	12 Months Ended
	Dec. 31, 2023
Nature of the Organization and Business [Abstract]
Nature of the Organization and Business	Note 1 – Nature of the Organization and Business   Corporate History   Quantum Computing Inc. (“QCi” or the “Company”) was formed in the State of Nevada on July 25, 2001, under its prior name, Ticketcart, Inc. The Company redomiciled to Delaware on February 22, 2018 and changed its name to Quantum Computing Inc. Effective July 20, 2018, the trading symbol for the Company’s common stock, par value $0.0001, on the OTC Market changed from “IBGH” to “QUBT”. On July 15, 2021 the Company uplisted to the Nasdaq Stock Market LLC (“Nasdaq”). On June 16, 2022, the Company merged with QPhoton, Inc. (“QPhoton”), a developer of quantum photonic systems and related technologies and applications.   Nature of Business   QCi is an American company utilizing integrated photonics and non-linear quantum optics to deliver quantum and ancillary non-quantum products for high-performance computing applications based on proprietary photonics technology. Quantum’s products are designed to operate at room temperature and low power. Our core photonics technology enables the execution of a go-to-market strategy which emphasizes accessibility and affordability. Our quantum systems enable subject matter experts (SMEs) and end users to deliver critical business solutions today.   The Company initially focused on providing software tools and applications for several commercially available quantum computers. However, following the June 2022 merger with QPhoton and its associated intellectual property and engineering team, the Company now offers integrated high-performance quantum systems, ancillary non-quantum products and services.   The core of our quantum offerings today is our Entropy Quantum Computing (“EQC”) technology. We have built room-temperature, photonic quantum information processing systems underpinned by a series of patented and patent pending technologies. Our technology, supported by professional services through our “Quantum Solutions” offering, enables our clients to solve complex optimization problems. In addition, our engineering teams are using our leading-edge photonics technology to continue to enhance and further develop quantum LIDAR sensing and imaging systems, quantum-secured network solutions, and photonic chips.   Going Concern   The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the continuity of operations, the realization of assets, and the satisfaction of liabilities in the normal course of business. Cash and cash equivalents on hand were $2.1 million as of December 31, 2023. The Company has historically incurred losses and negative cash flows from operations. As of December 31, 2023, the Company also had an accumulated deficit of $131.9 million and a working capital deficit of $2.2 million. Furthermore, we have not achieved a level of sales adequate to support the Company’s cost structure and may need to raise additional funds in the next twelve months by selling additional equity or incurring debt. It is management’s opinion that these conditions raise substantial doubt about our ability to continue as a going concern.

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Significant Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 – Significant Accounting Policies:   Basis of Presentation and Principles of Consolidation:   The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as determined by the Financial Accounting Standards Board (the “FASB”), including ASC 810, Consolidation. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year end is December 31.   Risk and Uncertainties   The Company is subject to certain risks and uncertainties and believes changes in any of the following areas could have a material adverse effect on the Company’s future financial position or results of operations or cash flows: new product development, including market receptivity; litigation or claims against the Company based on intellectual property, patent, product regulation or other factors; competition from other products; general economic conditions; the ability to attract and retain qualified employees; and, ultimately, to sustain profitable operations.   Use of Estimates   These consolidated financial statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the valuation of goodwill and intangible assets, deferred tax assets, equity-based transactions and liquidity assessment. Actual results may differ from these estimates.   Cash and Cash Equivalents   Highly liquid investments with a maturity of three months or less when purchased are considered to be cash equivalents. As of December 31, 2023 and 2022, there were no cash equivalents. The Company maintains its cash in deposit and money market accounts with high quality financial institutions which, at times, may exceed federally insured limits. The Company has not experienced any losses on these deposits and believes it is not exposed to significant credit risk on cash.   Revenue   The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, by analyzing contracts with its customers using a five-step approach:     1. Identify the contract         2. Identify the performance obligations         3. Determine the transaction price         4. Allocate the transaction price to the performance obligations         5. Recognize revenue when performance obligations are satisfied   The Company recognized a small amount of revenue in 2023 and 2022, which was primarily derived from contracts to perform professional services. Revenue from time and materials-based contracts is recognized as the direct hours worked during the period times the contractual hourly rate, plus direct materials and other direct costs as appropriate, plus negotiated materials handling burdens, if any. Revenue from units-based contracts is recognized as the number of units delivered or performed during the period times the contractual unit price. Revenue from fixed price contracts is recognized as work is performed with estimated profits recorded on a percentage of completion basis. The Company has no cost-plus type contracts at this time.   The Company includes depreciation and amortization expenses in manufacturing overhead, which is a component of cost of revenue. However, at the present time manufacturing overhead, including depreciation and amortization expense related to production equipment, is not material and the primary components of cost of revenue are direct labor and direct materials, with a small amount of shipping expenses.   Accounts Receivable   Accounts receivable consists of amounts due from customers for work performed on contracts. The Company records accounts receivable at their net realizable value. Periodically the Company evaluates its accounts receivable to establish a provision for credit losses, when deemed necessary, based on the history of past write-offs, collections and current credit conditions. Within 2022, certain accounts receivable, attributable to a single customer, were determined not to be collectible and management recorded a provision and wrote off the uncollectible receivables against that account. The customer accounts receivable as of December 31, 2023 are considered fully collectible and thus management has not recorded a provision for credit losses.   Provision for Credit Losses   The Company estimates losses on loans and other financial instruments in accordance with Accounting Standards Update (“ASU”) 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 introduces the current expected credit losses (“CECL”) methodology for estimating allowances for credit losses. The CECL framework requires the Company to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supporting forecasts. Under CECL, the allowance for credit losses is measured as the difference between the financial asset’s cost basis and the net amount expected to be collected on the financial asset. CECL allows us to use information about past events including historical loan loss experience, current conditions, and reasonable and supportable forecasts to assess the collectability of the financial assets. The receivables for financial assets as of December 31, 2023 are not considered fully collectible and thus management has recorded a provision for credit losses. Note 10, Loan Receivable, for additional information.   Inventory   Inventory is stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis which approximates actual cost on a first in-first out (“FIFO”) method. Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory, deterioration and other factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are made for estimated excess, obsolescence or impaired inventory and are charged to cost of revenue. Once the cost of the inventory is reduced, a new lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. Factors influencing these adjustments include changes in demand, product life cycle and development plans, component cost trends, product pricing, physical deterioration and quality issues. Revisions to these adjustments would be required if these factors differ from our estimates.   Operating Leases   The Company determines if an arrangement is a lease at inception. Operating lease right-of-use (“ROU”) assets are included in right-of-use assets, net on the consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current operating lease liabilities and non-current operating lease liabilities, respectively, on the consolidated balance sheets.   Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheet. All of our operating leases are comprised of office space leases, and as of December 31, 2023 and 2022, we had no finance leases.   Business Combinations and Valuation of Goodwill   We account for business combinations under the acquisition method of accounting. This method requires the recording of acquired assets and assumed liabilities at their acquisition date fair values. The excess of the purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Results of operations related to business combinations are included prospectively beginning with the date of acquisition and transaction costs related to business combinations are recorded withing general and administrative expenses.   The Company reviews goodwill for impairment on an annual basis or whenever events or changes in circumstances indicate the carrying value may not be recoverable. The Company performs an annual impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, income tax effects from any tax-deductible goodwill carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable. The Company has determined that it has a single reporting unit for purposes of performing its goodwill impairment test. As the Company uses the market approach to assess impairment, its common stock price is an important component of the fair value calculation. If the Company’s stock price continues to experience significant price and volume fluctuations, this will impact the fair value of the reporting unit and can lead to potential impairment in future periods. The Company performed its annual impairment test during the second quarter of fiscal 2023 and 2022 and determined that its goodwill was not impaired. As of December 31, 2023 and 2022, we had not identified any factors that indicated there was an impairment of our goodwill and determined that no additional impairment analysis was then required.   Property and Equipment   Property and equipment are stated at cost or contributed value. Depreciation of furniture, software and equipment is calculated using the straight-line method over their estimated useful lives, and leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the lease term. The cost and related accumulated depreciation of equipment retired or sold are removed from the accounts and any differences between the undepreciated amount and the proceeds from the sale are recorded as a gain or loss on sale of equipment. Maintenance and repairs are charged against expense as incurred.   Impairment of Long-Lived Assets   The Company has long-lived assets such as tangible property and equipment, identified intangible assets consisting of acquired patents and core technology. When events or changes in circumstances occur that could indicate the carrying value of long-lived assets may not be recoverable, the Company assesses recoverability by determining whether the undiscounted cash flows estimated to be generated by those assets are less than the carrying amounts of those assets. If the undiscounted cash flow is less, an impairment charge is recognized for the excess of the carrying amounts of these assets over the fair values. Fair values are determined by discounted future cash flows, appraisals or other methods.   During the years ended December 31, 2023 and 2022, the Company did not record any impairment from long-lived assets.   Fair Value of Financial Instruments   The carrying amount of certain financial instruments held by the Company, such as cash equivalents, accounts receivable, contract assets and liabilities, accounts payable, and accrued and other current liabilities, approximate fair value due to their short maturities. The carrying amount of the liabilities for the convertible preferred stock warrants represent their fair value. The carrying amounts of the Company’s borrowings and lease liabilities approximate fair value due to the market interest rates that these obligations bear and interest rates currently available to the Company.   Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:     Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities;     Level 2 Inputs other than quoted prices included within Level 1 that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and     Level 3 Unobservable inputs that are supported by little or no market activity for the related assets or liabilities.   The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. As of December 31, 2023, the Company had $793 thousand in Level 1 assets, comprised of U.S. Government mutual funds, and no carrying value for Level 3 liabilities, comprised of the QPhoton Warrants, as defined below. As of December 31, 2022, the Company had $528 thousand in carrying value for Level 3 liabilities, comprised of the QPhoton Warrants.   Research and Development Costs   Research and development costs include costs directly attributable to the conduct of research and development programs to enhance existing products and services and to develop future technologies, including the cost of services provided by outside contractors, and mandatory compliance fees and contractual obligations. All costs associated with research and development are expensed as incurred.   Software Development Costs   Software development costs incurred subsequent to the establishment of technological feasibility for software intended to be sold, licensed or otherwise marketed to customers will be capitalized, but development costs not meeting the criteria for capitalization are expensed as incurred. With respect to internal use software, the Company will capitalize such development costs incurred during the application development stage, but development costs incurred prior to that stage will be expensed as incurred. No amortization expense will be recorded until the software is ready for its intended use. To date the Company has not incurred any capitalizable software development costs.   Stock-Based Compensation   The Company has adopted ASU 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 expands the scope of ASC 718, Share-Based Payment, to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of ASC 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost. ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, and that ASC 718 does not apply to share based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606, Revenue from Contracts with Customers.   Stock-based compensation expense for expected-to-vest awards is valued under the single-option approach and amortized on a straight-line basis, accounting for actual forfeitures as they occur. We utilize the Black Scholes pricing model in order to determine the fair value of stock-based option awards. The Black Scholes pricing model requires various highly subjective assumptions including volatility, expected option life, and risk-free interest rate. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management judgment. If factors change and different assumptions are used, our stock-based compensation expense could be materially different in the future.   Loss Per Share   Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if the common share equivalents had been issued (computed using the “If-Converted” method), unless the effect of such issuances would have been anti-dilutive.   The following table sets forth the computation of basic and diluted loss per share (in thousands, except per share data):       Year Ended December 31,       2023     2022   Numerator:             Net loss   $ (27,022 )   $ (25,978 ) Less: Series A convertible preferred stock dividends     861       889   Net loss available to common stockholders – basic and diluted   $ (27,883 )   $ (26,867 ) Denominator:                 Weighted average shares used in computing net loss per common share – basic and diluted     66,611       36,680   Loss per share - basic and diluted   $ (0.42 )   $ (0.73 )   Net loss per share is based on the weighted average number of common shares and common share equivalents outstanding during the period.   In periods with a reported net loss, the effect of anti-dilutive stock options, unvested restricted common stock and warrants are excluded and diluted loss per share is equal to basic loss per share. Due to a net loss in the years ended December 31, 2022 and 2023, there were therefore no dilutive securities and hence basic and diluted loss per share were the same. The following is a summary of the weighted average common stock equivalents for the securities outstanding during the respective periods that have been excluded from the computation of diluted net loss per common share, as their effect would be anti-dilutive (in thousands):       Year Ended December 31,       2023     2022   Warrants     6,053       3,976   Options     12,280       6,830   Unvested restricted common stock     1,192       -   Total potentially dilutive shares     19,525       10,778     As all potentially dilutive securities are anti-dilutive as of December 31, 2023 and 2022, diluted net loss per share is the same as basic net loss per share for each period.   Recently Issued Accounting Pronouncements   From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption. The Company has evaluated the recently implemented accounting standards and concluded that none currently apply to the Company.

Restatement of Previously Issued Financial Statements	12 Months Ended
	Dec. 31, 2023
Restatement of Previously Issued Financial Statements [Abstract]
Restatement of Previously Issued Financial Statements	Note 3 – Restatement of Previously Issued Financial Statements   Subsequent to the issuance of our Original Form 10-K and our subsequent retention of BPM to replace BF Borgers as our independent registered public accounting firm, management became aware of various adjustments to be recorded to our consolidated financial statements. Accordingly, our consolidated balance sheets as of December 31, 2023 and 2022, and our consolidated statements of operations, consolidated statements of stockholders’ equity, and our consolidated statements of cash flows for the years ended December 31, 2023 and 2022, have been restated for various errors, omissions, reclassifications or changes to accounting policy made primarily with regard to the purchase accounting of the QPhoton Merger, stock-based compensation accounting, financing costs, and other matters further described below. The restated consolidated financial statements also reflect the correction of certain previously-identified errors and out-of-period adjustments that were deemed immaterial to the annual or interim period in which they were recorded and have now been restated to properly reflect the corrections in the appropriate periods.   Disclosures   In Note 1, we expanded disclosures (i) for risks and uncertainties, valuation of goodwill, impairment of long-lived assets, income taxes, and net loss and (ii) to clearly indicate that depreciation and amortization expenses are included in cost of revenue, but that the amounts are not material.   In Note 2, we expanded and revised disclosures (i) to clarify (a) that software development costs incurred subsequent to the establishment of technological feasibility for software intended to be sold, licensed or otherwise marketed to customers will be capitalized, but development costs not meeting the criteria for capitalization are expensed as incurred, (b) that with respect to internal use software, the Company will capitalize such development costs incurred during the application development stage, and (c) that through December 31, 2023, the Company has not incurred any material capitalizable development costs, (ii) to appropriately detail the methodology and computation of basic and diluted loss per share and (iii) to reflect the Company’s change in accounting policy election for stock based compensation to no longer estimate forfeitures, but rather to account for forfeitures as they occur.   In Note 3, we explained the drivers of the restatements of the Previously Issued Financial Statements.   In Note 12, we clarified the basis for calculating the number of reported warrants to purchase shares of the Company’s common stock issued in connection with the QPhoton Merger.   In Note 14, we expanded the disclosure to clarify that the interest rates implicit in our leases are not readily determinable and therefore that is the basis for using our incremental borrowing rate as the discount rate for our leases.   Reclassifications   We have made certain reclassifications. In the Consolidated Statements of Operations and Consolidated Statements of Cash Flows, we reclassified certain ATM facility-related financing fees and Series A Preferred Stock dividends, which were each previously presented as Interest Expense in Other Income and Expense and have been reclassified as direct deductions to equity and shown as cash used for financing activities. We additionally revised the presentation of operating expenses to classify expenses as (1) Research and Development, (2) Sales and Marketing, and (3) General and Administrative, as compared to previously-reported categories that included (1) Salaries and Benefits, (2) Professional Services, (3) Research & Development, (4) Stock Based Compensation, and (5) Selling General & Administrative. For the Consolidated Balance Sheets, we made certain reclassifications related to (1) right-of-use assets and operating liabilities and (2) other current liabilities for litigation reserves.   Adjustments   The following is a description of the areas in which the errors were identified and for which we made correcting adjustments to our consolidated financial statements.   (1) QPhoton purchase accounting – We adjusted the final purchase price accounting for identifiable intangibles and the value attributable to the QPhoton Warrants, as defined below, including associated mark-to-market quarterly adjustments.   (2) Stock-based compensation – We adjusted expenses and prior period retained earnings to reflect the change in our accounting policy election to account for forfeitures as they occur, as well as to refine assumptions used in calculating the fair value. We also ensured all such expenditures were accrued and accounted for in the appropriate periods based on vesting schedules and underlying agreements.   (3) Debt issuance costs – We corrected errors to appropriately accrete issuance costs for the Streeterville Unsecured Note, as defined below, over the life of the loan.   (4) Uncollectable reserve – We identified a reserve for collection risk related to notes receivable.   (5) Accrued Expenses – We identified and corrected errors to record liabilities for performance-based bonus expenditures and state franchise fees to reflect the expenses in the appropriate period.   (6) Financing Expenditures – We corrected the presentation of Series A Preferred Stock dividends and ATM proceeds and adjusted the valuation of the Series A convertible preferred stock warrants.   (7) Other - We corrected certain classifications, previously identified errors and out of period adjustments that were deemed immaterial to the annual or interim period in which they were recorded and restated prior periods to reflect these corrections in the appropriate periods.   The following table presents the effect of the aforementioned adjustments on our Consolidated Balance Sheets as of December 31, 2023 and 2022 and indicates the category of the adjustments by reference to the above descriptions of the errors for which we made corrections:       Year Ended December 31, 2023       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Assets                         Current assets                         Cash and cash equivalents   $ 2,059     $ -             $ 2,059   Accounts receivable     65       -               65   Inventory     73       -               73   Loans receivable, net of provision for credit losses     557       (278 )     (4 )     279   Prepaid expenses and other current assets     427       (247 )     (7 )     180   Total current assets     3,181       (525 )             2,656   Property and equipment, net     2,870       -               2,870   Operating lease right-of-use assets     800       251       (7 )     1,051   Intangible Assets, net     11,388       688       (1 )     12,076   Goodwill     60,360       (4,787 )     (1 )     55,573   Other non-current assets     129       -               129   Total assets   $ 78,728     $ (4,373 )           $ 74,355                                     Liabilities and Stockholders’ Equity                                 Current liabilities                                 Accounts payable   $ 1,462     $ -             $ 1,462   Accrued expenses     411       228       (2)(5 )     639   Financial liabilities, current, net of issuance costs     2,496       (571 )     (3 )     1,925   Other current liabilities     250       536       (7 )     786   Total current liabilities     4,619       193               4,812   Operating lease liabilities     840       -               840   Total liabilities     5,459       193               5,652                                     Stockholders’ equity                                 Preferred stock     -       -               -   Common stock     8       -               8   Additional paid-in capital     222,980       (22,345 )     (1)(2)(6)(7 )     200,635   Accumulated deficit     (149,719 )     17,779       (1)(2)(3)(4)(5)(6)(7 )     (131,940 ) Total stockholders’ equity     73,269       (4,566 )             68,703   Total liabilities and stockholders’ equity   $ 78,728     $ (4,373 )           $ 74,355         Year Ended December 31, 2022       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Assets                         Current assets                         Cash and cash equivalents   $ 5,308     $ -             $ 5,308   Accounts receivable     13       -               13   Prepaid expenses and other current assets     408       (279 )     (7 )     129   Total current assets     5,729       (279 )             5,450   Property and equipment, net     975       -               975   Operating lease right-of-use assets     1,187       86       (7 )     1,273   Intangible assets, net     22,224       (7,044 )     (1 )     15,180   Goodwill     59,126       (3,553 )     (1 )     55,573   Other non-current assets     60       -               60   Total assets   $ 89,301     $ (10,790 )           $ 78,511                                     Liabilities and Stockholders’ Equity                                 Current liabilities                                 Accounts payable   $ 872     $ -             $ 872   Accrued expenses     3,780       (819 )     (2)(5 )     2,961   Financial liabilities, current     536       (536 )     (7 )     -   Other current liabilities     132       628       (6)(7 )     760   Total current liabilities     5,320       (727 )             4,593   Financial liabilities, net of issuance costs     7,858       (670 )     (3 )     7,188   Warrant liability     -       528       (1 )     528   Operating lease liabilities     1,226       (148 )     (7 )     1,078   Total liabilities     14,404       (1,017 )             13,387                                     Stockholders’ equity                                 Preferred stock     -       -               -   Common stock     6       -               6   Additional paid-in capital     194,879       (25,704 )     (1)(2)(6)(7 )     169,175   Accumulated deficit     (119,988 )     15,931       (1)(2)(3)(4)(5)(6)(7 )     (104,057 ) Total stockholders’ equity     74,897       (9,773 )             65,124   Total liabilities and stockholders’ equity   $ 89,301     $ (10,790 )           $ 78,511     The following tables present the effect of the aforementioned reclassifications and adjustments on our consolidated statements of operations for the years ended December 31, 2023 and 2022 and indicate the category of the adjustments by reference to the above descriptions of the errors for which we made corrections:       Year Ended December 31, 2023       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Total revenue   $ 358     $ -             $ 358   Cost of revenue     196       -               196   Gross profit     162       -               162   Operating expenses     27,384       (979 )     (2)(5 )     26,405   Loss from operations     (27,222 )     979               (26,243 ) Non-operating income (expense)                                 Interest and other income     295       -               295   Interest expense, net     (2,804 )     1,202       (3)(6 )     (1,602 ) Change in value of warrant liability     -       528       (1 )     528   Loss before income tax provision     (29,731 )     2,709               (27,022 ) Income tax provision     -       -               -   Net loss     (29,731 )     2,709               (27,022 )  Less: Series A convertible preferred stock dividends     -       (861 )     (6 )     (861 ) Net loss available to common stockholders   $ (29,731 )   $ 1,848             $ (27,883 )                                   Loss per share – basic and diluted   $ (0.38 )   $ (0.04 )           $ (0.42 ) Weighted average shares used in computing net loss per common share – basic and dilutive     77,451       (10,840 )             66,611         Year Ended December 31, 2022       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Total revenue   $ 136     $ -                 $ 136   Cost of revenue     61       -               61   Gross profit     75       -               75   Operating expenses     36,654       (7,934 )     (2 )(5)     28,720   Loss from operations     (36,579 )     7,934               (28,645 ) Non-operating income (expense)                                 Interest and other income     47       -               47   Interest expense, net     (2,062 )     1,290       (3 )(6)     (772 ) Change in value of warrant liability     -       3,392       (1 )     3,392   Loss before income tax provision     (38,594 )     12,616               (25,978 ) Income tax provision     -       -               -   Net loss     (38,594 )     12,616               (25,978 ) Less: Series A convertible preferred stock dividends     -       (889 )     (6 )     (889 ) Net loss available to common stockholders   $ (38,594 )   $ 11,727             $ (26,867 )                                   Loss per share – basic and diluted   $ (0.69 )   $ (0.04 )           $ (0.73 ) Weighted average shares used in computing net loss per common share – basic and dilutive     55,963       (19,283 )             36,680      The following tables present the effect of the aforementioned adjustments on our consolidated statements of cash flows for the years ended December 31, 2023 and 2022 and indicate the category of the adjustments by reference to the above descriptions of the errors for which we made corrections:       Year Ended December 31, 2023       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Cash flows from operating activities:                         Net loss   $ (29,731 )     2,709               (27,022 ) Adjustments to reconcile net loss to net cash from operations                                 Depreciation and intangibles amortization     1,958       1,349       (1 )     3,307   Amortization of issuance costs     -       925       (3 )     925   Change in fair value of warrant liabilities     -       (528 )     (1 )     (528 ) Provision for credit losses     -       279       (4 )     279   Other recognized losses (gains)     4       1       (7 )     5   Stock-based compensation expense     8,723       (4,452 )     (2 )     4,271   Stock-based compensation expense for services     -       284       (2 )     284   Changes in operating assets and liabilities                                 Accounts receivable     (52 )     -               (52 ) Inventory     (70 )     -               (70 ) Prepaid expenses and other current assets     (78 )     (32 )     (7 )     (110 ) Other non-current assets     318       (165 )     (7 )     153   Accounts payable     583       13               596   Accrued expenses and other current liabilities     (985 )     1,095       (2)(7 )     110   Other long-term liabilities     (611 )     148       (7 )     (463 ) Net cash used in operating activities     (19,941 )     1,626             (18,315 )                                   Cash flows from investing activities:                                 Purchase of property and equipment     (2,118 )     (6 )     (7 )     (2,112 ) Issuance of loan receivable     (500 )     -             (500 ) Net cash used in investing activities     (2,618 )     (6 )             (2,612 )                                   Cash flows from financing activities:                                 Payments of financial liabilities, net of interest     (6,187 )     -               (6,187 ) Series A Preferred dividend payments     -       (865 )     (6 )     (865 ) Proceeds from stock issuance related to ATM facility     25,496       (766 )     (6 )     24,730   Net cash provided by financing activities     19,309       (1,631 )             17,678                                     Net decrease in cash     (3,249 )     -               (3,249 ) Cash and cash equivalents, beginning of period     5,308       -               5,308   Cash and cash equivalents, end of period   $ 2,059     $ -             $ 2,059         Year Ended December 31, 2022       As Previously           Description of           Reported     Adjustments     Adjustments     As restated   Cash flows from operating activities:                         Net loss   $ (38,594 )     12,616               (25,978 ) Adjustments to reconcile net loss to net cash from operations                                 Depreciation and amortization     3,433       (1,570 )     (1 )     1,863   Amortization of issuance costs     -       547       (3 )     547   Change in fair value of warrant liabilities     -       (3,392 )     (1 )     (3,392 ) Other recognized losses (gains)     -       78       (7 )     78   Stock-based compensation expense     17,761       (8,438 )     (2 )     9,323   Stock-based compensation expense for services     -       2,350       (2 )     2,350   Changes in operating assets and liabilities                                 Accounts receivable     (13 )     -               (13 ) Prepaid expenses and other current assets     92       (237 )     (7 )     (145 ) Other non-current assets     (1,128 )     (86 )     (7 )     (1,214 ) Accounts payable     219       -               219   Accrued expenses and other current liabilities     (462 )     143       (2)(7 )     (319 ) Other long-term liabilities     1,451       (148 )     (7 )     1,303   Net cash used in operating activities     (17,241 )     1,863               (15,378 )                                   Cash flows from investing activities:                                 Purchase of property and equipment     (870 )     -               (870 ) Net cash used for QPhoton, Inc. Merger     (1,356 )     -               (1,356 ) Net cash used in investing activities     (2,226 )     -               (2,226 )                                   Cash flows from financing activities:                                 Proceeds raised from financial liabilities, net of issuance costs     8,036       (1,076 )     (3 )     6,960   Series A Preferred dividend payments     -       (787 )     (6 )     (787 ) Net cash provided by financing activities     8,036       (1,863 )             6,173                                     Net decrease in cash     (11,431 )     -               (11,431 ) Cash and cash equivalents, beginning of period     16,739       -               16,739   Cash and cash equivalents, end of period   $ 5,308     $ -             $ 5,308

Business Combinations	12 Months Ended
	Dec. 31, 2023
Business Combinations [Abstract]
Business Combinations	Note 4 – Business Combinations   Merger with QPhoton, Inc.   On May 19, 2022, the Company, QPhoton, and Yuping Huang, the principal stockholder of QPhoton, entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which the Company agreed to acquire QPhoton through a series of merger transactions (collectively with the other transactions contemplated by the Merger Agreement, the “Transaction”). On June 16, 2022, all conditions precedent having been met or waived by the Parties, the Company closed the Transactions. The merger with QPhoton adds to the Company’s portfolio of quantum computing products and enables the Company to offer a wider range of quantum information services. The Company accounted for the Transactions using the acquisition method in accordance with ASC 805, Business Combinations, with the purchase price being allocated to tangible and identifiable intangible assets acquired and liabilities assumed based on their respective estimated fair values on the acquisition date. Fair values were determined using management estimates. The results of QPhoton are included within the consolidated financial statements commencing on the acquisition date.   Pursuant to the Merger Agreement, immediately following the closing of the Transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub I (a wholly owned subsidiary of the Company) merged with and into QPhoton, with QPhoton surviving the merger as a wholly-owned subsidiary of the Company, immediately after which the surviving corporation merged with and into Merger Sub II (also a wholly owned subsidiary of the Company), with Merger Sub II surviving the merger as a wholly-owned subsidiary of the Company (the “Surviving Company”). The merger consideration payable to the stockholders of QPhoton (the “Merger Consideration”) consisted of (i) 5,802,206 shares of the Company’s common stock, par value $0.0001 per share, (ii) 2,377,028 shares of a new series of the Company’s preferred stock, par value $0.0001 per share, designated Series B convertible preferred stock (“Series B Preferred Stock”), and (iii) warrants to purchase up to 7,028,337 shares of Common Stock (the “QPhoton Warrants”). Each share of Series B Preferred Stock converts into 10 shares of the Company’s common stock. On an as-converted basis, the total Merger Consideration consisted of 36,600,823 shares of the company’s common stock. The Merger Consideration for shareholders Yuping Huang and Stevens Institute of Technology was issued in 2022. A third alleged shareholder, BV Advisory, rejected the Merger Consideration and commenced litigation in Delaware Chancery Court (see Note 9, Contingencies – Legal Proceedings, in this Amendment for additional information and Item 3, Legal Proceedings, in the Original Form 10-K for a full discussion), and to date that litigation has not been resolved. Accordingly, as of December 31, 2023 and 2022, we had only issued 32,940,738 shares of the Company’s common stock on an as-converted basis, which includes 26,615,235 shares of common stock and 6,325,503 of the QPhoton Warrants.   and the remaining Merger Consideration for the other stockholder of QPhoton will be issued upon presentation of certain required documents and surrender of their QPhoton shares.   The purchase price was approximately $71.0 million, or $69.9 million net of cash acquired, consisting of Company common stock, Series B Preferred Stock and QPhoton Warrants. The Merger Agreement did not include any contingent consideration, and under ASC 805, transaction costs are required to be expensed so legal and accounting fees incurred for the Transactions were not included in the purchase price. As the Transactions were structured as an exchange of equity securities, the purchase price was calculated based on the fair market value (in this case the Nasdaq closing price) of the total shares of the Company securities payable to the shareholders of the acquired company, QPhoton. The closing price of the Company’s common stock on June 16, 2022 was $2.27 (the “Merger Closing Stock Price”). While the total shares of the Company’s common stock offered for QPhoton on an as-converted basis was 36,600,823, the fair market valuation contemplated 31,299,417 of the shares, which assumed full conversion of the 2,377,028 shares of Series B Preferred Stock to common stock at the 10:1 ratio, and that only 1,726,931 of the 7,028,337 QPhoton Warrants would eventually be exercised to purchase common stock (specifically only the QPhoton Warrants for which the associated Company options and/or warrants had an exercise price at or below $2.27 at the time of the Transaction). The 1,726,931 QPhoton Warrants were valued at the Merger Closing Stock Price. Further, the QPhoton Warrants are treated as a derivative, whose value is tied to future value of the Company’s common stock, and will be marked-to-market on a quarterly basis.   The fair value of the prepaid expenses and security deposits was set at book value, and the fair value of the property and equipment was written up to the purchase cost to reflect the recent purchase dates of the equipment relative to the closing date of the Transactions. To estimate the fair value of the identifiable intangible assets, the Company engaged a third-party valuation expert (the “Third-Party Valuation Expert”), to conduct an independent analysis in line with purchase price accounting standards. The Third-Party Valuation Expert concluded:   ● that there was no fair value attributable to customer relationships due to the lack of current customer contracts;   ● a fair value of $3.25 million attributable to the non-compete agreement with the founder using the with-and-without method, based on a variation of the income approach. The with-and-without methodology employed uses two scenarios to value the non-compete asset: (1) the “with scenario” captures the estimated cash flows from the business if all of the existing assets were in place including the non-compete asset; and (2) the “without scenario” captures the estimated cash flows from the business if all of the existing assets were in place except the non-compete asset. The difference between the two scenarios is attributed to the presumed loss of cash flows without the non-compete asset in place and represents the value of the non-compete agreement;   ● a fair value of $1.0 million attributable to the QPhoton trade name and trademark using the relief from royalty methodology. In the application of the relief from royalty method, the Third-Party Valuation Expert estimated the value of the trade names/trademarks by capitalizing the royalties saved by virtue of the Company owning the trade names/trademarks. In other words, the Company realizes a benefit from owning the intangible asset rather than paying a rent or royalty for the use of the asset;     ● a fair value of $12.7 million attributable to the technology and licensed patents using the relief from royalty methodology. In calculating the fair value of the technology and licensed patents, the Third-Party Valuation Expert followed the same approach as the trade name/trademark analysis.    The Company accepted the Third-Party Valuation Expert’s valuation. Although the valuation analysis was performed in 2023, for the purposes of the consolidated financial statements in this Amendment, the Company has recorded and reported the results of the valuation as of the Closing date, June 16, 2022.   The following table summarizes the purchase price paid and adjusted acquisition date fair values of assets acquired and liabilities assumed by the Company, including the final results of the analysis performed by the Third-Party Valuation Expert for the intangibles (in thousands):   Purchase price       Common stock   $ 13,171   Series B convertible preferred     53,959   Contingently issuable warrants     3,920   Purchase price     71,050   Less: cash acquired     (1,144 ) Purchase price, net of cash acquired     69,906   Less:         Prepaid expenses     16   Property and equipment at cost     116   Security deposits     98   Non-compete agreement with founder     3,251   Trade names and trademarks     1,009   Developed Technology and licensed patents     12,731   Accounts payable and other current liabilities     (2,888 ) Goodwill   $ 55,573      The amount allocated to goodwill and intangible assets reflects the benefits the Company expected to realize from the growth of the acquisition’s operations.   Note Purchase Agreement – the Company and QPhoton   On February 18, 2022, the Company entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with QPhoton, pursuant to which the Company agreed to loan money to QPhoton using two unsecured promissory notes (each, a “Note”), each in the principal amount of $1.25 million, subject to the terms and conditions of the Note Purchase Agreement. Also, on February 18, 2022, pursuant to the terms of the Note Purchase Agreement, the Company loaned the principal amount of $1.25 million to QPhoton. On April 1, 2022, pursuant to the terms of the Note Purchase Agreement, the Company loaned the principal amount of $1.25 million to QPhoton, for a total loan under the two Notes of $2.5 million.   The Note Purchase Agreement contains customary representations and warranties by QPhoton and the Company, as well as a “most favored nations” provision for the benefit of the Company. The Notes issued under the Note Purchase Agreement, including the Notes issued on February 18, 2022 and April 1, 2022, provide that the indebtedness evidenced by the applicable Note bears simple interest at the rate of 6% per annum (or 15% per annum during the occurrence of an event of default, as defined in the Notes), and becomes due and payable in full on the earlier of (i) March 1, 2023, subject to extension by one year at the option of QPhoton, (ii) a change of control (as defined in the Notes) of QPhoton or (iii) an event of default. As a result of the merger, the Note and accrued interest is eliminated through consolidation. However, the two Notes were not forgiven or converted to equity and remain outstanding under the terms and conditions of the Note Purchase Agreement.

Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2023
Intangible Assets and Goodwill [Abstract]
Intangible Assets and Goodwill	Note 5 – Intangible Assets and Goodwill   As a result of the merger with QPhoton, the Company has the following amounts related to intangible assets (in thousands):         December 31, 2023     December 31, 2022       Gross Carrying Amount     Accumulated Amortization     Net Carrying Amount     Gross Carrying Amount     Accumulated Amortization     Net Carrying Amount   Non-compete agreement with founder   $ 3,251     $ (1,716 )   $ 1,535     $ 3,251     $         (632 )   $ 2,619   Website domain name and trademark     1,009       (320 )     689       1,009       (118 )     891   Technology and licensed patents     12,731       (2,880 )     9,851       12,731       (1,061 )     11,670   Total   $ 16,991     $ (4,915 )   $ 12,076     $ 16,991     $ (1,811 )   $ 15,180     The amortization expense of the Company’s intangible assets for the years ended December 31, 2023 and 2022 was $3.1 million and $1.8 million, respectively. The Company expects future amortization expense to be the following (in thousands):       Amortization   2024   $ 3,104   2025     2,472   2026     2,021   2027     1,903   2028     1,819   Thereafter     757   Total   $ 12,076     The Company recorded goodwill resulting from the Transactions, calculated as the difference between the total purchase price and the value of tangible and intangible assets acquired less the liabilities assumed. The Company recorded goodwill of $55.6 million resulting from the Transactions. The following table provides a summary of the changes in goodwill for the years ended December 31, 2023 and 2022 (in thousands):       December 31,       2023     2022   Goodwill, at beginning of year   $ 55,573     $ -   Goodwill additions     -       55,573   Goodwill, at end of year   $ 55,573     $ 55,573     The Company tested the intangible assets and goodwill for impairment as of December 31, 2023 and concluded there was no impairment of intangible assets or goodwill at that time.

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Taxes [Abstract]
Income Taxes	Note 6 – Income Taxes:   The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, management concludes that it is more-likely-than-not that the deferred tax assets will not be realized. Realization of deferred tax assets is also dependent upon future earnings, if any, the timing and amount of which are uncertain.   The Company records a liability for the uncertain tax positions taken or expected to be taken on the Company’s tax return when it is more-likely-than-not that the tax position might be challenged despite the Company’s belief that the tax return positions are fully supportable, and additional taxes will be due as a result. To the extent that the assessment of such tax positions changes, for example, based on the outcome of a tax audit, the change in estimate is recorded in the period in which the determination is made. The provision for income taxes includes the impact of provisions for uncertain tax positions.   Income tax expense attributable to pretax loss from continuing operations differed from the amounts computed by applying the U.S. federal income tax rate of 21% to pretax loss from continuing operations as a result of both temporary and permanent differences in the U.S. GAAP vs tax treatment of certain types of expenses, including stock-based compensation, depreciation and amortization, research and development and meals and entertainment. Additionally, the Company's policy is to account for interest and penalties as income tax expense. As of December 31, 2023, the Company had no interest related to unrecognized tax benefits, and no amounts for penalties related to unrecognized tax benefits were recognized in the provision for income taxes. We do not anticipate any significant change within twelve months of this reporting date.   As of December 31, 2023, the Company had federal and state net operating loss carryforwards of approximately $49 million. All of the federal NOL carryforwards were generated during 2018 or later and will carryforward indefinitely but will be subject to 80% taxable income limitation beginning tax years after December 31, 2021, as provided by the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act (PL 116-136). Furthermore, the utilization of NOLs and tax credit carryforwards to offset future taxable income may be subject to an annual limitation as a result of ownership changes that have occurred previously or may occur in the future. Under Sections 382 and 383 of the Internal Revenue Code, a corporation that undergoes an ownership change may be subject to limitations on its ability to utilize its pre-change NOLs and other tax attributes otherwise available to offset future taxable income and/or tax liability. An ownership change is defined as a cumulative change of 50% or more in the ownership positions of certain stockholders during a rolling three-year period. The Company has determined that ownership changes have occurred, primarily driven by the Transactions, and hence the Company’s ability to use its NOLs or tax credit carryforwards may be restricted.   As of December 31, 2023, in addition to the $13 million in tax-effected NOL carryforwards, at an assumed tax rate of 26%, the significant components of the Company’s net deferred tax assets included stock-based compensation of $11 million, capitalized research and development expenditures of approximately $2 million and an intangible asset basis difference of $1 million. As of December 31, 2022, in addition to the $9 million in tax-effected NOL carryforwards, also at an assumed tax rate of 26%, the significant components of the Company’s net deferred tax assets included stock-based compensation of $10 million and capitalized research and development expenditures of approximately $1 million. The Company believes that it is more likely than not that the benefit from the net deferred tax assets will not be realized. Accordingly, it has provided a full valuation allowance on any potential deferred tax assets The valuation allowance increased by approximately $6.0 million for the period ended December 31, 2023. The provision for income taxes is not material in the years presented due to there being no taxable income.   The Company has federal R&D credit carryforwards of approximately $250,000 which will be applied against payroll taxes, not against income taxes. The Company has no state R&D credit carryforwards.   The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions, with varying statutes of limitations. The tax years from inception through 2023 remain open to examination due to the carryover of unused net operating losses that are being carried forward for tax purposes.

Property and Equipment	12 Months Ended
	Dec. 31, 2023
Property and Equipment [Abstract]
Property and Equipment	Note 7 – Property and Equipment   The Company’s property and equipment are primarily located at the Company’s leased facilities in Hoboken, NJ and Tempe, AZ and consist of (in thousands):       December 31,   Classification   2023     2022   Computer and lab equipment   $ 2,999     $ 985   Network equipment     29       12   Furniture and fixtures     32       28   Software     49       19   Leasehold improvements     33       3   Total cost of property and equipment     3,142       1,046   Accumulated depreciation     272       71   Property and equipment, net   $ 2,870     $ 975     The Company recorded depreciation expense of $203 thousand and $52 thousand during the years ended December 31, 2023 and 2022, respectively, using useful lives of the Company’s long-lived assets are as follows:       Estimated Useful Life (Years)   Computer and laboratory equipment   5   Network equipment   4   Furniture and fixtures   7   Software   3   Leasehold improvements   Lessor of lease term or 5     Maintenance and repairs are charged to operations when incurred. When property and equipment are sold or otherwise disposed, the asset account and related accumulated depreciation and amortization accounts are relieved, and any gain or loss is included in other income or expense.

Financial Liabilities	12 Months Ended
	Dec. 31, 2023
Financial Liabilities [Abstract]
Financial Liabilities	Note 8 – Financial Liabilities   The Company has the following amounts related to financial liabilities (in thousands):       December 31,       2023     2022   Remaining loan balances   $ 2,063     $ 8,250   Remaining unamortized debt issuance costs     (138 )     (1,062 ) Financial liabilities, net   $ 1,925     $ 7,188     Additionally, the Company has accrued interest of $14 thousand and $223 thousand as of December 31, 2023 and 2022, respectively, which is included in Other Current Liabilities.   Unsecured Promissory Note   On September 23, 2022, the Company entered into a note purchase agreement (the “Unsecured NPA”) with Streeterville Capital, LLC (“Streeterville”), pursuant to which Streeterville purchased an unsecured promissory note (the “Note” or the “Streeterville Unsecured Note”) in the initial principal amount of $8.25 million. The Note bears interest at 10% per annum. The maturity date of the Note is 18 months from the date of its issuance (the “Maturity Date”). The Note carries an original issue discount of $750 thousand, which is included in the principal balance of the Note. If the Company elects to prepay the Note prior to the Maturity Date, it must pay to Streeterville 120% of the portion of the Outstanding Balance the Company elects to prepay.   Beginning on the date that was six months after the issuance date of the Note, Streeterville has the right to redeem up to $750 thousand of the outstanding balance of the Note per month (“Redemption Amount”) by providing written notice to the Company (“Redemption Notice”). Upon receipt of any Redemption Notice, the Company shall pay the applicable Redemption Amount in cash to Streeterville within three trading days of the Company’s receipt of such Redemption Notice. No prepayment premium shall be payable in respect of any Redemption Amount. As of December 31, 2023, Streeterville has redeemed $7.0 million of the outstanding balance of the Note. The outstanding balances were $1.9 million and $7.2 million as of December 31, 2023 and 2022, respectively   Pursuant to the terms of the Unsecured NPA, the parties provided customary representations and warranties to each other. Also, until amounts due under the Note are paid in full, the Company agreed, among other things, to: (i) timely make all filings under the Securities Exchange Act of 1934, (ii) ensure the Company’s common stock continues to be listed on the Nasdaq, (iii) ensure trading in the Company’s common stock will not be suspended, halted, chilled, frozen, reach zero bid or otherwise cease trading on Company’s principal trading market, (iv) ensure the Company will not make any Restricted Issuance (as defined in the Note) without Streeterville’s prior written consent, which consent may be granted or withheld in Streeterville’s sole and absolute discretion, (v) ensure the Company will not enter into any agreement or otherwise agree to any covenant, condition, or obligation that locks up, restricts in any way or otherwise prohibits the Company from entering into certain additional transactions with Streeterville, and (vi) with the exception for Permitted Liens (as defined in the Note) ensure the Company will not pledge or grant a security interest in any of its assets without Streeterville’s prior written consent, which consent may be granted on withheld in Streeterville’s sole and absolute discretion.   The Note sets forth certain standard events of default (such event, an “Event of Default”) that generally, if uncured within seven trading days, may result in the discretion of Streeterville in certain penalties under the terms of the Note. In this regard, upon an Event of Default, Streeterville may accelerate the Note by written notice to the Company, with the outstanding balance becoming immediately due and payable in cash at the Mandatory Default Amount (as defined in the Note). Additionally, upon written notice given by Streeterville to the Company, interest shall accrue on the Outstanding Balance beginning on the date the applicable Event of Default occurred at an interest rate equal to the lesser of 15% per annum simple interest or the maximum rate permitted under applicable law upon an Event of Default.

Contingencies	12 Months Ended
	Dec. 31, 2023
Contingencies [Abstract]
Contingencies	Note 9 – Contingencies    Indemnification Arrangements   We enter into standard indemnification arrangements in our ordinary course of business. Pursuant to these arrangements, we indemnify, hold harmless, and agree to reimburse the indemnified parties for losses suffered or incurred by the indemnified parties (generally our business partners or customers) in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to our products. The term of these indemnification agreements is generally perpetual any time after the execution of the agreement. The maximum potential amount of future payments we could be required to make under these agreements is not determinable. We have never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the estimated fair value of these agreements is minimal.   We have entered into indemnification agreements with our directors and officers that may require us to indemnify our directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of a culpable nature. These agreements also require us to advance their expenses incurred as a result of any proceeding against them as to which they could be indemnified and to make good faith determination whether or not it is practicable for us to obtain directors and officers insurance. We currently have directors and officers liability insurance.   Legal Proceedings   From time to time, we may be involved in legal proceedings arising in the ordinary course of business. In general, management believes that ordinary course of business matters will not have a material adverse effect on our financial position or results of operations and are adequately covered by our liability insurance. However, it is possible that consolidated cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one of more of these contingencies or because of the diversion of management’s attention and the incurrence of significant expenses.   As part of our business combination with QPhoton in June 2022, we acquired a payable to BV Advisory Partners, LLC (“BV Advisory”). On March 1, 2021, QPhoton entered into a Note Purchase Agreement with BV Advisory. Under the Note Purchase Agreement, on March 1, 2021, March 23, 2021 and July 9, 2021, BV Advisory purchased convertible promissory notes from QPhoton for $200 thousand, $150 thousand, and $150 thousand, respectively, for a total of $501 thousand (the “BV Notes”), which is included in Other Current Liabilities as of December 31 2023 and 2022. The BV Notes all bore interest at a rate of 6% per annum and matured two years from the grant date. However, QPhoton only received approximately $375 thousand in cash proceeds as $125 thousand was paid by BV Advisory directly to The Trustees of the Stevens Institute of Technology (“Stevens Institute”) on behalf of QPhoton to satisfy QPhoton’s obligations to reimburse costs incurred under the terms of their patent license agreement with the Stevens Institute.   On June 16, 2022, QPhoton tendered a cashier’s check to BV Advisory in the amount of $535,684, representing the full principal balance of the BV Notes and accrued interest through June 16, 2022. On July 14, 2022 BV Advisory returned the cashier’s check and disputed the calculation of the amount paid to settle the BV Notes. The BV Notes and accrued interest are recorded as short-term liabilities. On August 15, 2022, BV Advisory filed a complaint in the Court of Chancery of the State of Delaware naming the Company and certain of its directors and officers (among others) as defendants. BV Advisory Partners, LLC v. Quantum Computing Inc., et al., C.A. No. 2022-0719-VCG (Del. Ch.). BV Advisory seeks, among other relief, monetary damages for an alleged breach of the Note Purchase Agreement between BV Advisory and QPhoton, Inc., the predecessor in interest to QPhoton, LLC, as well as monetary damages for breach of an alleged binding letter of intent among Barksdale Global Holdings, LLC, Inference Ventures, LLC and QPhoton, Inc. The Company believes that BV Advisory’s claims have no merit and intends to defend itself vigorously. The Company filed a motion to dismiss the complaint in December 2022, and in March 2023 Plaintiff filed a second amended complaint. The Company filed a motion to dismiss the second amended complaint, oral argument was held on October 11, 2023 and at this time that motion is pending before the Court. BV Advisory’s claims are not covered by the Company’s liability insurance. The Company does not believe it is necessary to accrue an amount in addition to the principal and interest on the BV Notes at this time.

Loan Receivable	12 Months Ended
	Dec. 31, 2023
Loan Receivable [Abstract]
Loan Receivable	Note 10 – Loan Receivable   On May 16, 2023, the Company entered into a Summary of Proposed Terms (the “Letter of Intent”) with millionways to provide bridge loans to millionways and enter into due diligence to acquire up to 100% of the AI firm. On June 6, 2023, the Company entered into a Note Purchase Agreement (the “MW Agreement”) with millionways, pursuant to which the Company agreed to purchase from millionways up to three unsecured promissory notes (each, a “MW Note”), in an aggregate principal amount of up to $2.0 million, subject to the terms and conditions of the MW Agreement. Also on June 6, 2023, pursuant to the terms of the MW Agreement, the Company purchased the MW Notes from millionways and loaned an aggregate principal amount of $500 thousand to millionways. The MW Agreement contains customary representations and warranties by millionways and the Company, as well as a “most favored nations” provision for the benefit of the Company. The MW Notes issued under the MW Agreement, including the MW Notes issued on June 6, 2023, provide that the indebtedness evidenced by the applicable MW Note bears simple interest at the rate of 10% per annum (or 15% per annum during the occurrence of an event of default, as defined in the MW Notes), and becomes due and payable in full on the earlier of (i) May 16, 2024, (ii) a change of control (as defined in the MW Notes) of millionways, (iii) dollar-for-dollar prepayment for additional capital received through any vehicle from a third party or (iv) an event of default.   The Company reserved $279 thousand of the outstanding $558 thousand receivable as uncollectible based on credit risk in the consolidated financial statements as of December 31, 2023.

Capital Stock	12 Months Ended
	Dec. 31, 2023
Capital Stock [Abstract]
Capital Stock	Note 11 – Capital Stock:   Series A Convertible Preferred Offering   From November 10, 2021 through November 17, 2021, the Company conducted a private placement offering (the “Private Placement”) pursuant to securities purchase agreements with 7 accredited investors (the “Series A Investors”), whereby the Series A Investors purchased from the Company an aggregate of 1,545,459 shares of the Company’s newly created Series A convertible preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”) and warrants to purchase 1,545,459 shares of the Company’s common stock (the “Preferred Warrants”) for an aggregate purchase price of $8.5 million. The Private Placement was completed and closed to further investment on November 17, 2021.   The Series A Preferred Stock ranks senior to common stock with respect to the payment of dividends and liquidation rights. Each holder of Series A Preferred Stock is entitled to receive, with respect to each share of Series A Preferred Stock then outstanding and held by such holder, dividends at the rate of 10% per annum (the “Preferred Dividends.”) The Company is obligated to pay the Preferred Dividends quarterly, in arrears, within fifteen days of the end of each quarter. The Company has the option to pay the Preferred Dividends in cash or in the Company’s common stock, at a price per share of common stock equal to the average of the closing sale price of the common stock for the five trading days preceding the applicable dividend payment date. The Preferred Dividends are accrued monthly, but not compounded, and are recorded as interest expense, because the Preferred Dividends are mandatory and not declared at the discretion of the Board of Directors.   The number of shares of the Company’s common stock issuable upon conversion of any share of Series A Preferred Stock shall be determined by dividing (x) the Conversion Amount of such share of Series A Preferred Stock by (y) the Conversion Price. “Conversion Amount” means, with respect to each share of Series A Preferred Stock, as of the applicable date of determination, the sum of (1) the stated value thereof plus (2) any accrued dividends. “Conversion Price” means, with respect to each share of Series A Preferred Stock, as of any optional conversion date, Mandatory Conversion Date or other date of determination, $5.50, subject to adjustment for stock splits, dividends, recapitalizations and similar corporate events.   The Preferred Warrants are two-year warrants to purchase shares of the Company’s common stock at an exercise price of $7.00 per share, subject to adjustment, and are exercisable at any time on or after the date that is six months following the issuance date. The Preferred Warrants provide for cashless exercise in the event the underlying shares of the Company’s common stock are not registered. As of December 31, 2023, all of the Preferred Warrants had expired unexercised.   In connection with the Purchase Agreement, the Company and the Series A Investors entered into a registration rights agreement (the “Registration Rights Agreement”) pursuant to which the Company agreed to file a registration statement to register the shares of common stock underlying the Series A Preferred Stock and warrants within 180 days. Pursuant to the Registration Rights Agreement, the Series A Investors received certain rights, including but not limited to piggyback registration rights, providing that the holder be given notice of any proposed registration of securities by the Company, and requiring that the Company register all or any portion of the registrable securities that the holders request to be registered, in each case, subject to the terms and conditions of the Registration Rights Agreement.   On April 27, 2022, the Company filed a Resale Form S-3 as required by the Registration Rights Agreement, pursuant to which the Company agreed to file a registration statement to register the shares of common stock underlying the Series A Preferred Stock and warrants within 180 days from the closing of the Private Placement. The Resale Form S-3 went effective on June 2, 2022.   On June 13, 2022, one of the Series A Investors, Falcon Capital Partners, converted 45,455 shares of Series A Preferred stock into 47,728 shares of the Company’s common stock.   On February 9, 2023, one of the Series A Investors, Greenfield Children, LLC, converted 10,000 shares of Series A Preferred stock plus accrued dividends into 11,096 shares of the Company’s common stock.   Authorized Classes of Stock   As of September 9, 2024, the Board has authorized two classes of preferred stock. The Board has authorized 1,550,000 shares of preferred stock as the Series A Preferred stock, par value $0.0001 per share, of which 1,490,004 shares are issued and outstanding. The Board has also authorized 3,079,864 shares of preferred stock as the Series B Preferred Stock, par value $0.0001 per share, none of which are issued and outstanding.   At-the-Market Facility   From January 19, 2023 through December 31, 2023, the Company sold 17,571,926 shares of common stock through its At-The-Market (ATM) facility, managed by Ascendiant Capital Markets, LLC, at an average price of $1.45. The Company received net proceeds of $24.7 million.   Warrants    The table below summarizes the warrants outstanding as of December 31, 2023 (in thousands, except exercise prices):   Issuance Date   Expiration Date   Exercise Price     Issued     Exercised     Forfeited / Canceled     Warrants Outstanding   August 18, 2020   August 18, 2025   $ 2.00       171       (150 )     -       21   November 15, 2021   November 15, 2023   $ 7.00       1,545               (1,545 )     -   June 16, 2022   May 9, 2027   $ 0.0001       6,325       -       (3,309 )     3,016     In connection with a restricted stock units offering in June 2020, the Company issued warrants in August 2020 to purchase 171,000 shares of the Company’s common stock, at an exercise price of $2.00. Those warrants are exercisable for five years from the date of issuance.   In connection with the offering of Series A Preferred Stock in November 2021, the Company issued warrants to purchase 1,545,459 shares of the Company’s common stock at an exercise price of $7.00. Those warrants were exercisable for two years from the date of issuance and have now expired.   In connection with the QPhoton Merger on June 16, 2022, the Company issued warrants to purchase 6,325,503 shares of the Company’s common stock at an exercise price of $0.0001. Those warrants are exercisable when and if stock options and warrants issued and outstanding as of June 15, 2022 (the “Underlying Options”), are exercised. As of December 31, 2023, none of the QPhoton Warrants linked to the outstanding Underlying Options are expected to be exercised as the exercise prices of the Underlying Options are above the current stock price as of December 31, 2023. The total Merger Consideration consisted of 36,600,823 shares of the Company’s common stock on an as-converted basis, including the 7,028,337 QPhoton Warrants. As discussed in Note 4, Business Combinations, two QPhoton shareholders received their Merger Consideration and a third alleged shareholder rejected the Merger Consideration and commenced litigation in Delaware Chancery Court (see Note 9, Contingencies – Legal Proceedings, in this Amendment for additional information and Item 3, Legal Proceedings, in the Original Form 10-K for a full discussion), and to date that litigation has not been resolved. Accordingly, as of December 31, 2023 and 2022, we had only issued 6,325,503 of the QPhoton Warrants, of which approximately 52% have been forfeited as of December 31, 2023. Further, as discussed in Note 2, Significant Accounting Policies – Fair Value of Financial Instruments, the QPhoton Warrants issued on June 16, 2022, are considered Level 3 liabilities for fair value measurement on the valuation hierarchy. Accordingly, the Company recognized mark-to-market gains of $528 thousand and $3.4 million during the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, the QPhoton Warrants have no carrying value as a liability on the Company’s consolidated balance sheet.

Stock-based Compensation	12 Months Ended
	Dec. 31, 2023
Stock-Based Compensation [Abstract]
Stock-based Compensation	Note 12 – Stock-based Compensation   Incentive Plans   The Company’s 2019 Equity and Incentive Plan, as amended in 2021 (the “2019 Plan”) enabled the Company to grant incentive stock options or nonqualified stock options and other equity awards to employees, directors and consultants of the Company up to a total of 3 million shares of common stock. All 3 million shares available for issue under the 2019 Plan have been issued.   On July 5, 2022, the Board of Directors adopted the Company’s 2022. Equity and Incentive Plan (the “2022 Plan”), which provides for the issuance of up to 16 million shares of the Company’s common stock. The 2022 Plan was approved by a majority of the stockholders in September 2022. Per the 2022 Plan, the 2022 Plan reserves increased automatically by 1 million shares on January 1, 2023, providing for a total issuance of up to 17 million shares of common stock. As of December 31, 2023, a total of 13.8 million shares and options were issued and outstanding under the 2022 Plan.   The following table presents the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted:       Year Ended       December 31,       2023     2022   Exercise price     $0.85 – 1.84       $1.67 – 2.61   Risk-free interest rate     4.7 – 5.0%       0.6 – 4.5%   Expected volatility     98 – 137%       127 – 164%   Expected dividend yield     0%       0%   Expected life of options (in years)     5.0       5.0     The following table summarizes the Company’s option activity:   Weighted Average Number of Shares (in thousands)   Weighted Average Exercise Price     Contractual Term (in years)   Outstanding as of December 31, 2021                   As previously reported     5,197     $ 7.68       2.5   Adjustments (1)     (1,100 )     (2.45 )     1.4   As restated     4,097       5.23       3.9   Granted     6,853       1.38       5.0   Forfeited     (1,785 )     3.17       -   Outstanding as of December 31, 2022     9,165       3.51       4.2   Granted     5,340       1.38       5.0   Forfeited     (662 )     4.41       -   Outstanding as of December 31, 2023     13,843     $ 2.64       3.7                             Vested as of December 31, 2022     6,413     $ 3.58       4.2   Vested as of December 31, 2023     8,803     $ 3.21       3.4     The following table summarizes the exercise price range as of December 31, 2023 (in thousands):   Exercise Price     Outstanding Options     Exercisable Options   $ 0.00 – 1.00        180        10   $ 1.00 – 2.00        5,695        1,935   $ 2.00 – 3.00        6,359        5,318   $ 3.00 – 5.00        65        65   $ 5.00 – 7.00        726        713   $ 7.00 – 12.00        818        762             13,843       8,803     The weighted average grant-date fair value of stock options granted during the years ended December 31, 2023 and 2022 was $1.38 per share and $2.39 per share, respectively, and as of December 31, 2023, total unrecognized compensation cost related to common stock options was $5.8 million, which is expected to be recognized over a period of 4.0 years.   Stock-based compensation   The Company recognized stock-based compensation expense related to common stock options and restricted shares of common stock in the following expense categories of its consolidated statements of operations (in thousands):       Year Ended December 31,       2023     2022   Research and development     2,080       509   Selling and marketing     (279 )     494   General and administrative     2,470       8,320   Total stock-based compensation   $ 4,271     $ 9,323     For the years ended December 31, 2023 and 2022, the statement of stockholders’ equity was lower by $33 thousand and higher by $170 thousand, respectively, as compared to the statement of cash flows for timing differences between award dates and the realization of stock-based compensation expense.   In terms of new issuances, the Company issued 2,353,600 shares of common stock to employees in 2023 as performance and incentive awards (the “2023 Incentive Shares”), as compared to 20,000 in such awards in 2022. The 2023 Incentive Shares included 853,600 shares of common stock issued to 35 employees as payment in lieu of cash for 2022 performance bonuses (the “Bonus Incentive Shares”) and 1,500,000 shares of common stock as long-term incentive bonuses to five employees identified as key technical staff (the “Retention Incentive Shares”). The Bonus Incentive Shares are restricted with the following vesting schedule: one-half vested on December 31, 2023 and one-half vesting on December 31, 2024. As of December 31, 2023, the Company canceled 23,600 of the issued shares that were forfeited by employees no longer with the Company. The Retention Incentive Shares are restricted and will vest annually in equal amounts over a five-year period as follows: twenty percent (20%) will vest on each of December 31, 2023, December 31, 2024¸ December 31, 2025, December 31, 2026, and December 31, 2027, subject to the grantee continuing to perform services for the Company in the capacity in which the grant was received on each applicable vesting date. In conjunction with these offerings, the Company recognized $1.1 million of stock-based compensation expense during the year ended December 31, 2023, and expects future expense related to these offerings to total $2.1 million over the remaining vesting periods.     Stock-based compensation for services   The Company recognized $284 thousand and $2.4 million during the years ended December 31, 2023 and 2022, respectively, in stock-based compensation for services in lieu of cash payments to certain consultants, including expenses for both shares issued and stock option awards granted. The difference in stock-based compensation for services on the statement of stockholders’ equity as compared to the statement of cash flows for the years ended December 31, 2023 and 2022, was driven by approximately $2.3 million in shares awarded to a consultant who served as an advisor on the QPhoton Merger, comprised of 750,000 shares of common stock to Draper, Inc. and 750,000 shares of common stock to Carriage House Capital, Inc. The expense was recognized in 2022 at the time of the merger, though the shares were not awarded and issued until 2023. Also in 2023, the Company issued 75,000 shares of common stock to FMW Media Works as compensation for services rendered in support of marketing and communications.   In 2022, the Company issued 157,000 shares of common stock as compensation for services rendered in support of business development activities.

Related Party Transactions	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 13 – Related Party Transactions   There were no related party transactions during the years ended December 31, 2023 and 2022.

Operating Leases	12 Months Ended
	Dec. 31, 2023
Operating Leases [Abstract]
Operating Leases	Note 14 – Operating Leases:   The Company has use of space in five different locations, Hoboken, NJ, Tempe, AZ, Leesburg, VA, Arlington, VA, and Minneapolis, MN, under lease or membership agreements, which expire at various dates through October 31, 2028. The Company’s leases do not provide an implicit rate, and the rates implicit in our leases are not readily determinable. Therefore, the Company uses its incremental borrowing rate as the discount rate when measuring operating lease assets and liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. The Company’s leases all contain options to extend or renew the lease or membership term.   The table below reconciles the undiscounted future minimum lease payments under these operating leases to the total operating lease liabilities recognized on the consolidate balance sheet as of December 31, 2023 (in thousands):   Year   Lease Payments Due   2024   $ 383   2025     576   2026     592   2027     516   2028     191   Total minimum payments     2,258   Less: imputed Interest     (1,298 ) Present value of operating lease liabilities     960   Less: current portion included in other current liabilities     (120 ) Long-term operating lease liabilities     840     Other information related to operating lease liabilities consists of the following:       Year Ended December 31,       2023     2022                 Cash paid for operating lease liabilities (in thousands)   $ 411     $ 125   Weighted average remaining lease term in years     3.7       4.7   Weighted average discount rate     10 %     10 %

License Agreement – Stevens Institute of Technology	12 Months Ended
	Dec. 31, 2023
License Agreement – Stevens Institute of Technology [Abstract]
License Agreement – Stevens Institute of Technology	Note 15 – License Agreement – Stevens Institute of Technology   Effective December 17th, 2020, QPhoton signed a License Agreement with the Stevens Institute. The License Agreement enables the Company to commercially use technology such as licensed patents, licensed patent applications and licensed “Know-How”. QPhoton is also able to issue sublicenses for the technology under the agreement. The agreement is effective until the later of: (i) the 30-year anniversary of the effective date, or (ii) the expiration of the licensed patent or licensed patent application that is last to expire. As part of the merger of the Company and QPhoton, the Stevens License Agreement was assigned to the Company.   During the term of the agreement and prior to any commercialization or sublicensing of the technology by the Company, the Company shall be required to submit annual reports to the Stevens Institute reporting on all research, development, and efforts toward commercialization and/or sublicensing made during the year. Once any commercialization and/or sublicensing has been initiated, the Company shall deliver quarterly reports to the Stevens Institute reporting on the revenue received by the Company, all sublicenses derived from the sale of licensed products, and the net sales price associated with each transaction. The Company will be responsible for reimbursing Stevens for any costs associated with the prosecution and maintenance of the licensed patents and licensed patent applications moving forward.   Consideration for the agreement   As consideration for the license and other rights granted under the agreement, QPhoton agreed to pay the following: (i) $35 thousand within 30 days of execution of the agreement, (ii) $28 thousand within 30 days of each annual anniversary of the effective date, (iii) equity in the Company equivalent to nine percent of the membership units of the Company within 30 days of the execution of the agreement, and (iv) royalties of 3.5% of the Net Sales Price of each licensed product sold or licensed by the Company during the quarter then-ended, for which it also received payment, concurrent with the delivery of the relevant quarterly report.   As of December 31, 2023, the Company has begun to commercialize some of the licensed technology, though the Company has not recorded any related revenue and hence has not incurred any royalty expenses payable to the Stevens Institute.

Subsequent Events	12 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 16 – Subsequent Events    On January 31, 2024, BV Advisory and its chief executive officer, Keith Barksdale (the “BV Defendants”), alleged stockholders of and claimants against the Company, filed a motion for reconsideration of his original 2023 motion to dismiss. The motion and our opposition were argued before the Superior Court of New Jersey (the “NJ Court”) on February 15, 2024. On March 7, 2024, the NJ Court issued an order, granting the BV Defendant’s motion dismissing the Company’s case on procedural grounds because, according to the NJ Court, the Company can assert its claims. On April 1, 2024, the Company filed a motion in New Jersey Superior Court for reconsideration of the Court’s March 7, 2024 order dismissing the Company’s defamation and fraud complaint (the “QCi v BV Complaint in NJ Court”) against the BV Defendants on procedural grounds. On May 1, 2024, the NJ Court affirmed its initial order dismissing the case with prejudice and directed the Company to file its claims in Delaware. The Company, as plantiff on the QCi v BV Complaint in NJ Court, is currently evaluating whether it should file the claims in Delaware. On May 28, 2024, the Delaware Court of Chancery issued rulings dismissing the BV Advisory petition to appoint a receiver for the Company without prejudice and granting in part the Company’s motion to dismiss the BV Advisory lawsuit for breach of contract and related claims, dismissing eight of the ten counts in the complaint. The Parties are working with the Court to schedule briefing and resolution of the two remaining counts.   From January 1, 2024, through March 1, 2024, the Company repaid $2,094,378 of principal and accrued interest on the Streeterville Unsecured Note, for a cumulative redemption amount of $9,094,378. As of March 1, 2024, the Company had fully repaid the Streeterville Unsecured Note.   On March 19, 2024, the Company entered into a Redemption and Waiver Agreement (the “Redemption Agreement”) with the current holders (the “Series A Holders”) of its Series A Preferred Stock. Pursuant to the Redemption Agreement, the Company agreed to redeem all outstanding shares of the Series A Preferred Stock for an aggregate cash purchase price of $8,195,000, or $5.50 per share, at its sole discretion, in 18 monthly payments (each a “Monthly Redemption Threshold” payment), which may be accelerated at the Company’s sole discretion. In addition, the Series A Holders agreed to waive (the “Waivers”), on a month-by-month basis following each monthly payment, certain rights granted to them in (i) the Preferred Stock Certificate of Designation (the “Preferred Stock COD”), including for the accrual and payment of accrued and future dividends; and (ii) the Preferred Stock Securities Purchase Agreement (the “Preferred Stock SPA”). In the event the Company opts to not make a Monthly Redemption Threshold payment, the Waivers are forfeited and the terms revert to those detailed in the Preferred Stock COD and Preferred Stock SPA. As of September 9, 2024, the Company has redeemed 496,698 shares of Series A Preferred Stock for a cumulative redemption amount of $2.7 million in cash paid to the Series A Holders. As of September 9, 2024 there are 993,306 shares of Series A Preferred Stock issued and outstanding.   On August 6, 2024, the Company entered into a Securities Purchase Agreement with Streeterville, pursuant to which the Company issued and sold to Streeterville a Secured Convertible Promissory Note (the “Streeterville Secured Convertible Note”) in the original principal amount of $8.25 million (the “Principal Amount”). The Principal Amount includes an original issue discount of $750 thousand. In exchange for the Streeterville Secured Convertible Note, Streeterville paid $7.5 million in cash. The Streeterville Secured Convertible Note accrues interest at a rate of 10% per annum and has a maturity date of 18 months from the Effective Date, unless earlier prepaid, redeemed or accelerated in accordance with its terms prior to such date. The Company intends to use the net proceeds from the sale of the Streeterville Secured Convertible Note primarily for general working capital purposes, including for (i) operations as the Company increases its sales and marketing efforts; (ii) capital expenditures in outfitting its chip fabrication facility in Tempe, AZ; and (iii) for any other planned or unplanned expenditures that might arise in support of the Company’s business plan. Ascendiant Capital Markets, LLC served as the placement agent on the transaction and received a fee of $450 thousand.   There are no other events of a subsequent nature that in management’s opinion are reportable.

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2023
Significant Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation: The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as determined by the Financial Accounting Standards Board (the “FASB”), including ASC 810, Consolidation. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year end is December 31.
Risk and Uncertainties	Risk and Uncertainties The Company is subject to certain risks and uncertainties and believes changes in any of the following areas could have a material adverse effect on the Company’s future financial position or results of operations or cash flows: new product development, including market receptivity; litigation or claims against the Company based on intellectual property, patent, product regulation or other factors; competition from other products; general economic conditions; the ability to attract and retain qualified employees; and, ultimately, to sustain profitable operations.
Use of Estimates	Use of Estimates These consolidated financial statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the valuation of goodwill and intangible assets, deferred tax assets, equity-based transactions and liquidity assessment. Actual results may differ from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Highly liquid investments with a maturity of three months or less when purchased are considered to be cash equivalents. As of December 31, 2023 and 2022, there were no cash equivalents. The Company maintains its cash in deposit and money market accounts with high quality financial institutions which, at times, may exceed federally insured limits. The Company has not experienced any losses on these deposits and believes it is not exposed to significant credit risk on cash.
Revenue	Revenue The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, by analyzing contracts with its customers using a five-step approach:   1. Identify the contract         2. Identify the performance obligations         3. Determine the transaction price         4. Allocate the transaction price to the performance obligations         5. Recognize revenue when performance obligations are satisfied The Company recognized a small amount of revenue in 2023 and 2022, which was primarily derived from contracts to perform professional services. Revenue from time and materials-based contracts is recognized as the direct hours worked during the period times the contractual hourly rate, plus direct materials and other direct costs as appropriate, plus negotiated materials handling burdens, if any. Revenue from units-based contracts is recognized as the number of units delivered or performed during the period times the contractual unit price. Revenue from fixed price contracts is recognized as work is performed with estimated profits recorded on a percentage of completion basis. The Company has no cost-plus type contracts at this time. The Company includes depreciation and amortization expenses in manufacturing overhead, which is a component of cost of revenue. However, at the present time manufacturing overhead, including depreciation and amortization expense related to production equipment, is not material and the primary components of cost of revenue are direct labor and direct materials, with a small amount of shipping expenses.
Accounts Receivable	Accounts Receivable Accounts receivable consists of amounts due from customers for work performed on contracts. The Company records accounts receivable at their net realizable value. Periodically the Company evaluates its accounts receivable to establish a provision for credit losses, when deemed necessary, based on the history of past write-offs, collections and current credit conditions. Within 2022, certain accounts receivable, attributable to a single customer, were determined not to be collectible and management recorded a provision and wrote off the uncollectible receivables against that account. The customer accounts receivable as of December 31, 2023 are considered fully collectible and thus management has not recorded a provision for credit losses.
Provision for Credit Losses	Provision for Credit Losses The Company estimates losses on loans and other financial instruments in accordance with Accounting Standards Update (“ASU”) 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 introduces the current expected credit losses (“CECL”) methodology for estimating allowances for credit losses. The CECL framework requires the Company to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supporting forecasts. Under CECL, the allowance for credit losses is measured as the difference between the financial asset’s cost basis and the net amount expected to be collected on the financial asset. CECL allows us to use information about past events including historical loan loss experience, current conditions, and reasonable and supportable forecasts to assess the collectability of the financial assets. The receivables for financial assets as of December 31, 2023 are not considered fully collectible and thus management has recorded a provision for credit losses. Note 10, Loan Receivable, for additional information.
Inventory	Inventory Inventory is stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis which approximates actual cost on a first in-first out (“FIFO”) method. Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory, deterioration and other factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are made for estimated excess, obsolescence or impaired inventory and are charged to cost of revenue. Once the cost of the inventory is reduced, a new lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. Factors influencing these adjustments include changes in demand, product life cycle and development plans, component cost trends, product pricing, physical deterioration and quality issues. Revisions to these adjustments would be required if these factors differ from our estimates.
Operating Leases	Operating Leases The Company determines if an arrangement is a lease at inception. Operating lease right-of-use (“ROU”) assets are included in right-of-use assets, net on the consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current operating lease liabilities and non-current operating lease liabilities, respectively, on the consolidated balance sheets. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheet. All of our operating leases are comprised of office space leases, and as of December 31, 2023 and 2022, we had no finance leases.
Business Combinations and Valuation of Goodwill	Business Combinations and Valuation of Goodwill We account for business combinations under the acquisition method of accounting. This method requires the recording of acquired assets and assumed liabilities at their acquisition date fair values. The excess of the purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Results of operations related to business combinations are included prospectively beginning with the date of acquisition and transaction costs related to business combinations are recorded withing general and administrative expenses.   The Company reviews goodwill for impairment on an annual basis or whenever events or changes in circumstances indicate the carrying value may not be recoverable. The Company performs an annual impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, income tax effects from any tax-deductible goodwill carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable. The Company has determined that it has a single reporting unit for purposes of performing its goodwill impairment test. As the Company uses the market approach to assess impairment, its common stock price is an important component of the fair value calculation. If the Company’s stock price continues to experience significant price and volume fluctuations, this will impact the fair value of the reporting unit and can lead to potential impairment in future periods. The Company performed its annual impairment test during the second quarter of fiscal 2023 and 2022 and determined that its goodwill was not impaired. As of December 31, 2023 and 2022, we had not identified any factors that indicated there was an impairment of our goodwill and determined that no additional impairment analysis was then required.
Property and Equipment	Property and Equipment Property and equipment are stated at cost or contributed value. Depreciation of furniture, software and equipment is calculated using the straight-line method over their estimated useful lives, and leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the lease term. The cost and related accumulated depreciation of equipment retired or sold are removed from the accounts and any differences between the undepreciated amount and the proceeds from the sale are recorded as a gain or loss on sale of equipment. Maintenance and repairs are charged against expense as incurred.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company has long-lived assets such as tangible property and equipment, identified intangible assets consisting of acquired patents and core technology. When events or changes in circumstances occur that could indicate the carrying value of long-lived assets may not be recoverable, the Company assesses recoverability by determining whether the undiscounted cash flows estimated to be generated by those assets are less than the carrying amounts of those assets. If the undiscounted cash flow is less, an impairment charge is recognized for the excess of the carrying amounts of these assets over the fair values. Fair values are determined by discounted future cash flows, appraisals or other methods. During the years ended December 31, 2023 and 2022, the Company did not record any impairment from long-lived assets.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amount of certain financial instruments held by the Company, such as cash equivalents, accounts receivable, contract assets and liabilities, accounts payable, and accrued and other current liabilities, approximate fair value due to their short maturities. The carrying amount of the liabilities for the convertible preferred stock warrants represent their fair value. The carrying amounts of the Company’s borrowings and lease liabilities approximate fair value due to the market interest rates that these obligations bear and interest rates currently available to the Company. Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:   Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities;   Level 2 Inputs other than quoted prices included within Level 1 that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and   Level 3 Unobservable inputs that are supported by little or no market activity for the related assets or liabilities. The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. As of December 31, 2023, the Company had $793 thousand in Level 1 assets, comprised of U.S. Government mutual funds, and no carrying value for Level 3 liabilities, comprised of the QPhoton Warrants, as defined below.
Research and Development Costs	Research and Development Costs Research and development costs include costs directly attributable to the conduct of research and development programs to enhance existing products and services and to develop future technologies, including the cost of services provided by outside contractors, and mandatory compliance fees and contractual obligations. All costs associated with research and development are expensed as incurred.
Software Development Costs	Software Development Costs Software development costs incurred subsequent to the establishment of technological feasibility for software intended to be sold, licensed or otherwise marketed to customers will be capitalized, but development costs not meeting the criteria for capitalization are expensed as incurred. With respect to internal use software, the Company will capitalize such development costs incurred during the application development stage, but development costs incurred prior to that stage will be expensed as incurred. No amortization expense will be recorded until the software is ready for its intended use. To date the Company has not incurred any capitalizable software development costs.
Stock-Based Compensation	Stock-Based Compensation The Company has adopted ASU 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 expands the scope of ASC 718, Share-Based Payment, to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of ASC 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost. ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, and that ASC 718 does not apply to share based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606, Revenue from Contracts with Customers. Stock-based compensation expense for expected-to-vest awards is valued under the single-option approach and amortized on a straight-line basis, accounting for actual forfeitures as they occur. We utilize the Black Scholes pricing model in order to determine the fair value of stock-based option awards. The Black Scholes pricing model requires various highly subjective assumptions including volatility, expected option life, and risk-free interest rate. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management judgment. If factors change and different assumptions are used, our stock-based compensation expense could be materially different in the future.
Loss Per Share	Loss Per Share Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if the common share equivalents had been issued (computed using the “If-Converted” method), unless the effect of such issuances would have been anti-dilutive. The following table sets forth the computation of basic and diluted loss per share (in thousands, except per share data):     Year Ended December 31,       2023     2022   Numerator:             Net loss   $ (27,022 )   $ (25,978 ) Less: Series A convertible preferred stock dividends     861       889   Net loss available to common stockholders – basic and diluted   $ (27,883 )   $ (26,867 ) Denominator:                 Weighted average shares used in computing net loss per common share – basic and diluted     66,611       36,680   Loss per share - basic and diluted   $ (0.42 )   $ (0.73 ) Net loss per share is based on the weighted average number of common shares and common share equivalents outstanding during the period. In periods with a reported net loss, the effect of anti-dilutive stock options, unvested restricted common stock and warrants are excluded and diluted loss per share is equal to basic loss per share. Due to a net loss in the years ended December 31, 2022 and 2023, there were therefore no dilutive securities and hence basic and diluted loss per share were the same. The following is a summary of the weighted average common stock equivalents for the securities outstanding during the respective periods that have been excluded from the computation of diluted net loss per common share, as their effect would be anti-dilutive (in thousands):     Year Ended December 31,       2023     2022   Warrants     6,053       3,976   Options     12,280       6,830   Unvested restricted common stock     1,192       -   Total potentially dilutive shares     19,525       10,778   As all potentially dilutive securities are anti-dilutive as of December 31, 2023 and 2022, diluted net loss per share is the same as basic net loss per share for each period.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption. The Company has evaluated the recently implemented accounting standards and concluded that none currently apply to the Company.

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Significant Accounting Policies [Abstract]
Schedule of Basic and Diluted Loss per Share	The following table sets forth the computation of basic and diluted loss per share (in thousands, except per share data):     Year Ended December 31,       2023     2022   Numerator:             Net loss   $ (27,022 )   $ (25,978 ) Less: Series A convertible preferred stock dividends     861       889   Net loss available to common stockholders – basic and diluted   $ (27,883 )   $ (26,867 ) Denominator:                 Weighted average shares used in computing net loss per common share – basic and diluted     66,611       36,680   Loss per share - basic and diluted   $ (0.42 )   $ (0.73 )
Schedule of Securities Outstanding	The following is a summary of the weighted average common stock equivalents for the securities outstanding during the respective periods that have been excluded from the computation of diluted net loss per common share, as their effect would be anti-dilutive (in thousands):     Year Ended December 31,       2023     2022   Warrants     6,053       3,976   Options     12,280       6,830   Unvested restricted common stock     1,192       -   Total potentially dilutive shares     19,525       10,778

Restatement of Previously Issued Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2023
Restatement of Previously Issued Financial Statements [Abstract]
Schedule of Consolidated Balance Sheets	The following table presents the effect of the aforementioned adjustments on our Consolidated Balance Sheets as of December 31, 2023 and 2022 and indicates the category of the adjustments by reference to the above descriptions of the errors for which we made corrections:     Year Ended December 31, 2023       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Assets                         Current assets                         Cash and cash equivalents   $ 2,059     $ -             $ 2,059   Accounts receivable     65       -               65   Inventory     73       -               73   Loans receivable, net of provision for credit losses     557       (278 )     (4 )     279   Prepaid expenses and other current assets     427       (247 )     (7 )     180   Total current assets     3,181       (525 )             2,656   Property and equipment, net     2,870       -               2,870   Operating lease right-of-use assets     800       251       (7 )     1,051   Intangible Assets, net     11,388       688       (1 )     12,076   Goodwill     60,360       (4,787 )     (1 )     55,573   Other non-current assets     129       -               129   Total assets   $ 78,728     $ (4,373 )           $ 74,355                                     Liabilities and Stockholders’ Equity                                 Current liabilities                                 Accounts payable   $ 1,462     $ -             $ 1,462   Accrued expenses     411       228       (2)(5 )     639   Financial liabilities, current, net of issuance costs     2,496       (571 )     (3 )     1,925   Other current liabilities     250       536       (7 )     786   Total current liabilities     4,619       193               4,812   Operating lease liabilities     840       -               840   Total liabilities     5,459       193               5,652                                     Stockholders’ equity                                 Preferred stock     -       -               -   Common stock     8       -               8   Additional paid-in capital     222,980       (22,345 )     (1)(2)(6)(7 )     200,635   Accumulated deficit     (149,719 )     17,779       (1)(2)(3)(4)(5)(6)(7 )     (131,940 ) Total stockholders’ equity     73,269       (4,566 )             68,703   Total liabilities and stockholders’ equity   $ 78,728     $ (4,373 )           $ 74,355         Year Ended December 31, 2022       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Assets                         Current assets                         Cash and cash equivalents   $ 5,308     $ -             $ 5,308   Accounts receivable     13       -               13   Prepaid expenses and other current assets     408       (279 )     (7 )     129   Total current assets     5,729       (279 )             5,450   Property and equipment, net     975       -               975   Operating lease right-of-use assets     1,187       86       (7 )     1,273   Intangible assets, net     22,224       (7,044 )     (1 )     15,180   Goodwill     59,126       (3,553 )     (1 )     55,573   Other non-current assets     60       -               60   Total assets   $ 89,301     $ (10,790 )           $ 78,511                                     Liabilities and Stockholders’ Equity                                 Current liabilities                                 Accounts payable   $ 872     $ -             $ 872   Accrued expenses     3,780       (819 )     (2)(5 )     2,961   Financial liabilities, current     536       (536 )     (7 )     -   Other current liabilities     132       628       (6)(7 )     760   Total current liabilities     5,320       (727 )             4,593   Financial liabilities, net of issuance costs     7,858       (670 )     (3 )     7,188   Warrant liability     -       528       (1 )     528   Operating lease liabilities     1,226       (148 )     (7 )     1,078   Total liabilities     14,404       (1,017 )             13,387                                     Stockholders’ equity                                 Preferred stock     -       -               -   Common stock     6       -               6   Additional paid-in capital     194,879       (25,704 )     (1)(2)(6)(7 )     169,175   Accumulated deficit     (119,988 )     15,931       (1)(2)(3)(4)(5)(6)(7 )     (104,057 ) Total stockholders’ equity     74,897       (9,773 )             65,124   Total liabilities and stockholders’ equity   $ 89,301     $ (10,790 )           $ 78,511
Schedule of Consolidated Statements of Operations	The following tables present the effect of the aforementioned reclassifications and adjustments on our consolidated statements of operations for the years ended December 31, 2023 and 2022 and indicate the category of the adjustments by reference to the above descriptions of the errors for which we made corrections:     Year Ended December 31, 2023       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Total revenue   $ 358     $ -             $ 358   Cost of revenue     196       -               196   Gross profit     162       -               162   Operating expenses     27,384       (979 )     (2)(5 )     26,405   Loss from operations     (27,222 )     979               (26,243 ) Non-operating income (expense)                                 Interest and other income     295       -               295   Interest expense, net     (2,804 )     1,202       (3)(6 )     (1,602 ) Change in value of warrant liability     -       528       (1 )     528   Loss before income tax provision     (29,731 )     2,709               (27,022 ) Income tax provision     -       -               -   Net loss     (29,731 )     2,709               (27,022 )  Less: Series A convertible preferred stock dividends     -       (861 )     (6 )     (861 ) Net loss available to common stockholders   $ (29,731 )   $ 1,848             $ (27,883 )                                   Loss per share – basic and diluted   $ (0.38 )   $ (0.04 )           $ (0.42 ) Weighted average shares used in computing net loss per common share – basic and dilutive     77,451       (10,840 )             66,611       Year Ended December 31, 2022       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Total revenue   $ 136     $ -                 $ 136   Cost of revenue     61       -               61   Gross profit     75       -               75   Operating expenses     36,654       (7,934 )     (2 )(5)     28,720   Loss from operations     (36,579 )     7,934               (28,645 ) Non-operating income (expense)                                 Interest and other income     47       -               47   Interest expense, net     (2,062 )     1,290       (3 )(6)     (772 ) Change in value of warrant liability     -       3,392       (1 )     3,392   Loss before income tax provision     (38,594 )     12,616               (25,978 ) Income tax provision     -       -               -   Net loss     (38,594 )     12,616               (25,978 ) Less: Series A convertible preferred stock dividends     -       (889 )     (6 )     (889 ) Net loss available to common stockholders   $ (38,594 )   $ 11,727             $ (26,867 )                                   Loss per share – basic and diluted   $ (0.69 )   $ (0.04 )           $ (0.73 ) Weighted average shares used in computing net loss per common share – basic and dilutive     55,963       (19,283 )             36,680
Schedule of Consolidated Statements of Cash Flows	The following tables present the effect of the aforementioned adjustments on our consolidated statements of cash flows for the years ended December 31, 2023 and 2022 and indicate the category of the adjustments by reference to the above descriptions of the errors for which we made corrections:     Year Ended December 31, 2023       As Previously           Description of             Reported     Adjustments     Adjustments     As restated   Cash flows from operating activities:                         Net loss   $ (29,731 )     2,709               (27,022 ) Adjustments to reconcile net loss to net cash from operations                                 Depreciation and intangibles amortization     1,958       1,349       (1 )     3,307   Amortization of issuance costs     -       925       (3 )     925   Change in fair value of warrant liabilities     -       (528 )     (1 )     (528 ) Provision for credit losses     -       279       (4 )     279   Other recognized losses (gains)     4       1       (7 )     5   Stock-based compensation expense     8,723       (4,452 )     (2 )     4,271   Stock-based compensation expense for services     -       284       (2 )     284   Changes in operating assets and liabilities                                 Accounts receivable     (52 )     -               (52 ) Inventory     (70 )     -               (70 ) Prepaid expenses and other current assets     (78 )     (32 )     (7 )     (110 ) Other non-current assets     318       (165 )     (7 )     153   Accounts payable     583       13               596   Accrued expenses and other current liabilities     (985 )     1,095       (2)(7 )     110   Other long-term liabilities     (611 )     148       (7 )     (463 ) Net cash used in operating activities     (19,941 )     1,626             (18,315 )                                   Cash flows from investing activities:                                 Purchase of property and equipment     (2,118 )     (6 )     (7 )     (2,112 ) Issuance of loan receivable     (500 )     -             (500 ) Net cash used in investing activities     (2,618 )     (6 )             (2,612 )                                   Cash flows from financing activities:                                 Payments of financial liabilities, net of interest     (6,187 )     -               (6,187 ) Series A Preferred dividend payments     -       (865 )     (6 )     (865 ) Proceeds from stock issuance related to ATM facility     25,496       (766 )     (6 )     24,730   Net cash provided by financing activities     19,309       (1,631 )             17,678                                     Net decrease in cash     (3,249 )     -               (3,249 ) Cash and cash equivalents, beginning of period     5,308       -               5,308   Cash and cash equivalents, end of period   $ 2,059     $ -             $ 2,059         Year Ended December 31, 2022       As Previously           Description of           Reported     Adjustments     Adjustments     As restated   Cash flows from operating activities:                         Net loss   $ (38,594 )     12,616               (25,978 ) Adjustments to reconcile net loss to net cash from operations                                 Depreciation and amortization     3,433       (1,570 )     (1 )     1,863   Amortization of issuance costs     -       547       (3 )     547   Change in fair value of warrant liabilities     -       (3,392 )     (1 )     (3,392 ) Other recognized losses (gains)     -       78       (7 )     78   Stock-based compensation expense     17,761       (8,438 )     (2 )     9,323   Stock-based compensation expense for services     -       2,350       (2 )     2,350   Changes in operating assets and liabilities                                 Accounts receivable     (13 )     -               (13 ) Prepaid expenses and other current assets     92       (237 )     (7 )     (145 ) Other non-current assets     (1,128 )     (86 )     (7 )     (1,214 ) Accounts payable     219       -               219   Accrued expenses and other current liabilities     (462 )     143       (2)(7 )     (319 ) Other long-term liabilities     1,451       (148 )     (7 )     1,303   Net cash used in operating activities     (17,241 )     1,863               (15,378 )                                   Cash flows from investing activities:                                 Purchase of property and equipment     (870 )     -               (870 ) Net cash used for QPhoton, Inc. Merger     (1,356 )     -               (1,356 ) Net cash used in investing activities     (2,226 )     -               (2,226 )                                   Cash flows from financing activities:                                 Proceeds raised from financial liabilities, net of issuance costs     8,036       (1,076 )     (3 )     6,960   Series A Preferred dividend payments     -       (787 )     (6 )     (787 ) Net cash provided by financing activities     8,036       (1,863 )             6,173                                     Net decrease in cash     (11,431 )     -               (11,431 ) Cash and cash equivalents, beginning of period     16,739       -               16,739   Cash and cash equivalents, end of period   $ 5,308     $ -             $ 5,308

Business Combinations (Tables)	12 Months Ended
	Dec. 31, 2023
Business Combinations [Abstract]
Schedule of Adjusted Acquisition Date Fair Values of Assets Acquired and Liabilities Assumed By the Company	The following table summarizes the purchase price paid and adjusted acquisition date fair values of assets acquired and liabilities assumed by the Company, including the final results of the analysis performed by the Third-Party Valuation Expert for the intangibles (in thousands): Purchase price       Common stock   $ 13,171   Series B convertible preferred     53,959   Contingently issuable warrants     3,920   Purchase price     71,050   Less: cash acquired     (1,144 ) Purchase price, net of cash acquired     69,906   Less:         Prepaid expenses     16   Property and equipment at cost     116   Security deposits     98   Non-compete agreement with founder     3,251   Trade names and trademarks     1,009   Developed Technology and licensed patents     12,731   Accounts payable and other current liabilities     (2,888 ) Goodwill   $ 55,573

Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2023
Intangible Assets and Goodwill [Abstract]
Schedule of Amounts Related to Intangible Assets	As a result of the merger with QPhoton, the Company has the following amounts related to intangible assets (in thousands):     December 31, 2023     December 31, 2022       Gross Carrying Amount     Accumulated Amortization     Net Carrying Amount     Gross Carrying Amount     Accumulated Amortization     Net Carrying Amount   Non-compete agreement with founder   $ 3,251     $ (1,716 )   $ 1,535     $ 3,251     $         (632 )   $ 2,619   Website domain name and trademark     1,009       (320 )     689       1,009       (118 )     891   Technology and licensed patents     12,731       (2,880 )     9,851       12,731       (1,061 )     11,670   Total   $ 16,991     $ (4,915 )   $ 12,076     $ 16,991     $ (1,811 )   $ 15,180
Schedule of Future Amortization Expense	The Company expects future amortization expense to be the following (in thousands):     Amortization   2024   $ 3,104   2025     2,472   2026     2,021   2027     1,903   2028     1,819   Thereafter     757   Total   $ 12,076
Schedule of Changes in Goodwill	The following table provides a summary of the changes in goodwill for the years ended December 31, 2023 and 2022 (in thousands):     December 31,       2023     2022   Goodwill, at beginning of year   $ 55,573     $ -   Goodwill additions     -       55,573   Goodwill, at end of year   $ 55,573     $ 55,573

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2023
Property and Equipment [Abstract]
Schedule of Long-Lived Tangible Assets	The Company’s property and equipment are primarily located at the Company’s leased facilities in Hoboken, NJ and Tempe, AZ and consist of (in thousands):     December 31,   Classification   2023     2022   Computer and lab equipment   $ 2,999     $ 985   Network equipment     29       12   Furniture and fixtures     32       28   Software     49       19   Leasehold improvements     33       3   Total cost of property and equipment     3,142       1,046   Accumulated depreciation     272       71   Property and equipment, net   $ 2,870     $ 975   The Company recorded depreciation expense of $203 thousand and $52 thousand during the years ended December 31, 2023 and 2022, respectively, using useful lives of the Company’s long-lived assets are as follows:     Estimated Useful Life (Years)   Computer and laboratory equipment   5   Network equipment   4   Furniture and fixtures   7   Software   3   Leasehold improvements   Lessor of lease term or 5

Financial Liabilities (Tables)	12 Months Ended
	Dec. 31, 2023
Financial Liabilities [Abstract]
Schedule of Amounts Related to Financial Liabilities	The Company has the following amounts related to financial liabilities (in thousands):     December 31,       2023     2022   Remaining loan balances   $ 2,063     $ 8,250   Remaining unamortized debt issuance costs     (138 )     (1,062 ) Financial liabilities, net   $ 1,925     $ 7,188

Capital Stock (Tables)	12 Months Ended
	Dec. 31, 2023
Capital Stock [Abstract]
Schedule of Warrants Outstanding	The table below summarizes the warrants outstanding as of December 31, 2023 (in thousands, except exercise prices): Issuance Date   Expiration Date   Exercise Price     Issued     Exercised     Forfeited / Canceled     Warrants Outstanding   August 18, 2020   August 18, 2025   $ 2.00       171       (150 )     -       21   November 15, 2021   November 15, 2023   $ 7.00       1,545               (1,545 )     -   June 16, 2022   May 9, 2027   $ 0.0001       6,325       -       (3,309 )     3,016

Stock-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2023
Stock-Based Compensation [Abstract]
Schedule of Grant-Date Fair Value of Stock Options Granted	The following table presents the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted:     Year Ended       December 31,       2023     2022   Exercise price     $0.85 – 1.84       $1.67 – 2.61   Risk-free interest rate     4.7 – 5.0%       0.6 – 4.5%   Expected volatility     98 – 137%       127 – 164%   Expected dividend yield     0%       0%   Expected life of options (in years)     5.0       5.0
Schedule of Option Activity	The following table summarizes the Company’s option activity: Weighted Average Number of Shares (in thousands)   Weighted Average Exercise Price     Contractual Term (in years)   Outstanding as of December 31, 2021                   As previously reported     5,197     $ 7.68       2.5   Adjustments (1)     (1,100 )     (2.45 )     1.4   As restated     4,097       5.23       3.9   Granted     6,853       1.38       5.0   Forfeited     (1,785 )     3.17       -   Outstanding as of December 31, 2022     9,165       3.51       4.2   Granted     5,340       1.38       5.0   Forfeited     (662 )     4.41       -   Outstanding as of December 31, 2023     13,843     $ 2.64       3.7                             Vested as of December 31, 2022     6,413     $ 3.58       4.2   Vested as of December 31, 2023     8,803     $ 3.21       3.4
Schedule of Exercise Price Range	The following table summarizes the exercise price range as of December 31, 2023 (in thousands): Exercise Price     Outstanding Options     Exercisable Options   $ 0.00 – 1.00        180        10   $ 1.00 – 2.00        5,695        1,935   $ 2.00 – 3.00        6,359        5,318   $ 3.00 – 5.00        65        65   $ 5.00 – 7.00        726        713   $ 7.00 – 12.00        818        762             13,843       8,803
Schedule of Stock-Based Compensation Expense Related to Common Stock Options and Restricted Shares of Common Stock	The Company recognized stock-based compensation expense related to common stock options and restricted shares of common stock in the following expense categories of its consolidated statements of operations (in thousands):     Year Ended December 31,       2023     2022   Research and development     2,080       509   Selling and marketing     (279 )     494   General and administrative     2,470       8,320   Total stock-based compensation   $ 4,271     $ 9,323

Operating Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Operating Leases [Abstract]
Schedule of Undiscounted Future Minimum Lease Payments under these Operating Lease	The table below reconciles the undiscounted future minimum lease payments under these operating leases to the total operating lease liabilities recognized on the consolidate balance sheet as of December 31, 2023 (in thousands): Year   Lease Payments Due   2024   $ 383   2025     576   2026     592   2027     516   2028     191   Total minimum payments     2,258   Less: imputed Interest     (1,298 ) Present value of operating lease liabilities     960   Less: current portion included in other current liabilities     (120 ) Long-term operating lease liabilities     840
Schedule of Other Information Related to Operating Lease Liabilities	Other information related to operating lease liabilities consists of the following:     Year Ended December 31,       2023     2022                 Cash paid for operating lease liabilities (in thousands)   $ 411     $ 125   Weighted average remaining lease term in years     3.7       4.7   Weighted average discount rate     10 %     10 %

Nature of the Organization and Business (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Jul. 20, 2018
Nature of the Organization and Business [Line Items]
Entity Incorporation, Date of Incorporation		Jul. 25, 2001
Common stock, par value (in Dollars per share)	[1]	$ 0.0001	$ 0.0001
Cash and cash equivalents		$ 2,100
Accumulated deficit	[1]	(131,940)	$ (104,057)
Working capital deficit		$ 2,200
Corporate History [Member]
Nature of the Organization and Business [Line Items]
Common stock, par value (in Dollars per share)				$ 0.0001
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Significant Accounting Policies (Details) - USD ($) $ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Significant Accounting Policies [Line Items]
Initial term		12 months
Value of assets		$ 793
Carrying value	[1]		$ 528
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Significant Accounting Policies (Details) - Schedule of Basic and Diluted Loss per Share - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Numerator:
Net loss	[1]	$ (27,022)	$ (25,978)
Less: Series A convertible preferred stock dividends		861	889
Net loss available to common stockholders – basic	[1]	$ (27,883)	$ (26,867)
Denominator:
Weighted average shares used in computing net loss per common share – basic (in Shares)	[1]	66,611	36,680
Loss per share - basic (in Dollars per share)	[1]	$ (0.42)	$ (0.73)
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Significant Accounting Policies (Details) - Schedule of Basic and Diluted Loss per Share (Parentheticals) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Schedule of Basic and Diluted Loss per Share [Abstract]
Net loss available to common stockholders – diluted		$ (27,883)	$ (26,867)
Weighted average shares used in computing net loss per common share – diluted	[1]	66,611	36,680
Loss per share - diluted	[1]	$ (0.42)	$ (0.73)
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Significant Accounting Policies (Details) - Schedule of Securities Outstanding - shares shares in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Securities Outstanding [Line Items]
Total potentially dilutive shares	19,525	10,778
Warrants [Member]
Schedule of Securities Outstanding [Line Items]
Total potentially dilutive shares	6,053	3,976
Options [Member]
Schedule of Securities Outstanding [Line Items]
Total potentially dilutive shares	12,280	6,830
Unvested restricted common stock [Member]
Schedule of Securities Outstanding [Line Items]
Total potentially dilutive shares	1,192

Restatement of Previously Issued Financial Statements (Details) - Schedule of Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
Current assets
Cash and cash equivalents	[1]	$ 2,059		$ 5,308
Accounts receivable		65		13
Inventory	[1]	73
Loans receivable, net of provision for credit losses		279
Prepaid expenses and other current assets		180		129
Total current assets	[1]	2,656		5,450
Property and equipment, net	[1]	2,870		975
Operating lease right-of-use assets	[1]	1,051		1,273
Intangible Assets, net	[1]	12,076		15,180
Goodwill		55,573	[1]	55,573	[1]
Other non-current assets	[1]	129		60
Total assets	[1]	74,355		78,511
Current liabilities
Accounts payable	[1]	1,462		872
Accrued expenses	[1]	639		2,961
Financial liabilities, current
Financial liabilities, current, net of issuance costs		1,925
Other current liabilities		786		760
Total current liabilities	[1]	4,812		4,593
Financial liabilities, net of issuance costs				7,188
Warrant liability		3,920		528
Operating lease liabilities	[1]	840		1,078
Total liabilities	[1]	5,652		13,387
Stockholders’ equity
Preferred stock	[1]
Common stock	[1]	8		6
Additional paid-in capital	[1]	200,635		169,175
Accumulated deficit	[1]	(131,940)		(104,057)
Total stockholders’ equity		68,703	[1]	65,124	[1]	15,022
Total liabilities and stockholders’ equity	[1]	74,355		78,511
As Previously Reported [Member]
Current assets
Cash and cash equivalents		2,059		5,308
Accounts receivable		65		13
Inventory		73
Loans receivable, net of provision for credit losses		557
Prepaid expenses and other current assets		427		408
Total current assets		3,181		5,729
Property and equipment, net		2,870		975
Operating lease right-of-use assets		800		1,187
Intangible Assets, net		11,388		22,224
Goodwill		60,360		59,126
Other non-current assets		129		60
Total assets		78,728		89,301
Current liabilities
Accounts payable		1,462		872
Accrued expenses		411		3,780
Financial liabilities, current				536
Financial liabilities, current, net of issuance costs		2,496
Other current liabilities		250		132
Total current liabilities		4,619		5,320
Financial liabilities, net of issuance costs				7,858
Warrant liability
Operating lease liabilities		840		1,226
Total liabilities		5,459		14,404
Stockholders’ equity
Preferred stock
Common stock		8		6
Additional paid-in capital		222,980		194,879
Accumulated deficit		(149,719)		(119,988)
Total stockholders’ equity		73,269		74,897		16,202
Total liabilities and stockholders’ equity		78,728		89,301
Adjustments [Member]
Current assets
Cash and cash equivalents
Accounts receivable
Inventory
Loans receivable, net of provision for credit losses	[2]	(278)
Prepaid expenses and other current assets	[3]	(247)		(279)
Total current assets		(525)		(279)
Property and equipment, net
Operating lease right-of-use assets	[3]	251		86
Intangible Assets, net	[4]	688		(7,044)
Goodwill	[4]	(4,787)		(3,553)
Other non-current assets
Total assets		(4,373)		(10,790)
Current liabilities
Accounts payable
Accrued expenses	[5],[6]	228		(819)
Financial liabilities, current	[3]			(536)
Financial liabilities, current, net of issuance costs	[7]	(571)
Other current liabilities	[3]	536		628	[8]
Total current liabilities		193		(727)
Financial liabilities, net of issuance costs	[7]			(670)
Warrant liability	[4]			528
Operating lease liabilities				(148)	[3]
Total liabilities		193		(1,017)
Stockholders’ equity
Preferred stock
Common stock
Additional paid-in capital		(22,345)		(25,704)
Accumulated deficit		17,779		15,931
Total stockholders’ equity		(4,566)		(9,773)		$ (1,180)	[9]
Total liabilities and stockholders’ equity		$ (4,373)		$ (10,790)
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements. [2] Uncollectable reserve – We identified a reserve for collection risk related to notes receivable. [3] Other - We corrected certain classifications, previously identified errors and out of period adjustments that were deemed immaterial to the annual or interim period in which they were recorded and restated prior periods to reflect these corrections in the appropriate periods. [4] QPhoton purchase accounting – We adjusted the final purchase price accounting for identifiable intangibles and the value attributable to the QPhoton Warrants, as defined below, including associated mark-to-market quarterly adjustments. [5] Accrued Expenses – We identified and corrected errors to record liabilities for performance-based bonus expenditures and state franchise fees to reflect the expenses in the appropriate period. [6] Stock-based compensation – We adjusted expenses and prior period retained earnings to reflect the change in our accounting policy election to account for forfeitures as they occur, as well as to refine assumptions used in calculating the fair value. We also ensured all such expenditures were accrued and accounted for in the appropriate periods based on vesting schedules and underlying agreements. [7] Debt issuance costs – We corrected errors to appropriately accrete issuance costs for the Streeterville Unsecured Note, as defined below, over the life of the loan. [8] Financing Expenditures – We corrected the presentation of Series A Preferred Stock dividends and ATM proceeds. [9] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Restatement of Previously Issued Financial Statements (Details) - Schedule of Consolidated Statements of Operations - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Schedule of Consolidated Statements of Operations [Line Items]
Total revenue	[1]	$ 358	$ 136
Cost of revenue	[1]	196	61
Gross profit	[1]	162	75
Operating expenses	[1]	26,405	28,720
Loss from operations	[1]	(26,243)	(28,645)
Non-operating income (expense)
Interest and other income		295	47
Interest expense, net		(1,602)	(772)
Change in value of warrant liability	[1]	528	3,392
Loss before income tax provision	[1]	(27,022)	(25,978)
Income tax provision	[1]
Net loss	[1]	(27,022)	(25,978)
Less: Series A convertible preferred stock dividends		(861)	(889)
Net loss available to common stockholders	[1]	$ (27,883)	$ (26,867)
Loss per share – basic (in Dollars per share)	[1]	$ (0.42)	$ (0.73)
Weighted average shares used in computing net loss per common share – basic (in Shares)	[1]	66,611	36,680
As Previously Reported [Member]
Schedule of Consolidated Statements of Operations [Line Items]
Total revenue		$ 358	$ 136
Cost of revenue		196	61
Gross profit		162	75
Operating expenses		27,384	36,654
Loss from operations		(27,222)	(36,579)
Non-operating income (expense)
Interest and other income		295	47
Interest expense, net		(2,804)	(2,062)
Change in value of warrant liability
Loss before income tax provision		(29,731)	(38,594)
Income tax provision
Net loss		(29,731)	(38,594)
Less: Series A convertible preferred stock dividends
Net loss available to common stockholders		$ (29,731)	$ (38,594)
Loss per share – basic (in Dollars per share)		$ (0.38)	$ (0.69)
Weighted average shares used in computing net loss per common share – basic (in Shares)		77,451	55,963
Adjustments [Member]
Schedule of Consolidated Statements of Operations [Line Items]
Total revenue
Cost of revenue
Gross profit
Operating expenses	[2],[3]	(979)	(7,934)
Loss from operations		979	7,934
Non-operating income (expense)
Interest and other income
Interest expense, net	[4],[5]	1,202	1,290
Change in value of warrant liability	[6]	528	3,392
Loss before income tax provision		2,709	12,616
Income tax provision
Net loss		2,709	12,616
Less: Series A convertible preferred stock dividends	[5]	(861)	(889)
Net loss available to common stockholders		$ 1,848	$ 11,727
Loss per share – basic (in Dollars per share)		$ (0.04)	$ (0.04)
Weighted average shares used in computing net loss per common share – basic (in Shares)		(10,840)	(19,283)
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements. [2] Accrued Expenses – We identified and corrected errors to record liabilities for performance-based bonus expenditures and state franchise fees to reflect the expenses in the appropriate period. [3] Stock-based compensation – We adjusted expenses and prior period retained earnings to reflect the change in our accounting policy election to account for forfeitures as they occur, as well as to refine assumptions used in calculating the fair value. We also ensured all such expenditures were accrued and accounted for in the appropriate periods based on vesting schedules and underlying agreements. [4] Debt issuance costs – We corrected errors to appropriately accrete issuance costs for the Streeterville Unsecured Note, as defined below, over the life of the loan. [5] Financing Expenditures – We corrected the presentation of Series A Preferred Stock dividends and ATM proceeds. [6] QPhoton purchase accounting – We adjusted the final purchase price accounting for identifiable intangibles and the value attributable to the QPhoton Warrants, as defined below, including associated mark-to-market quarterly adjustments.

Restatement of Previously Issued Financial Statements (Details) - Schedule of Consolidated Statements of Operations (Parentheticals) - $ / shares shares in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Schedule of Consolidated Statements of Operations [Line Items]
Loss per share – diluted	[1]	$ (0.42)	$ (0.73)
Weighted average shares used in computing net loss per common share – dilutive	[1]	66,611	36,680
As Previously Reported [Member]
Schedule of Consolidated Statements of Operations [Line Items]
Loss per share – diluted		$ (0.38)	$ (0.69)
Weighted average shares used in computing net loss per common share – dilutive		77,451	55,963
Adjustments [Member]
Schedule of Consolidated Statements of Operations [Line Items]
Loss per share – diluted		$ (0.04)	$ (0.04)
Weighted average shares used in computing net loss per common share – dilutive		(10,840)	(19,283)
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Restatement of Previously Issued Financial Statements (Details) - Schedule of Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022
Cash flows from operating activities:
Net loss	[1]	$ (27,022)		$ (25,978)
Adjustments to reconcile net loss to net cash from operations
Depreciation and intangibles amortization	[2]	3,307		1,863
Amortization of issuance costs	[2]	925		547
Change in fair value of warrant liabilities	[1]	(528)		(3,392)
Provision for credit losses	[2]	279
Other recognized losses (gains)	[2]	5		78
Stock-based compensation expense	[2]	4,271		9,323
Stock-based compensation expense for services		284		2,350
Changes in operating assets and liabilities
Accounts receivable	[2]	(52)		(13)
Inventory	[2]	(70)
Prepaid expenses and other current assets	[2]	(110)		(145)
Other non-current assets	[2]	153		(1,214)
Accounts payable	[2]	596		219
Accrued expenses and other current liabilities				(319)
Accrued expenses and other current liabilities		110
Other long-term liabilities	[2]	(463)		1,303
Net cash used in operating activities	[2]	(18,315)		(15,378)
Cash flows from investing activities:
Purchase of property and equipment	[2]	(2,112)		(870)
Net cash used for QPhoton, Inc. Merger	[2]			(1,356)
Issuance of loan receivable	[2]	(500)
Net cash used in investing activities	[2]	(2,612)		(2,226)
Cash flows from financing activities:
Proceeds raised from financial liabilities, net of issuance costs		(6,187)		6,960
Series A Preferred dividend payments		(865)		(787)
Proceeds from stock issuance related to ATM facility	[2]	24,730
Net cash provided by financing activities	[2]	17,678		6,173
Net decrease in cash	[2]	(3,249)		(11,431)
Cash and cash equivalents, beginning of period	[2]	5,308		16,739
Cash and cash equivalents, end of period	[2]	2,059		5,308
As Previously Reported [Member]
Cash flows from operating activities:
Net loss		(29,731)		(38,594)
Adjustments to reconcile net loss to net cash from operations
Depreciation and intangibles amortization		1,958		3,433
Amortization of issuance costs
Change in fair value of warrant liabilities
Provision for credit losses
Other recognized losses (gains)		4
Stock-based compensation expense		8,723		17,761
Stock-based compensation expense for services
Changes in operating assets and liabilities
Accounts receivable		(52)		(13)
Inventory		(70)
Prepaid expenses and other current assets		(78)		92
Other non-current assets		318		(1,128)
Accounts payable		583		219
Accrued expenses and other current liabilities				(462)
Accrued expenses and other current liabilities		(985)
Other long-term liabilities		(611)		1,451
Net cash used in operating activities		(19,941)		(17,241)
Cash flows from investing activities:
Purchase of property and equipment		(2,118)		(870)
Net cash used for QPhoton, Inc. Merger				(1,356)
Issuance of loan receivable		(500)
Net cash used in investing activities		(2,618)		(2,226)
Cash flows from financing activities:
Proceeds raised from financial liabilities, net of issuance costs		(6,187)		8,036
Series A Preferred dividend payments
Proceeds from stock issuance related to ATM facility		25,496
Net cash provided by financing activities		19,309		8,036
Net decrease in cash		(3,249)		(11,431)
Cash and cash equivalents, beginning of period		5,308		16,739
Cash and cash equivalents, end of period		2,059		5,308
Adjustments [Member]
Cash flows from operating activities:
Net loss		2,709		12,616
Adjustments to reconcile net loss to net cash from operations
Depreciation and intangibles amortization	[3]	1,349		(1,570)
Amortization of issuance costs	[4]	925		547
Change in fair value of warrant liabilities	[3]	(528)		(3,392)
Provision for credit losses	[5]	279
Other recognized losses (gains)	[6]	1		78
Stock-based compensation expense	[7]	(4,452)		(8,438)
Stock-based compensation expense for services	[7]	284		2,350
Changes in operating assets and liabilities
Accounts receivable
Inventory
Prepaid expenses and other current assets	[6]	(32)		(237)
Other non-current assets	[6]	(165)		(86)
Accounts payable		13
Accrued expenses and other current liabilities	[6],[7]			143
Accrued expenses and other current liabilities	[6],[7]	1,095
Other long-term liabilities	[6]	148		(148)
Net cash used in operating activities		1,626		1,863
Cash flows from investing activities:
Purchase of property and equipment		(6)	[6]
Net cash used for QPhoton, Inc. Merger
Issuance of loan receivable
Net cash used in investing activities		(6)
Cash flows from financing activities:
Proceeds raised from financial liabilities, net of issuance costs				(1,076)	[4]
Series A Preferred dividend payments		(865)	[8]	(787)
Proceeds from stock issuance related to ATM facility	[8]	(766)
Net cash provided by financing activities		(1,631)		(1,863)
Net decrease in cash
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements. [2] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements. [3] QPhoton purchase accounting – We adjusted the final purchase price accounting for identifiable intangibles and the value attributable to the QPhoton Warrants, as defined below, including associated mark-to-market quarterly adjustments. [4] Debt issuance costs – We corrected errors to appropriately accrete issuance costs for the Streeterville Unsecured Note, as defined below, over the life of the loan. [5] Uncollectable reserve – We identified a reserve for collection risk related to notes receivable. [6] Other - We corrected certain classifications, previously identified errors and out of period adjustments that were deemed immaterial to the annual or interim period in which they were recorded and restated prior periods to reflect these corrections in the appropriate periods. [7] Stock-based compensation – We adjusted expenses and prior period retained earnings to reflect the change in our accounting policy election to account for forfeitures as they occur, as well as to refine assumptions used in calculating the fair value. We also ensured all such expenditures were accrued and accounted for in the appropriate periods based on vesting schedules and underlying agreements. [8] Financing Expenditures – We corrected the presentation of Series A Preferred Stock dividends and ATM proceeds.

Business Combinations (Details) $ / shares in Units, $ in Thousands			12 Months Ended
		Apr. 01, 2022 USD ($)	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Jun. 06, 2023	Mar. 01, 2023	Jun. 16, 2022 $ / shares	Feb. 18, 2022 USD ($)
Business Combinations [Line Items]
Common stock par value (in Dollars per share) | $ / shares	[1]		$ 0.0001	$ 0.0001
Warrants purchased			7,028,337
Common stock, shares issued	[1]		77,451,000	55,963,000
Common stock shares QPhoton warrants			36,600,823
Net of cash acquired (in Dollars) | $	[2]			$ 1,356
Exercise price (in Dollars per share) | $ / shares			$ 2.27
Principal balance (in Dollars) | $		$ 1,250
Loans assumed (in Dollars) | $		$ 2,500
Percentage of interest rate		15.00%						6.00%
Extension year						1 year
Patented Technology [Member]
Business Combinations [Line Items]
Fair value of attributable to technology and licensed patents (in Dollars) | $			$ 12,700
Purchase Agreement [Member]
Business Combinations [Line Items]
Promissory note principal amount (in Dollars) | $								$ 1,250
Warrant [Member]
Business Combinations [Line Items]
Warrants purchased			7,028,337
Common stock shares QPhoton warrants			6,325,503	6,325,503
Maximum [Member]
Business Combinations [Line Items]
Stock conversion ratio			10
Percentage of interest rate					15.00%
Minimum [Member]
Business Combinations [Line Items]
Stock conversion ratio			1
Percentage of interest rate					10.00%
Non-Compete Agreement [Member]
Business Combinations [Line Items]
Fair value (in Dollars) | $			$ 3,250
Common Stock [Member]
Business Combinations [Line Items]
Share price (in Dollars per share) | $ / shares							$ 2.27
QPhoton [Member]
Business Combinations [Line Items]
Warrants purchased			1,726,931
Common stock shares QPhoton warrants			6,325,503
Converted shares			31,299,417
Fair value of attributable to trade name and trademark (in Dollars) | $			$ 1,000
Principal balance (in Dollars) | $								$ 1,250
Common Stock [Member]
Business Combinations [Line Items]
Common stock, shares issued			32,940,738	32,940,738
Common stock shares QPhoton warrants			26,615,235
Converted shares			36,600,823
Common Stock [Member] | Warrant [Member]
Business Combinations [Line Items]
Converted shares			7,028,337
Common Stock [Member] | Merger with QPhoton, Inc. [Member]
Business Combinations [Line Items]
Consideration of common shares			5,802,206
Common stock par value (in Dollars per share) | $ / shares			$ 0.0001
Common stock, shares issued			36,600,823
Series B Preferred Stock [Member]
Business Combinations [Line Items]
Converts shares			10
Purchase price approximately (in Dollars) | $			$ 71,000
Net of cash acquired (in Dollars) | $			$ 69,900
Converted shares			2,377,028
Series B Preferred Stock [Member] | Merger with QPhoton, Inc. [Member]
Business Combinations [Line Items]
Preferred stock shares issued			2,377,028
Preferred stock, par value (in Dollars per share) | $ / shares			$ 0.0001
Series B Preferred Stock [Member] | QPhoton [Member]
Business Combinations [Line Items]
Warrants purchased			1,726,931
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements. [2] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Business Combinations (Details) - Schedule of Adjusted Acquisition Date Fair Values of Assets Acquired and Liabilities Assumed By the Company - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Purchase price
Common stock	$ 13,171
Series B convertible preferred	53,959
Contingently issuable warrants	3,920	$ 528
Purchase price	71,050
Less: cash acquired	(1,144)
Purchase price, net of cash acquired	69,906
Less:
Prepaid expenses	16
Property and equipment at cost	116
Security deposits	98
Non-compete agreement with founder	3,251
Trade names and trademarks	1,009
Developed Technology and licensed patents	12,731
Accounts payable and other current liabilities	(2,888)
Goodwill	$ 55,573

Intangible Assets and Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Intangible Assets and Goodwill [Abstract]
Amortization expense of intangible assets	$ 3.1	$ 1.8
Goodwill	$ 55.6

Intangible Assets and Goodwill (Details) - Schedule of Amounts Related to Intangible Assets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Amounts Related to Intangible Assets [Line Items]
Gross Carrying Amount	$ 16,991	$ 16,991
Accumulated Amortization	(4,915)	(1,811)
Net Carrying Amount	12,076	15,180
Non-compete agreement with founder [Member]
Schedule of Amounts Related to Intangible Assets [Line Items]
Gross Carrying Amount	3,251	3,251
Accumulated Amortization	(1,716)	(632)
Net Carrying Amount	1,535	2,619
Website domain name and trademark [Member]
Schedule of Amounts Related to Intangible Assets [Line Items]
Gross Carrying Amount	1,009	1,009
Accumulated Amortization	(320)	(118)
Net Carrying Amount	689	891
Technology and licensed patents [Member]
Schedule of Amounts Related to Intangible Assets [Line Items]
Gross Carrying Amount	12,731	12,731
Accumulated Amortization	(2,880)	(1,061)
Net Carrying Amount	$ 9,851	$ 11,670

Intangible Assets and Goodwill (Details) - Schedule of Future Amortization Expense - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Future Amortization Expense [Abstract]
2024	$ 3,104
2025	2,472
2026	2,021
2027	1,903
2028	1,819
Thereafter	757
Total	$ 12,076	$ 15,180

Intangible Assets and Goodwill (Details) - Schedule of Changes in Goodwill - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022
Schedule of Changes in Goodwill [Abstract]
Goodwill, at beginning of year		$ 55,573	[1]
Goodwill additions				55,573
Goodwill, at end of year	[1]	$ 55,573		$ 55,573
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Line Items]
Federal income tax rate	21.00%
Taxable income			80.00%
Cumulative change percentage	50.00%
Tax-effected carryforwards	$ 13,000,000	$ 9,000,000
Carryforwards assumed tax rate	26.00%	26.00%
Net deferred tax assets	$ 11,000,000	$ 10,000,000
Capitalized research and development expenditures	2,000,000	$ 1,000,000
Intangible asset	1,000,000
Valuation allowance increased	6,000,000
Federal R&D credit carryforwards	250,000
Maximum [Member]
Income Taxes [Line Items]
Net operating loss carry forwards	$ 49,000,000

Property and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Property and Equipment [Abstract]
Depreciation expense	$ 203	$ 52

Property and Equipment (Details) - Schedule of Long-Lived Tangible Assets - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Accumulated depreciation		$ 272	$ 71
Property and equipment, net	[1]	2,870	975
Computer and Lab Equipment [Member]
Property, Plant and Equipment [Line Items]
Total cost of property and equipment		2,999	985
Network Equipment [Member]
Property, Plant and Equipment [Line Items]
Total cost of property and equipment		$ 29	12
Estimated Useful Life		4 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Total cost of property and equipment		$ 32	28
Estimated Useful Life		7 years
Software [Member]
Property, Plant and Equipment [Line Items]
Total cost of property and equipment		$ 49	19
Estimated Useful Life		3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Total cost of property and equipment		$ 33	3
Estimated Useful Life		Lessor of lease term or 5
l cost of property and equipment [Member]
Property, Plant and Equipment [Line Items]
Total cost of property and equipment		$ 3,142	$ 1,046
Computer and Laboratory Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life		5 years
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Financial Liabilities (Details) $ in Thousands		12 Months Ended
	Sep. 23, 2022 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Financial Liabilities (Details) [Line Items]
Accrued interest		$ 14	$ 223
Streeterville Capital, LLC [Member]
Financial Liabilities (Details) [Line Items]
Outstanding balance		1,900	$ 7,200
Unsecured Promissory Note [Member]
Financial Liabilities (Details) [Line Items]
Principal amount	$ 8,250
Interest percentage	10.00%
Maturity date	18 years
Original issue discount	$ 750
Outstanding balance percentage	120.00%
Redemption amount		750
Outstanding balance		$ 7,000
Trading days		7
Interest rate		15.00%

Financial Liabilities (Details) - Schedule of Amounts Related to Financial Liabilities - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Amounts Related to Financial Liabilities [Abstract]
Remaining loan balances	$ 2,063	$ 8,250
Remaining unamortized debt issuance costs	(138)	(1,062)
Financial liabilities, net	$ 1,925	$ 7,188

Contingencies (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Jun. 16, 2022	Jul. 09, 2021	Mar. 23, 2021	Mar. 01, 2021
Contingencies [Line Items]
Purchase of convertible promissory note	$ 501		$ 150	$ 150	$ 200
QPhoton [Member]
Contingencies [Line Items]
Cash proceeds	375
BV Advisory [Member]
Contingencies [Line Items]
Cash proceeds	$ 125
Cashier's check		$ 535,684
BV Notes [Member]
Contingencies [Line Items]
Percentage of interest	6.00%
Matured term	2 years

Loan Receivable (Details) - USD ($) $ in Thousands		Dec. 31, 2023	Jun. 06, 2023	May 16, 2023	Dec. 31, 2022	Apr. 01, 2022	Feb. 18, 2022
Loan Receivable [Line Items]
Principal amount			$ 2,000
Interest rate, percentage						15.00%	6.00%
Loans receivable, net of provision for credit losses	[1]	$ 279
millionways [Member]
Loan Receivable [Line Items]
Acquire, percentage				100.00%
Principal amount			$ 500
Loans receivable, net of provision for credit losses		$ 558
Minimum [Member]
Loan Receivable [Line Items]
Interest rate, percentage			10.00%
Maximum [Member]
Loan Receivable [Line Items]
Interest rate, percentage			15.00%
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Capital Stock (Details) - USD ($) $ / shares in Units, $ in Thousands							12 Months Ended
		Feb. 09, 2023	Jan. 19, 2023	Jun. 16, 2022	Jun. 13, 2022	Nov. 17, 2021	Dec. 31, 2023		Dec. 31, 2022		Sep. 03, 2024	Nov. 30, 2021	Aug. 31, 2020
Capital Stock [Line Items]
Purchase of warrants							7,028,337
Conversion price per share (in Dollars per share)							$ 5.5
Warrants term							2 years
Received net proceeds (in Dollars)									$ 6,960
Issued warrants shares				6,325,503
Exercise price per share (in Dollars per share)				$ 0.0001
Common stock shares QPhoton warrants							36,600,823
Forfeited percentage							52.00%
Recognized mark-to-market gains (in Dollars)	[1]						$ (528)		$ (3,392)
Warrant [Member]
Capital Stock [Line Items]
Purchase of warrants							7,028,337
Common stock shares QPhoton warrants							6,325,503		6,325,503
Restricted Stock Units (RSUs) [Member]
Capital Stock [Line Items]
Warrants term													5 years
Exercise price (in Dollars per share)													$ 2
Issuance of warrant													171,000
Series A Preferred Stock [Member]
Capital Stock [Line Items]
Purchased shares						1,545,459
Convertible Preferred stock, par value (in Dollars per share)						$ 0.0001	$ 0.0001	[2]	$ 0.0001	[2]
Aggregate purchase price (in Dollars)						$ 8,500
Preferred dividends percentage							10.00%
Warrants term												2 years
Exercise price (in Dollars per share)												$ 7
Authorized shares of preferred stock	[2]						1,550,000		1,550,000
Preferred stock shares issued	[2]						1,490,000		1,500,000
Preferred stock shares outstanding	[2]						1,490,000		1,500,000
Issuance of warrant												1,545,459
Series A Preferred Stock [Member] | Preferred Warrants [Member]
Capital Stock [Line Items]
Purchase of warrants						1,545,459
Series A Preferred Stock [Member] | Falcon Capital Partners [Member]
Capital Stock [Line Items]
Shares converted					45,455
Series A Preferred Stock [Member] | Greenfield Children, LLC, [Member]
Capital Stock [Line Items]
Shares converted		10,000
Accrued dividend shares		11,096
Common Stock [Member]
Capital Stock [Line Items]
Shares converted							36,600,823
Common stock shares QPhoton warrants							26,615,235
Common Stock [Member] | Warrant [Member]
Capital Stock [Line Items]
Exercise price (in Dollars per share)							$ 7
Shares converted							7,028,337
Common Stock [Member] | Falcon Capital Partners [Member]
Capital Stock [Line Items]
Shares converted					47,728
Series B Preferred Stock [Member]
Capital Stock [Line Items]
Shares converted							2,377,028
Authorized shares of preferred stock	[2]						3,080,000		3,080,000
Preferred stock shares issued	[2]
Preferred stock shares outstanding	[2]
Other Offerings [Member]
Capital Stock [Line Items]
Sale of stock units			17,571,926
Average price (in Dollars per share)			$ 1.45
Received net proceeds (in Dollars)			$ 24,700
Forecast [Member]
Capital Stock [Line Items]
Preferred stock shares issued											1,490,004
Preferred stock shares outstanding											1,490,004
Forecast [Member] | Series A Preferred Stock [Member]
Capital Stock [Line Items]
Convertible Preferred stock, par value (in Dollars per share)											$ 0.0001
Authorized shares of preferred stock											1,550,000
Preferred stock shares issued											993,306
Preferred stock shares outstanding											993,306
Forecast [Member] | Series B Preferred Stock [Member]
Capital Stock [Line Items]
Convertible Preferred stock, par value (in Dollars per share)											$ 0.0001
Authorized shares of preferred stock											3,079,864
Preferred stock shares issued											0
Preferred stock shares outstanding											0
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements. [2] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Capital Stock (Details) - Schedule of Warrants Outstanding - Warrant [Member]	12 Months Ended
	Dec. 31, 2023 $ / shares shares
August 18, 2020 [Member]
Class of Warrant or Right [Line Items]
Expiration Date	Aug. 18, 2025
Exercise Price (in Dollars per share) | $ / shares	$ 2
Issued	171,000
Exercised	(150,000)
Forfeited / Canceled
Warrants Outstanding	21
November 15, 2021 [Member]
Class of Warrant or Right [Line Items]
Expiration Date	Nov. 15, 2023
Exercise Price (in Dollars per share) | $ / shares	$ 7
Issued	1,545,000
Forfeited / Canceled	(1,545,000)
Warrants Outstanding
June 16, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiration Date	May 09, 2027
Exercise Price (in Dollars per share) | $ / shares	$ 0.0001
Issued	6,325,000
Exercised
Forfeited / Canceled	(3,309,000)
Warrants Outstanding	3,016

Stock-based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Jan. 01, 2023	Jul. 05, 2022
Stock-based Compensation [Line Items]
Shares of common stock				1,000,000	16,000,000
Weighted average grant-date fair value of stock options granted (in Dollars per share)		$ 1.38	$ 1.38
Common stock options (in Dollars)		$ 5,800
Recognized over a period		4 years
Stockholders’ equity (in Dollars)		$ 33	$ 170
Common stock shares issued	[1]	77,451,000	55,963,000
Canceled of shares		23,600
		20.00%
Stock-based compensation expense (in Dollars)		$ 1,100
Offerings expense (in Dollars)		2,100
Stock-based compensation for services (in Dollars)		$ 284	$ 2,400
Shares awarded consultant		2,300,000
Stock-based compensation for services [Member]
Stock-based Compensation [Line Items]
Common stock shares issued		157,000
QPhoton [Member]
Stock-based Compensation [Line Items]
Shares awarded consultant		750,000	2,300,000
Warrant [Member]
Stock-based Compensation [Line Items]
Exercisable term		20 years
Common Stock [Member]
Stock-based Compensation [Line Items]
Shares of common stock				17,000,000
Shares issued		17,572,000
Common stock shares issued		853,600
Canceled of shares			(11,000)
Options 2019 [Member]
Stock-based Compensation [Line Items]
Shares of common stock		3,000,000
Shares issued		3,000,000
Options 2022 [Member]
Stock-based Compensation [Line Items]
Shares of common stock		13,800,000
Incentive Plans and Options [Member]
Stock-based Compensation [Line Items]
Weighted average grant-date fair value of stock options granted (in Dollars per share)		$ 1.38	$ 2.39
Bonus Incentive Shares [Member]
Stock-based Compensation [Line Items]
Shares issued		2,353,600	20,000
Common stock shares issued		1,500,000
Carriage House Capital, Inc [Member]
Stock-based Compensation [Line Items]
Common stock shares issued		750,000
FMW Media Work [Member]
Stock-based Compensation [Line Items]
Common stock shares issued		75,000
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Stock-based Compensation (Details) - Schedule of Grant-Date Fair Value of Stock Options Granted - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Grant-Date Fair Value of Stock Options Granted [Line Items]
Expected dividend yield	0.00%	0.00%
Expected life of options (in years)	5 years	5 years
Minimum [Member]
Schedule of Grant-Date Fair Value of Stock Options Granted [Line Items]
Exercise price (in Dollars per share)	$ 0.85	$ 1.67
Risk-free interest rate	4.70%	0.60%
Expected volatility	98.00%	127.00%
Maximum [Member]
Schedule of Grant-Date Fair Value of Stock Options Granted [Line Items]
Exercise price (in Dollars per share)	$ 1.84	$ 2.61
Risk-free interest rate	5.00%	4.50%
Expected volatility	137.00%	164.00%

Stock-based Compensation (Details) - Schedule of Option Activity - $ / shares shares in Thousands		12 Months Ended
	Dec. 31, 2021	Dec. 31, 2023	Dec. 31, 2022
Schedule of Option Activity [Line Items]
Weighted Average Number of Shares, Outstanding Ending balance	4,097	13,843	9,165
Weighted Average Exercise Price, Outstanding Ending balance	$ 5.23	$ 2.64	$ 3.51
Contractual Term, Outstanding Ending balance	3 years 10 months 24 days	3 years 8 months 12 days	4 years 2 months 12 days
Weighted Average Number of Shares, Vested		8,803	6,413
Weighted Average Exercise Price, Vested		$ 3.21	$ 3.58
Contractual Term, Vested		3 years 4 months 24 days	4 years 2 months 12 days
Weighted Average Number of Shares, Granted		5,340	6,853
Weighted Average Exercise Price, Granted		$ 1.38	$ 1.38
Contractual Term, Granted		5 years	5 years
Weighted Average Number of Shares, Forfeited		(662)	(1,785)
Weighted Average Exercise Price, Forfeited		$ 4.41	$ 3.17
Contractual Term, Forfeited
As previously reported [Member]
Schedule of Option Activity [Line Items]
Weighted Average Number of Shares, Outstanding Ending balance	5,197
Weighted Average Exercise Price, Outstanding Ending balance	$ 7.68
Contractual Term, Outstanding Ending balance	2 years 6 months
Adjustments [Member]
Schedule of Option Activity [Line Items]
Weighted Average Number of Shares, Outstanding Ending balance	(1,100)
Weighted Average Exercise Price, Outstanding Ending balance	$ (2.45)
Contractual Term, Outstanding Ending balance	1 year 4 months 24 days

Stock-based Compensation (Details) - Schedule of Exercise Price Range shares in Thousands	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Schedule of Exercise Price Range [Line Items]
Outstanding Options	13,843
Exercisable Options	8,803
0.00 – 1.00 [Member]
Schedule of Exercise Price Range [Line Items]
Outstanding Options	180
Exercisable Options	10
1.00 – 2.00 [Member]
Schedule of Exercise Price Range [Line Items]
Outstanding Options	5,695
Exercisable Options	1,935
2.00 – 3.00 [Member]
Schedule of Exercise Price Range [Line Items]
Outstanding Options	6,359
Exercisable Options	5,318
3.00 – 5.00 [Member]
Schedule of Exercise Price Range [Line Items]
Outstanding Options	65
Exercisable Options	65
5.00 – 7.00 [Member]
Schedule of Exercise Price Range [Line Items]
Outstanding Options	726
Exercisable Options	713
7.00 – 12.00 [Member]
Schedule of Exercise Price Range [Line Items]
Outstanding Options	818
Exercisable Options	762
Minimum [Member] | 0.00 – 1.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	$ 0
Minimum [Member] | 1.00 – 2.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	1
Minimum [Member] | 2.00 – 3.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	2
Minimum [Member] | 3.00 – 5.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	3
Minimum [Member] | 5.00 – 7.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	5
Minimum [Member] | 7.00 – 12.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	7
Maximum [Member] | 0.00 – 1.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	1
Maximum [Member] | 1.00 – 2.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	2
Maximum [Member] | 2.00 – 3.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	3
Maximum [Member] | 3.00 – 5.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	5
Maximum [Member] | 5.00 – 7.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	7
Maximum [Member] | 7.00 – 12.00 [Member]
Schedule of Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares	$ 12

Stock-based Compensation (Details) - Schedule of Stock-Based Compensation Expense Related to Common Stock Options and Restricted Shares of Common Stock - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	[1]	$ 4,271	$ 9,323
Research and development [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation		2,080	509
Selling and marketing [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation		(279)	494
General and administrative [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation		$ 2,470	$ 8,320
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Operating Leases (Details) - Schedule of Undiscounted Future Minimum Lease Payments Under these Operating Lease - USD ($) $ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Schedule of Undiscounted Future Minimum Lease Payments under these Operating Lease [Abstract]
2024		$ 383
2025		576
2026		592
2027		516
2028		191
Total minimum payments		2,258
Less: imputed Interest		(1,298)
Present value of operating lease liabilities		960
Less: current portion included in other current liabilities		(120)
Long-term operating lease liabilities	[1]	$ 840	$ 1,078
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

Operating Leases (Details) - Schedule of Other Information Related to Operating Lease Liabilities - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Other Information Related to Operating Lease Liabilities [Abstract]
Cash paid for operating lease liabilities (in thousands)	$ 411	$ 125
Weighted average remaining lease term in years	3 years 8 months 12 days	4 years 8 months 12 days
Weighted average discount rate	10.00%	10.00%

License Agreement – Stevens Institute of Technology (Details)	12 Months Ended
	Dec. 31, 2023
License Agreement – Stevens Institute of Technology [Abstract]
Consideration agreement, description	As consideration for the license and other rights granted under the agreement, QPhoton agreed to pay the following: (i) $35 thousand within 30 days of execution of the agreement, (ii) $28 thousand within 30 days of each annual anniversary of the effective date, (iii) equity in the Company equivalent to nine percent of the membership units of the Company within 30 days of the execution of the agreement, and (iv) royalties of 3.5% of the Net Sales Price of each licensed product sold or licensed by the Company during the quarter then-ended, for which it also received payment, concurrent with the delivery of the relevant quarterly report.

Subsequent Events (Details) - USD ($)					2 Months Ended
		Sep. 03, 2024	Aug. 06, 2024	Mar. 19, 2024	Mar. 01, 2024	Dec. 31, 2023	Dec. 31, 2022
Subsequent Events [Line Items]
Paid a cash						$ 2,100,000
Subsequent Event [Member]
Subsequent Events [Line Items]
Cumulative redemption amount					$ 9,094,378
Purchase price				$ 8,195,000
Purchase price per share (in Dollars per share)				$ 5.5
Subsequent Event [Member] | Streeterville [Member]
Subsequent Events [Line Items]
Repaid of principal amount					2,094,378
Accrued interest					$ 2,094,378
Series A Preferred Stock [Member]
Subsequent Events [Line Items]
Preferred stock issued (in Shares)	[1]					1,490,000	1,500,000
Preferred stock outstanding (in Shares)	[1]					1,490,000	1,500,000
Forecast [Member]
Subsequent Events [Line Items]
Redeemed shares (in Shares)		496,698
Paid a cash		$ 2,700,000	$ 7,500,000
Preferred stock issued (in Shares)		1,490,004
Preferred stock outstanding (in Shares)		1,490,004
Received fee			450,000
Forecast [Member] | Streeterville [Member]
Subsequent Events [Line Items]
Principal amount			8,250,000
Original issue discount amount			$ 750,000
Interest rate			10.00%
Maturity date			18 years
Forecast [Member] | Series A Preferred Stock [Member]
Subsequent Events [Line Items]
Preferred stock issued (in Shares)		993,306
Preferred stock outstanding (in Shares)		993,306
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.

---